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Introduction: The development of chronic, low-grade systemic inflammation in the elderly 
(inflammaging) has been shown to increase the risk for chronic diseases and geriatric syndromes 
while it has been also associated with accelerated skeletal muscle wasting, strength loss and 
functional impairments. 
Aim: The aim of the present thesis was i) to examine whether anabolic signaling, activation of 
amino acid transporters, ribosome biogenesis and proteasome activity in the aged skeletal muscle 
are affected by low-grade systemic inflammation in the fasted state and following exercise and 
protein feeding, and ii) to investigate differences in habitual physical activity, dietary intake, 
physical performance and blood indices of oxidative stress and antioxidant status among elderly men 
with low and elevated low-grade systemic inflammation. 
Methods: Forty-four male adults aged 63-75 years who complied with the inclusion criteria were 
included in the study. Initially they were screened for systemic levels of hs-CRP and then had their 
anthropometric profile, body composition, sarcopenia status and functional performance assessed. 
Habitual physical activity and daily dietary intake were assessed over a 7-day period using 
accelerometry and diet recalls, respectively. Of these 44 individuals, 12 with high systemic 
inflammation (HSI: hs-CRP: > 1.0 mg/L) and 12 with low (LSI: hs-CRP: ≤ 1.0 mg/L) were included 
in the clinical trial. On the experimental day, participants performed 8 sets of 10 repetitions at 70% 
of 1RM on a knee-extension machine and immediately after they ingested a whey protein bolus. 
Muscle biopsy samples were collected before exercise (fasted state) and at 3h following protein 
ingestion. Blood samples were collected before exercise and every 30 minutes during the 3-hour 
postprandial period. 
Results: In the fasted state, HSI exhibited higher chymotrypsin-like activity, protein carbonyl 
concentration and phosphorylated IKKα/β, by 40%, 47% and 37%, respectively, as compared to LSI 
(P < 0.05). No differences were detected among groups in terms of trypsin-like activity, protein 
expression of the proteasome β-subunits, nuclei levels of Nrf2 and 3-nitrotyrosine levels. In addition, 
a significant correlation (P < 0.05) was observed between hs-CRP levels and chymotrypsin like 
activity. At 3h following protein ingestion, chymotrypsin-like activity increased in HSI and LSI by 
44% (P < 0.05) and 86% (P < 0.05), respectively (without group differences), while trypsin-like 
activity increased only LSI by 38% (P < 0.05). Protein carbonyls decreased in HSI by 31% (P < 
0.05) while Nrf2 increased only LSI by 28% (P < 0.05). Protein expression of β and βi proteasome 
subunits as well as 3-nitrotyrosine levels and phosphorylation of IKKα/β remained unaltered in the 
postprandial period in both groups. Moreover, rpS6 phosphorylation increased only in LSI at 3h 
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after protein ingestion (by 1.5 fold, P < 0.05) and the rise was significantly higher compared to that 
in HSI (P < 0.05). Protein expression of amino acid transporters and ribosome biogenesis indices 
demonstrated no changes in either group. In addition, at baseline LSI was more physically active 
than HSI performing more steps by 30% (P < 0.05) and spending more time in MVPA by 42% (P < 
0.05). Also, LSI demonstrated higher antioxidant vitamin intake (P < 0.05) that was accompanied 
by increased plasma antioxidant capacity (by 60%, P < 0.05), as compared to HSI. 
Conclusions: The results of the present thesis indicate that inflammaging is characterized by a 
pro-oxidative environment and increased proteasome activity in the fasted state, and by reduced 
translation efficiency following protein feeding. Moreover, higher physical activity level and 
increased antioxidant consumption on a daily basis are discriminant factors of inflammaging and 
healthy aging and therefore, may considered as crucial, lifestyle-based factors that may prevent the 
development of low-grade systemic inflammation.  
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Εισαγωγή: Η ανάπτυξη χρόνιας συστημικής φλεγμονής σε άτομα τρίτης ηλικίας (inflammaging), 
έχει δειχθεί ότι αυξάνει το κίνδυνο εμφάνισης χρόνιων ασθενειών και γηριατρικών συνδρόμων, ενώ 
έχει συσχετιστεί και με ταχύτερη απώλεια μυϊκής μάζας, δύναμης και λειτουργικής ικανότητας. 
Σκοπός: Σκοπός της παρούσας διδακτορικής διατριβής ήταν α) να εξετάσει εάν η διέγερση του 
αναβολικού σηματοδοτικού μονοπατιού, η ενεργοποίηση των μεταφορέων αμινοξέων, η 
ριβοσωμική βιογένεση και η ενεργότητα του πρωτεασώματος στο σκελετικό μυ ηλικιωμένων 
ατόμων επηρεάζονται από τη χρόνια συστημική φλεγμονή σε κατάσταση νηστείας καθώς και μετά 
από συνδυασμό άσκησης και κατανάλωσης πρωτεΐνης, και β) να διερευνήσει τις πιθανές διαφορές 
στα επίπεδα φυσικής δραστηριότητας, στη διατροφική πρόσληψη, στη φυσική απόδοση καθώς και 
σε δείκτες  οξειδωτικού στρες και αντιοξειδωτικής ικανότητας, μεταξύ ηλικιωμένων ανδρών με 
χαμηλή και υψηλή χρόνια συστημική φλεγμονή. 
Μεθοδολογία: 44 άνδρες εθελοντές ηλικίας 63-75 ετών οι οποίοι πληρούσαν τα κριτήρια 
συμμετοχής, συμπεριλήφθηκαν στη μελέτη. Αρχικά, υποβλήθηκαν σε αιμοληψία για τον 
προσδιορισμό των επιπέδων hs-CRP στην κυκλοφορία και στη συνέχεια υποβλήθηκαν σε 
αξιολόγηση του σωματικού ύψους και βάρους, της σύστασης σώματος, του επιπέδου σαρκοπενίας 
και της φυσικής απόδοσης. Επιπλέον αξιολογήθηκαν η φυσική δραστηριότητα και η διατροφική 
πρόσληψη για 7 συνεχόμενες ημέρες με χρήση επιταχυνσιομέτρων  και διατροφικών ημερολογίων, 
αντίστοιχα. Από τους 44 συμμετέχοντες, 12 με υψηλή χρόνια συστημική φλεγμονή (υψηλή ΧΣΦ: 
hs-CRP: > 1.0 mg/L) και 12 με χαμηλή  (χαμηλή ΧΣΦ: hs-CRP: ≤ 1.0 mg/L) έλαβαν μέρος στην 
κλινική δοκιμασία. Την ημέρα της κλινικής δοκιμασίας, οι συμμετέχοντες εκτέλεσαν 8 σετ των 10 
επαναλήψεων στο 70% της 1ΜΕ στο μηχάνημα εκτάσεις γονάτων και αμέσως μετά κατανάλωναν 
συμπλήρωμα πρωτεΐνης ορού γάλακτος, σε μία δόση. Δείγματα μυός (μυϊκές βιοψίες) συλλέχθηκαν 
πριν την άσκηση (σε κατάσταση νηστείας) καθώς και στις 3 ώρες μετά τη λήψη του συμπληρώματος 
πρωτεΐνης. Αιμοληψίες πραγματοποιήθηκαν πριν την άσκηση και κάθε 30 λεπτά για 3 ώρες μετά 
την κατανάλωση του συμπληρώματος πρωτεΐνης. 
Αποτελέσματα:  Στην κατάσταση νηστείας , η ομάδα υψηλής ΧΣΦ  παρουσίασε υψηλότερη 
ενεργότητα χυμοθρυψίνης, μεγαλύτερη συγκέντρωση πρωτεϊνικών καρβονυλίων και μεγαλύτερη 
ποσότητα φωσφορυλιωμένης κινάσης ΙΚΚα/β, κατά 40%, 47% και 37%, αντίστοιχα, σε σύγκριση 
με την ομάδα χαμηλής ΧΣΦ (P < 0.05). Δεν παρατηρήθηκαν διαφορές μεταξύ των δύο ομάδων όσον 
αφορά την ενεργότητα τρυψίνης, την έκφραση των β υπομονάδων του πρωτεασώματος και του 
ανοσοπρωτεασώματος, τα επίπεδα του Nrf2 στον πυρήνα καθώς και τα επίπεδα 3-νιτροτυροσίνης. 
Επίσης, σημαντική συσχέτιση εντοπίστηκε μεταξύ των επιπέδων hs-CRP και της ενεργότητας 
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χυμοθρυψίνης (P < 0.05) σε κατάσταση νηστείας. Στις 3 ώρες μετά την κατανάλωση του 
συμπληρώματος πρωτεΐνης, η ενεργότητα χυμοθρυψίνης αυξήθηκε σημαντικά και στις δυο ομάδες 
(υψηλή ΧΣΦ: +44%, χαμηλή ΧΣΦ: +86%, P < 0.05), χωρίς να διαφέρουν μεταξύ τους, ενώ η 
ενεργότητα της τρυψίνης αυξήθηκε μόνο στην ομάδα χαμηλής ΧΣΦ κατά 38% (P < 0.05). Η 
συγκέντρωση πρωτεϊνικών καρβονυλίων μειώθηκε κατά 31% στην ομάδα υψηλής ΧΣΦ (P < 0.05), 
ενώ τα επίπεδα του Nrf2 αυξήθηκαν σημαντικά μόνο την ομάδα χαμηλής ΧΣΦ (+28%, P < 0.05). 
Η έκφραση των β υπομονάδων του πρωτεασώματος και των αντίστοιχων βi του 
ανοσοπρωτεασώματος καθώς και τα επίπεδα 3-νιτροτυροσίνης και φωσφορυλιωμένης κινάσης 
ΙΚΚα/β παρέμειναν αμετάβλητα μετά την κατανάλωση της πρωτεΐνης. Επιπλέον, η φωσφορυλίωση 
της ριβοσωμικής πρωτεΐνης rpS6 αυξήθηκε σημαντικά στις 3 ώρες μετά τη λήψη του 
συμπληρώματος πρωτεΐνης μόνο στην ομάδα χαμηλής ΧΣΦ (+ 1.5 φορά, P < 0.05) και τα επίπεδά 
της διέφεραν σημαντικά από εκείνα της ομάδας υψηλής ΧΣΦ (P < 0.05). Η έκφραση των 
μεταφορέων αμινοξέων αλλά και η ενεργοποίηση δεικτών ριβοσωμικής βιογένεσης δεν 
παρουσίασαν σημαντικές μεταβολές σε καμία απ’ τις δυο ομάδες. Οι δυο ομάδες ωστόσο, διέφεραν 
σημαντικά μεταξύ τους όσον αφορά τα επίπεδα φυσικής δραστηριότητας, με την ομάδα χαμηλής 
ΧΣΦ να εκτελεί περισσότερα βήματα (+ 30%, P < 0.05) και να δαπανά περισσότερο χρόνο σε 
μέτρια-προς-υψηλής έντασης δραστηριότητες (+ 42%, P < 0.05) σε σύγκριση με την ομάδα υψηλής 
ΧΣΦ. Επίσης, η ομάδα χαμηλής ΧΣΦ παρουσίασε υψηλότερη πρόσληψη αντιοξειδωτικών 
βιταμινών σε σχέση με την ομάδα υψηλής ΧΣΦ (P < 0.05)η οποία συνοδευόταν και από υψηλότερη 
αντιοξειδωτική ικανότητα στο πλάσμα (+ 60%, P < 0.05). 
Συμπεράσματα: Τα αποτελέσματα της παρούσας διατριβής υποδεικνύουν ότι τα ηλικιωμένα 
άτομα με υψηλή ΧΣΦ χαρακτηρίζονται από αυξημένα επίπεδα οξειδωμένων πρωτεϊνών και 
αυξημένη ενεργοποίηση του πρωτεολυτικού μηχανισμού του πρωτεασώματος στο μυ, σε 
κατάσταση νηστείας, καθώς επίσης και από μειωμένη μεταφραστική δραστηριότητα στο ριβόσωμα, 
στη μεταγευματική περίοδο. Επιπλέον, μεγαλύτερα επίπεδα φυσικής δραστηριότητας σε ημερήσια 
βάση και μεγαλύτερη πρόσληψη αντιοξειδωτικών βιταμινών μέσω της διατροφής φαίνεται ότι 
διαφοροποιούν τα άτομα με χαμηλή και υψηλή ΧΣΦ, και επομένως θα πρέπει θεωρούνται 
καθοριστικοί παράγοντες για την υγεία στα άτομα τρίτης ηλικίας, οι οποίοι μπορούν να επιδράσουν 
ανασταλτικά στην εκδήλωση ΧΣΦ.  
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1.1 General Introduction 
1.1.1 Inflammaging 
Acute inflammation, is a fundamental and necessary response of the human immune system to 
harmful conditions such as infectious diseases and damaging agents, that in early life is beneficial 
and protective, ensuring survival [1]. On the other hand, the development of chronic inflammation, 
particularly in later life, has been associated with increased susceptibility to infectious diseases and 
age-related pathologies such as Alzheimer’s disease, atherosclerosis, diabetes (Type 2) and 
osteoporosis [2, 3] and thus can be detrimental. Indeed, aging is associated with low-grade chronic 
systemic inflammation, characterized by a 2- to 3-fold elevation in plasma levels of pro-
inflammatory cytokines and acute phase proteins, particularly that of interleukin-6 (IL-6), tumor 
necrosis factor-α (TNF-α), and C-reactive protein (CRP) [4, 5]. Since the beginning of 2000, when 
it was first introduced by Franceschi and his colleagues, the term “inflammaging” has been 
commonly adopted to describe this age-related chronic pro-inflammatory status [4]. In addition to 
IL-6, TNF-α and CRP, the pro-inflammatory cytokine interleukin-1 (IL-1) and the soluble receptors 
IL-1Ra, TNF receptor and soluble IL-6 receptor are also considered valuable markers of 
inflammaging being widely used for its identification [5-7]. According to many epidemiological and 
cross-sectional studies, inflammaging is associated with chronic diseases and geriatric syndromes 
such as cardiovascular diseases, atherosclerosis, metabolic syndrome, type 2 diabetes mellitus, 
neurodegenerative diseases, cancer, and chronic obstructive pulmonary disease [8-11] as well as 
with increased rate of frailty, morbidity, and mortality [1, 12, 13]. In addition, as indicated by large 
cohort studies increased levels of IL-6, TNF-α and CRP are good predictors of both physical and 
cognitive decline and the risk of mortality in the elderly [14, 15]. Therefore, being implicated in the 
pathogenesis of most age-related pathologies, inflammaging, represents a key determinant of 
successful aging and longevity and consequently a target perspective to counteract age-related 
pathologies. 
1.1.2 Pathogenesis of inflammaging 
Up to date, the underpinning mechanism that drives inflammaging remains unclear. Increasing 
amount of evidence suggests that inflammaging is a complex and multifactorial process, with 
different tissues, organs, and biological systems (i.e. muscle tissue, adipose tissue, liver, immune 
system, gut microbiota) contributing to its pathophysiology [16]. Thus, its origin cannot be simply 
attributed to a specific number of factors and mechanisms. However, it is believed that cumulative 
lifetime exposure to antigens as well as to chemical, physical, and nutritional stressors that the 
immune system has to cope with, in combination with the recent dramatic increase in life expectancy, 
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result in prolonged overstimulation of the immune system with advancing age and the propagation 
of inflammaging [1, 4]. 
This chronic stimulation of the immune system has been recognized to be triggered and sustained 
by a continuous interplay between oxidative stress and inflammation [17-20]. In fact, upon activation 
in response to pathogens, immune cells, and especially those of the innate immunity (i.e. neutrophils, 
macrophages and monocytes), release high amounts of reactive oxygen species (ROS) as part of 
their defensive action [20]. Although low levels of ROS are required for proper cell function and 
tissue homeostasis, overproduction of ROS in combination with the age-related reduction in 
antioxidant capacity, results in oxidative stress and oxidative damage of cell components such as 
DNA, proteins and lipids [18, 20]. ROS production though, not only triggers oxidative damage but 
also leads to pro-inflammatory cytokine production and promotes an inflammatory response through 
activation of the Toll-like-receptors (TLRs) and Nalp-3 inflammosome intracellular pathways [20] 
and stimulation of the redox-sensitive transcription factor NF-κB [19]. The consequent 
inflammatory response, characterized by increased cytokine secretion, elicits additional ROS 
production from immune cells (e.g., monocytes and macrophages) resulting in a vicious cycle that 
promotes a chronic pro-inflammatory phenotype [18] and provokes inflammaging. 
1.1.3 Inflammaging, skeletal muscle loss and functional impairment 
The concept of inflammaging has gained particular interest in the last few years, since beyond its 
strong association with chronic diseases and geriatric syndromes it has been also shown to be related 
with reduced skeletal muscle mass as well as with strength and physical performance impairments 
[21, 22]. Data form longitudinal studies provide compelling evidence that higher levels of 
inflammatory markers such IL-6, TNF-α and CRP are linked with greater risk of losing muscle mass 
[23], strength and physical function [24], though a cause-effect relationship remains to be 
established. In fact, data derived from 3075 older individuals (aged 70–79 years) in the Health, 
Aging, and Body Composition Study [25] indicate that those with elevated concentrations of IL-6 
and TNF-a exhibited smaller skeletal muscle area, less appendicular muscle mass, and reduced 
strength. In addition, a 5-year follow-up study examining >2000 elderly individuals (aged 70–79 
years) revealed that those with higher concentrations of TNF-α and its soluble receptor at baseline 
exhibited greater reductions in muscle mass and strength [26]. Likewise, raised IL-6 and CRP 
concentrations in the older adults have been related with a 2- to 3-fold greater risk of losing >40% 
of their muscle strength [27].  
In vivo and in vitro studies indicate that increased systemic inflammation may hamper the 
Akt/mTOR signaling pathway in skeletal muscle and attenuate the muscle’s anabolic potential 
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leading to ″anabolic resistance‶ [28-31] (Figure 1.1). In addition, elevated concentrations of pro-
inflammatory cytokines such as TNF-α and IL-6 induce activation of the NF-κB pathway and 
subsequent activation of the ubiquitin-proteasome system (UPS) resulting in protein degradation and 
skeletal muscle loss [32-36] (Figure 1.1). However, the verification of these mechanisms in the aged, 




Collectively, these data strongly suggest that inflammaging is associated with loss of skeletal 
muscle mass and function in the elderly and as such may predispose them to sarcopenia, significant 
functional limitations, frailty and hospitalization [22, 37]. The molecular mechanisms though, 
mediating the interaction between inflammaging, skeletal muscle loss and functional decline 
warrants further investigation. Moreover, the existing literature though, lacks a direct comparison of 
healthy elderly individuals characterized by low and elevated systemic inflammation in parameters 
related to strength and functional performance of the upper and lower body.  
1.1.4 Physical activity and dietary intake as potential regulators of inflammaging 
According to World Health Organization (WHO) physical activity (PA) is defined as any bodily 
movement produced by skeletal muscles (i.e. any form of recreational activities, walking, cycling, 
dancing, sports, activities around home etc.) and results in increased energy expenditure [38]. 
Regular participation in PA is strongly associated with health-related benefits and protects against 
Figure 1.1. Schematic representation of the proposed molecular mechanisms through which chronic 
inflammation may lead to loss of skeletal muscle mass. Green arrows indicate activation; Red arrows indicate 
deactivation. 
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cardiovascular [39, 40] and metabolic diseases [39, 41], cognitive impairment [42], mental health 
disorders [40, 43], obesity [39, 44], frailty [39, 45, 46], sarcopenia [47] and osteoporosis [40, 48]. 
Moreover, evidence form observational, cross-sectional studies indicates that habitual PA is 
associated with lower levels of inflammatory mediators such as IL-6, CRP, and TNF-α and reduced 
incidence of chronic low-grade systemic inflammation in older adults [23, 49-60]. Actually, there is 
evidence of an inverse relationship between PA and disease-related (i.e. chronic obstructive 
pulmonary disease and obesity) systemic inflammation in middle-aged adults [55, 56]. In addition, 
studies that objectively assessed daily PA in healthy older individuals have revealed that the time 
spent in moderate-to-vigorous PA is negatively associated with markers of systemic inflammation 
[23, 59], suggesting that the beneficial effect of PA on inflammatory status may be intensity-
dependent. However, observational studies are not designed to identify the underline mechanisms 
though which PA reduces inflammation, and thus, such an information is still missing. Furthermore, 
a direct comparison of objectively assessed daily PA, sedentary time and PA-related energy 
expenditure among healthy older individuals characterized by different inflammatory profile is still 
lacking. This comparison would shed light on the role of PA-related parameters (i.e. sedentary time, 
time in light, moderate and vigorous PA, total step count, energy expenditure) in the development 
of chronic low-grade systemic inflammation. 
Nutrition, including dietary pattern, is also a lifestyle factor that play a critical role in immune 
function and have the potential to modulate chronic inflammation [61-63] by inducing either a pro-
inflammatory or an anti-inflammatory effect [64]. For instance, high adherence to the Mediterranean 
diet which is mainly characterized by increased consumption of vegetables, fruit, legumes, whole-
nuts and fish has been inversely correlated with markers of systemic inflammation in healthy adults 
[65], while diets rich in fatty acids and glucose result in increased postprandial glycaemia and 
lipaemia and have been proposed to trigger chronic inflammation [66]. The interaction though 
between diet and inflammation is primarily mediated by the macronutrient and micronutrient profile 
[64]. There is substantial amount of evidence suggesting that glucose and saturated fatty acids when 
consumed in high doses may stimulate a chronic pro-inflammatory response in insulin-sensitive 
tissues [64, 67] and propagate chronic systemic inflammation [16]. On the other hand, increased 
polyunsaturated (PUFA) and monounsaturated (MUFA) fatty acid consumption has been reported 
to induce anti-inflammatory effects and protect against chronic inflammation and chronic 
inflammatory diseases [68]. Likewise, protein and amino acids derived from either plant- or dairy-
based protein sources are considered anti-inflammatory nutrients as they have been suggested to 
reduce local and systemic inflammation by reducing the production of inflammatory cytokines and 
ROS, and also by enhancing the activity of antioxidant enzymes [64, 69]. Further, there is also 
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evidence indicating that dietary antioxidants and trace elements such as vitamins A, C, E and 
selenium may improve immune function and prevent the onset of chronic inflammatory conditions 
[63]. However, there is no evidence regarding the differences in daily dietary intake among elderly 
individuals with low and elevated systemic inflammation. 
1.2 Thesis Objectives 
The primary objective of the present thesis was to investigate whether the development of 
chronic, low-grade systemic inflammation in the elderly i) accelerates muscle protein breakdown 
through proteasome activation and ii) induces anabolic resistance. Secondly, this thesis aimed at 
examining whether elderly individuals with low and elevated systemic inflammation differ among 
themselves in terms of i) habitual physical activity level, ii) dietary intake profile, iii) strength and 
iv) functional performance as well as in systemic levels of v) oxidative stress and vi) immune system 
markers. 
1.3 Research Design 
A total number of 50 male, older adults aged 63-75 years were initially recruited. Forty-four 
individuals that complied with the study criteria, were then screened for systemic levels of hs-CRP 
and had their anthropometric profile, body composition (with DXA), sarcopenia status (according 
to criteria established by the European Working Group on Sarcopenia in Older People, EWGSOP), 
functional capacity (based on the Short Physical Performance Battery, SPPB) and the knee-extension 
one repetition maximum (1RM) assessed. Moreover, individuals’ habitual physical activity level 
and daily dietary intake were also assessed using accelerometry (ActiGraph GT3X+, over a7-day 
period) and diet recalls (over a 7-day period), respectively. Of these 44 individuals, 12 with high 
systemic inflammation (hs-CRP: > 1.0 mg/L) and 12 with low (hs-CRP: ≤ 1.0 mg/L) were included 
in the clinical trial. In the experimental day (clinical trial), individuals arrived at the laboratory after 
an overnight fasted state and a baseline blood sample and a muscle biopsy from vastus lateralis 
muscle were collected. Immediately after, individuals performed 8 sets with 10 repetitions at 70% 
of 1RM and 2 min rest between each set, on a knee-extension machine. After exercise, they ingested 
0.4 g whey protein isolate/kg body weight, as a single bolus, and then they remained in a sitting 
position over a 3-hour period. Blood samples were collected every 30min during the 3-hour 
postprandial period while a second muscle biopsy was obtained at 3h (Figure 1.2). 
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Figure 1.2. Schematic representation of the clinical trial. Twenty-four subjects participated in the clinical trial, including an 
acute resistance exercise protocol and whey protein ingestion. Blood samples and muscle biopsies were collected in the fasted 
state before exercise as well as in the postprandial period.   
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Inflammaging and Skeletal Muscle: Can Protein Intake Make a Difference? 
Draganidis D, Karagounis LG, Athanailidis I, Chatzinikolaou A, Jamurtas AZ, Fatouros IG. 
Abstract 
Inflammaging is the chronic low-grade inflammatory state present in the elderly, characterized by 
increased systemic concentrations of proinflammatory cytokines. It has been shown that 
inflammaging increases the risk of pathologic conditions and age-related diseases, and that it also 
has been associated with increased skeletal muscle wasting, strength loss, and functional 
impairments. Experimental evidence suggests that the increased concentrations of proinflammatory 
cytokines and primary tumor necrosis factor a observed in chronic inflammation lead to protein 
degradation through proteasome activation and reduced skeletal muscle protein synthesis (MPS) via 
protein kinase B/Akt downregulation. Dairy and soy proteins contain all the essential amino acids, 
demonstrate sufficient absorption kinetics, and include other bioactive peptides that may offer 
nutritional benefits, in addition to those of stimulating MPS. Whey protein has antioxidative effects, 
primarily because of its ability to enhance the availability of reduced glutathione and the activity of 
the endogenous antioxidative enzyme system. Soy protein and isoflavone-enriched soy protein, 
meanwhile, may counteract chronic inflammation through regulation of the nuclear transcription 
factor kB signaling pathway and cytokine production. Although evidence suggests that whey protein, 
soy protein, and isoflavone enriched soy proteins may be promising nutritional interventions against 
the oxidative stress and chronic inflammation present in pathologic conditions and aging 
(inflammaging), there is a lack of information about the anabolic potential of dietary protein intake 
and protein supplementation in elderly people with increased systemic inflammation. The 
antioxidative and anti-inflammatory effects, as well as the anabolic potential of protein 
supplementation, should be further investigated in the future with well-designed clinical trials 
focusing on inflammaging and its associated skeletal muscle loss. 
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The progressive loss of skeletal muscle mass and function (i.e., muscle strength and endurance 
and ability to perform daily physical activities) with advancing age is a well-documented process 
[70-72] that may lead to functional limitations, frailty, and hospitalization [37, 73]. Muscle mass is 
maintained by a constant equilibrium between the rates of muscle protein synthesis (MPS) and 
degradation, in which a net increase or a decrease occurs when the balance is disturbed. Nutritional-
, hormonal-, neuropathic-, and inactivity-related factors all may contribute to deregulation of the 
molecular milieu of the aged muscle, resulting in muscle wasting and loss of independence [37]. In 
the elderly, the development of low-grade, chronic, systemic inflammation is often observed with 
age, characterized by a 2- to 3-fold elevation in circulating inflammatory mediators. This has been 
termed ‘‘inflammaging’’ (inflamm-aging) [5]. Proinflammatory cytokines are key components in 
this chronic inflammatory state; thus, the assessment of inflammaging primarily is based on the 
measurement of systemic concentrations of IL-6, IL-1, and TNF-a, their soluble receptors IL-1Ra, 
TNF receptor, and soluble IL-6 receptor, respectively, and that of the acute-phase C-reactive protein 
(CRP) [5-7]. Furthermore, inflammaging may be assessed at the skeletal muscle tissue level by the 
quantification of infiltrating macrophages, cytokine concentrations, and the examination of 
inflammatory pathways [6, 7]. Although the molecular mechanisms involved in the interaction 
between inflammaging and muscle loss is far from understood, research carried out in animal models 
revealed that augmented low-grade inflammation may favor muscle protein breakdown and inhibit 
protein synthesis [29, 74]. 
Although older adults exhibit anabolic resistance (i.e., a higher protein amount is required to 
maximally stimulate MPS than for young individuals) to protein intake, dietary protein is still the 
most potent anabolic stimulus in older adults, because it has been shown to efficiently activate the 
skeletal muscle anabolic response in the postprandial period, at rest, and after resistance exercise 
[75, 76]. A higher (>1.2 g/(kg body weight · d) compared with a lower (<1.0 g/(kg body weight · d) 
protein intake appears to preserve muscle quality in the aged with high levels of systemic 
inflammation [77], suggesting that adequate protein intake may preserve muscle function under 
chronic inflammatory conditions. Dairy proteins that include high amounts of branched-chain amino 
acids demonstrate fast (whey protein) and slow (casein) digestion and absorption kinetics and may 
efficiently stimulate MPS in healthy aged skeletal muscle [78-80]. Soy protein, on the other hand, 
which demonstrates somewhat slower kinetics than whey and faster digestion rates than casein [78], 
is also rich in branched-chain amino acids and able to upregulate MPS [78-80]. Whey and soy protein 
also possess antioxidant and anti-inflammatory properties [81, 82]. Thus, both animal and plant 
protein sources may represent efficient nutritional strategies to counteract inflammaging and its 
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detrimental effects on skeletal muscle. This review aims to provide evidence for an anti-
inflammatory and anticatabolic role of protein supplementation in aged skeletal muscle by 
presenting molecular and physiologic data that link protein consumption and muscle wasting under 
proinflammatory conditions. 
2.2. Inflammaging and its association with Frailty 
Chung et al. [83] proposed the molecular inflammation theory, according to which the age-related 
increase in reactive oxygen and nitrogen species concentrations and redox balance disturbances may 
lead to a chronic low-grade inflammatory state by activating redox-sensitive transcriptional factors. 
The NF-kB pathway is the most important redox-sensitive signaling pathway through which 
oxidative stress may increase the expression of numerous pro-inflammatory molecules, especially 
cytokines such as TNF-a, IL-6, IL-1b, and CRP, stimulating inflammation [32, 84]. As the 
inflammatory response escalates, additional reactive nitrogen and oxygen species are released from 
immune cells (e.g., monocytes and macrophages) resulting in a propagation of cytokine production 
[7, 17]. Thus, a vicious cycle is propagated, driving a chronic systemic proinflammatory state that 
in the elderly has been termed inflammaging [4] (Figure 2.1).  
Is inflammaging, however, associated with skeletal muscle wasting and strength loss? Data 
derived from 3075 men and women aged 70–79 y in the Health, Aging, and Body Composition 
Study [25] showed that those with high concentrations of IL-6 and TNF-a had smaller skeletal 
muscle area, less appendicular muscle mass, and reduced strength. Similarly, elderly subjects with 
elevated IL-6 and CRP concentrations demonstrated a 2- to 3-fold greater risk of losing >40% of 
their muscle strength [27]. Moreover, according to a 5-y follow-up study in 2177 men and women 
aged 70–79 y, increased baseline concentrations of TNF-a and its soluble receptor were linked to a 
greater decline in muscle mass and strength [26]. Although the underlying molecular pathway 
leading from inflammation to functional decline has not been clarified yet, increased IL-6 
concentrations in the elderly contribute to the development of disability and functional dependence 
[85-89] via direct interactions with key growth factors in skeletal muscle [90, 91]. These findings 
accord well with the observation that orally administered cyclo-oxygenase inhibitors in older adults 
engaged in resistance exercise lead to increased skeletal muscle mass and strength gains by reducing 
the production of IL-6 and muscle ring-finger-1 in skeletal  muscle [92]. Therefore, these studies 
provide compelling evidence of an association between inflammaging and a deterioration of skeletal 
muscle size and function.  
In vivo and in vitro studies indicate that inflammaging-related muscle wasting may be attributed 
to a TNF-a mediated upregulation of the NF-kB pathway and the subsequent activation of the 
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ubiquitin–proteasome system (UPS) [32-34]. Increased concentrations of pro-inflammatory 
cytokines, i.e., TNF-a and/or IL-6, have been shown to activate the inhibitor of NF-kB (IkB) kinase, 
which phosphorylates the IkB complex and results in its degradation, thereby allowing the 
translocation of the NF-kB complex into the nucleus [35]. The 20S proteasome is the catalytic part 
of the UPS, performing the degradation and removal of abnormal, misfolded, and denatured proteins, 
and it may also remove healthy proteins under certain circumstances [93-97]. Under conditions of 
chronic inflammation, increased NF-kB expression activates the UPS, resulting in protein 
degradation by the 20S proteasome subunit and muscle wasting [32, 34, 36, 98]. In experimental 
animals, infusion or injection of TNF-a resulted in a pronounced loss of skeletal muscle and body 
mass [99, 100], probably in a concentration-dependent manner [101]. Moreover, infusion of IL-6 
has been shown to alter amino acid turnover and decrease the phosphorylation of signaling proteins 
involved in the anabolic pathway, suggesting that increased IL-6 concentrations contribute to 
skeletal muscle atrophy [102, 103].  
An interaction between the NF-kB-related proteolytic cascade and anabolic pathways has also 
been observed in human skeletal muscle. Older humans exhibited a blunted MPS response to feeding 
compared with their younger counterparts that was attributed to NF-kB overexpression in their 
skeletal muscles [28]. Later studies revealed that the increased TNF-a–dependent NF-kB expression 
attenuates the activation of anabolic signaling molecules such as Akt and S6K1, leading to reduced 
MPS and insulin resistance [30, 31]. Thus, chronic inflammation may not only lead to NF-kB–
Figure 2.1. Schematic representation of the pathway linking inflammaging and frailty. CRP: C-reactive 
protein, MPS: Muscle protein synthesis, RNOS: Reactive oxygen and nitrogen species, ↓: decrease, ↑: increase. 
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related skeletal muscle wasting, but it also may hamper anabolic signaling pathways in skeletal 
muscle. Anti-inflammatory treatment with ibuprofen in aged rats reduced systemic inflammation, 
increased the rate of MPS and activation of anabolic intracellular signaling pathways, and 
significantly suppressed muscle protein breakdown [29]. Although the verification of this 
mechanism (Figure 2.1) in humans is still missing, this study clearly shows that inflammaging should 
be targeted by nutritional, exercise, and pharmaceutical interventions aimed at the limitation of 
sarcopenia and skeletal muscle loss. The molecular mechanisms regulating the TNF-a/NF-
kB/ubiquitin– proteasome pathway and its crosstalk with Akt-related signaling in the skeletal muscle 
of aged adults warrants further investigation. Although exercise-induced inflammation has been 
shown to activate muscle satellite cell content as part of the regeneration or remodeling process [104, 
105], there are limited data on the impact that age-related chronic inflammation has on satellite cells. 
Beenakker et al. [106] show that there is no association between chronic systemic inflammation and 
satellite cell number in patients with rheumatoid arthritis. Future investigations need to examine 
whether inflammaging affects satellite cell responses, and, if so, what the impact is of anabolic 
approaches, such as protein feeding and/or resistance exercise training on these responses. 
2.3. A Rationale for Protein Supplementation for Inflammaging 
Protein ingestion is a nutritional strategy that has been studied extensively as a means of 
attenuating age-dependent muscle loss and therefore maintain quality of life [107]. This mainly is 
due to the resulting postprandial aminoacidemia, which is known in the short term (hours) to 
stimulate MPS [108, 109], especially when combined with resistance-type exercise [47, 110, 111]. 
Evidence indicates that MPS is less sensitive to protein intake in elderly patients than it is in young 
individuals; thus, higher relative amounts of protein may be required in each meal to stimulate MPS 
maximally in the aged [110, 112, 113]. Although the RDA for protein intake in adults is 0.8 g/(kg 
body weight _ d), consumption of protein above the RDA has been proposed to more efficiently 
prevent muscle wasting and offer health benefits to the aged [76, 114, 115]. Higher protein intake in 
community-dwelling adults has been associated with an attenuation of skeletal muscle loss over a 3-
y follow-up [116], whereas protein intake has been negatively associated with skeletal muscle 
strength loss in inflammaging [77]. Apart from the anabolic potential of protein, higher intake in the 
elderly also has been proposed in order to boost glutathione synthesis by providing greater 
availability of cysteine, which is a precursor amino acid [117]. Because the glutamate cysteine ligase 
Michaelis constant for cysteine is close to intracellular cysteine concentrations, increased cysteine 
intake from dietary protein or other cysteine-rich sources may lead to substantial glutathione 
synthesis, especially when intracellular concentrations of glutathione are relatively low [117]. 
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Glutathione acts as a potent antioxidant in the intracellular environment, because it counteracts the 
produced reactive oxygen and nitrogen species and also downregulates signaling pathways 
mediating immune cell mobilization. Therefore, there is a potential link between protein intake and 
skeletal muscle health in older adults with low-grade inflammation. Recently, researchers have 
attempted to shed light on the antioxidant and anti-inflammatory properties of dairy and plant 
proteins by using both in vivo and in vitro experimental models. Therefore, the interaction between 
inflammaging and protein intake will be presented separately for each protein type in the following 
paragraphs. For each protein type, existing evidence will be reviewed in respect to the effect of 
proteins on 1) both systemic and local (skeletal muscle) anti-inflammatory and antioxidant potential, 
and 2) their ability to affect skeletal muscle loss and function. 
Dairy proteins. Over the last 5 years there has been growing interest in the antioxidant and anti-
inflammatory role of dairy proteins, primarily that of whey. In vitro models, although they use an 
artificial environment, have offered valuable insight in this area. When C2C12 myoblasts were 
incubated with whey protein (80.05 g/100 g) and various concentrations (0.1–0.4 g/L) of hydrogen 
peroxide, it was revealed that whey protein was able to prevent hydrogen peroxide–induced toxicity, 
reduce lipid peroxidation, and enhance the activity of several antioxidant enzymes [118]. Similarly, 
whey protein hydrolysates (WPHs; 100 mg/mL and 200 mg/mL pre- and postincubation, 
respectively) protected PC12 cells exposed to hydrogen peroxide from oxidative damage by 
reducing intracellular concentrations of Ca2+, suppressing mitochondrial apoptotic pathways (by 
14%), and maintaining the membrane potential of the mitochondrial membrane, thereby improving 
mitochondrial function [119]. In line with the results from Xu et al. [118] in C2C12 myoblasts, WPH 
supplementation in PC12 cells [119] upregulated the activity of antioxidant enzymes, such as 
catalase and superoxide dismutase (SOD). The antioxidant properties of whey protein were 
illustrated further when C2C12 muscle cell lines were treated with sheep whey protein (0.78–6.24 
mg) by increasing reduced glutathione concentrations and reducing TBARs and reactive oxygen 
species (ROS) [120]. Therefore, it appears that whey protein supplementation in the muscle and 
other cell lines prevents the onset of oxidative stress by enhancing the activity of endogenous 
antioxidant enzymes and increasing reduced glutathione availability, as well as maintaining 
mitochondria integrity. These results were corroborated in findings reported by studies that used 
rodent models [121-123].  
Intraperitoneal [4 mg/(kg body weight · d)] or oral [8 mg/(kg body weight · d)] ingestion of WPH 
in albino mice with hepatonephrotoxicity attenuated the elevation of serum markers of oxidative 
damage, such as glutathione pyruvate transaminase, alkaline phosphatase, creatinine, and TBARs, 
upregulated the activities of antioxidant enzymes, and preserved serum urea nitrogen at normal 
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concentrations, suggesting that WPH also has the ability to enhance the endogenous antioxidant 
system in vivo under pathologic conditions [121]. When the antioxidant properties of diets 
containing various amounts of whey and casein protein (20% casein compared with 10% casein and 
10% whey protein) were compared under conditions of elevated oxidative stress induced by iron 
overloading, it was shown that rats fed the diet including whey protein had greater levels of reduced 
glutathione and SOD activity in erythrocytes and reduced lipid peroxidation and DNA damage in 
leukocytes and colonocytes compared with those that received casein only, suggesting that whey 
was primarily responsible for the enhanced antioxidant defense [122]. Furthermore, diabetic rats 
supplemented with 100 mg whey protein/kg body weight exhibited considerable reductions in 
malondialdehyde, NO, and ROS concentrations and also preserved their glutathione concentrations 
[123]. These in vivo results, although derived from tissues other than skeletal muscle, are in 
agreement with those reported from in vitro studies [118-120] in which whey protein was 
systematically shown to possess antioxidant properties despite varying doses and supplementation 
protocols applied. This antioxidant profile of whey protein is attributed primarily to enhanced 
antioxidant enzyme activity and increased reduced glutathione concentrations.  
Although human supplementation studies in inflammaging are lacking, human protein feeding 
studies under proinflammatory conditions offer valuable information. The anti-inflammatory role of 
protein supplementation in humans has been tested in the context of exercise [124-129], as well as 
in various clinical proinflammatory conditions, such as cystic fibrosis and obesity [130-134]. 
Exercise, especially eccentric or unaccustomed, has been associated with microtrauma of skeletal 
muscle fibers and an intense aseptic type of inflammation that is characterized by immune cell 
activation, excessive ROS generation, perturbation of redox status, and deterioration of muscle 
performance [135-137]. During a 6-d block of intense training, athletes receiving a daily supplement 
containing protein, leucine, carbohydrate, and fat at 20, 7.5, 89, and 22 g/h, respectively, for 1–3 h 
postexercise over 6 d demonstrated increased counts of circulating neutrophil and respiratory burst 
activity on day 6 compared with those receiving only a carbohydrate control beverage [124]. 
However, in this case, we could not determine whether the effect was attributable to leucine, protein, 
or a combination of the supplement’s ingredients. In another study, well-trained cyclists performed 
3 high-intensity ride sessions over 4 d (day 3 was a rest day), with supplementation on days 1 and 2 
with a protein blend [whey protein isolate, calcium caseinate, and soy protein isolate (SPI)] at a 
dosage of 0.8 g protein/(kg fat-free mass · h) during a 4-h postexercise recovery period [125]. A 
protein effect was observed in the postexercise period, leading to reduced creatine kinase 
concentrations, but no significant alterations were observed for any of the oxidative stress and 
inflammatory markers measured [125]. Similarly, during a 9-wk weight-training period, 
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consumption of 33 g whey protein/d (3 servings of 11 g/d, in a bar form) did not prevent exercise-
induced oxidative stress, whereas an equal amount of soy protein (33 g/d, 3 servings of 11 g/d, in a 
bar form) preserved postexercise antioxidative capacity, as evidenced by free-radical scavenging 
capacity and plasma myeloperoxidase response [126]. In contrast to these findings, acute anti-
inflammatory and antioxidative properties have been attributed to whey protein after a cycling 
session to exhaustion [127, 128]. When whey protein [4 dosages of 0.28 g/(kg body weight · h)] was 
consumed immediately postexercise and daily during the recovery period after an exhaustive cycling 
trial that induced a marked inflammatory and oxidative stress response, an attenuation of IL-6, 
plasma TBARs, and CRP was observed during the first 4 h after exercise, whereas plasma total 
antioxidant capacity (TAC), protein carbonyls, and erythrocyte reduced glutathione and catalase 
concentrations remained unaltered [127, 128]. Similar findings (i.e., attenuated elevation of TBARs 
and protein carbonyls, and increased reduced glutathione availability) have been reported for whey 
protein in ultramarathon runners receiving daily 2 whey protein bars (14.3 g whey protein/100 g bar) 
for 2 mo [129]. Therefore, most of these human exercise studies support an anti-inflammatory and 
antioxidant role for whey protein. Nevertheless, these studies involved healthy young individuals, 
and data on skeletal muscle performance and molecular responses are lacking. We must mention, 
however, that one previous study suggested that antioxidant supplementation (i.e., vitamins C and 
E) may offset some positive adaptations induced by exercise training [138]. These findings were 
reported for young athletes, but, to our knowledge, no data exist for inflammaging.  
To our knowledge, only a small number of studies examined the effects of a nutritional 
intervention of dairy-based protein diets in aged adults on chronic inflammation and oxidative stress. 
Either acute (a bolus of 45 g of protein) or chronic (54 g of protein/d for a 12-wk period) consumption 
of whey protein isolate did not alter the responses of circulating proinflammatory markers such as 
IL-6, TNF-a, and CRP in overweight postmenopausal women and overweight adults aged 18–65 y, 
respectively [130, 131]. Similarly, when obese individuals received a soy-based protein diet, after a 
wash-out period, no changes in inflammatory and oxidative stress markers were observed [132]. In 
contrast, when whey isolate and calcium caseinate (45 g of each protein in a crossover design) were 
consumed in combination with a fat-rich meal by obese, nondiabetic individuals in the context of an 
acute clinical trial, an acute suppression of markers of low-grade inflammation was observed [133]. 
The anti-inflammatory potential of whey protein also was evident in cystic fibrosis patients who 
consumed 20 g whey protein/d for 3 mo [134]. These few human studies provided valuable insight 
regarding the anti-inflammatory role of protein in the presence of low-grade inflammation and partly 
verify the in vitro and in vivo results described earlier. Both dairy proteins seem to have a protective 
effect against low-grade inflammation, with whey eliciting a slightly greater attenuation of 
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proinflammatory cytokines than does casein [133]. Thus, the rationale for using dairy proteins to 
counteract low-grade inflammation and oxidative stress and prevent sarcopenia may be valid, and 
future investigations should explore this prospect in human skeletal muscle in inflammaging.  
Studies that investigated the effects of dairy protein on inflammatory and oxidative stress 
responses are presented in Table 2.1 
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Table 2.1. Evidence for the anti-inflammatory and anti-oxidative role of dairy proteins. 
Reference Cell/organism tested Condition Type of protein Supplementation 
Protocol 
Effects on Inflammation Effects on Oxidative stress 










N/A ↓ Lipid peroxidation 
↓ DNA oxidative damage 
↑Activity of SOD, CAT & GPx 
Jin et al. (2013) Rat pheochromocytoma 
line 12 cells (PC12) 
H2O2-induced 
oxidative stress 
WPH  100μg/mL WPH or 
200μg/mL WPH for 
2h and then other 
100 or 200 μg/mL 
WPH for 24h 
N/A ↓ ROS and Ca2+ levels 
↓ Activity of caspase-3 
↑ Bcl-2 mitochondrial expression 
↓ Bax mitochondrial expression 
↑ Activity of CAT & SOD 
Kerasioti et al. (2014) Muscle C2C12 Cells Tert-butyl 
hydroperoxide 
(tBHP) – induced 
oxidative stress 
Sheep WP 0.78 – 6.24 mg WP 
for 24 h 
N/A ↓ ROS levels 
↓ TBARS levels 
↑ GSH availability 
Athira et al. (2013) Albino mice Paracetamol-
induced oxidative 
stress 
WPH 4 mg/kg/day WPH 
intraperitoneally or 8 
mg/kg/day WPH 
orally for 4 days 
N/A ↓ Oxidative damage 
↓ TBARS levels 
↑ Activity of SOD, CAT & GPx 





WP + Casein 10g WP + 10g casein 
/ 100g diet for 6 
weeks 
N/A ↓ Lipid peroxidation 
↓ DNA damage 
↑ erythrocyte GSH levels 
↑ Activity of SOD 
Ebaid et al. (2011) Adult diabetic rats Wounded diabetic 
rats 
WP Orally 100mg/kg/day 
WP, for 30 days 
Restored IL-1β, TNF-α, IL-6, 
IL-4 & neutrophil infiltration 
during wound healing 
↓ MDA levels 
↓ NO & ROS concentrations 
Preserved GSH levels 
Nelson et al. (2013) Male cyclists/triathletes 
(35 ± 10 years) 
Exercise-induced 
inflammation 
WP + Leucine 20g WP+7.5g leucine 
/h, for 3h post 
exercise,  
daily for 6 days 
↔ IL-6 
↔ IL-10 
↑ neutrophil O2- (on day 6) 
 
Rowlands et al. (2008) Male cyclists  




WPI + Calcium 
Caseinate 
(*Soy nuggets also 
included) 
0.8g of protein/kg 






Brown et al. (2004) Male experienced 
weightlifters (19-25 years) 
Exercise-induced 
oxidative stress 
WP 33g/day WP  
(3 servings of 11g) 
N/A ↓ Plasma radical scavenging 
capacity 
Institutional Repository - Library & Information Centre - University of Thessaly




↑ Myeloperoxidase  




WP 4 doses of 0.28g 
WP/kg /h 
N/A ↓ TBARS levels 
↔ Plasma TAC & Protein Carbonyls 
↔ Erythrocyte GSH & CAT 









Samaras et al. (2014) Ultra-marathon runners 
(43 years) 
Resting oxidative 
stress levels  
WP 2 protein bars/day  
(*30,80g of protein per 
100g of bar of which 
14,3g WP) for two 
months 
N/A ↓ TBARS levels 
↓ Protein carbonyls 
↑ GSH Availability 
↔ TAC 







WPI 45g ↔ Plasma IL-6 
↔ Plasma TNF-α 
↔ Plasma CRP 
N/A 
Pal & Ellis (2010) Overweight/Obese 
individuals (18-65 years) 
Systemic  
inflammation 
WPI 54g WPI/day, 
 for 12 weeks 
↔ Plasma IL-6 
↔ Plasma TNF-α 
↔ Plasma CRP 
N/A 
Zemel et al. (2010) Overweight/Obese 




Non fat dry milk 30g of protein 
(distributed in 3 





↓ Plasma MDA 
↓ 8-isoprostane factor-α 
Holmer-Jensen et al. 
(2011) 
Obese non-diabetic 




WPI 45g of WPI 




Holmer-Jensen et al. 
(2011) 
Obese non-diabetic 






45g of protein (15E% 




Grey et al. (2003) Cystic fibrosis patients 
 (25 years) 
GSH availability WPI 20g of WPI/day (2 
servings of 10g/day) 
N/A ↑ Lymphocyte GSH levels 
1↑: Indicates increase, 2↓: Indicates decrease, 3↔: Indicates no effect, 4≈: Indicates maintenance, 5CAT: Catalase, 6CCL/RANTES: CC chemokine ligand-5, 7CRP: C-reactive 
protein, 8FFM: Fat free mass,  9GPx: Glutathione peroxidase, 10IL-1β: Interleukine-1β, 11IL-4: Interleukine-4, 12IL-6: Interleukine-6, 13IL-10: Interleukine-10, 14MDA:  
malondialdehyde, 15MCP-1: Monocyte chemotactic protein-1, 16NO: Nitric oxide, 17ROS: Reactive oxygen species, 18SOD: superoxide dismutase, 19TAC: Total antioxidant capacity, 
20TBARS: thiobarbituric acid reactive substances, 21TNF-α: tumor necrosis factor-α, 22WP: Whey protein, 23WPH: Whey protein hydrolysates, 24WPI: Whey protein isolate.  
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Table 2.2. Evidence for the anti-inflammatory and anti-oxidative role of soy protein, isoflavone enriched soy protein and soy milk. 
Reference Cell/organism tested Condition Type of protein Supplementation 
Protocol 
Effects on Inflammation Effects on Oxidative stress 




SPI 20% of the daily diet 
(8g of food the 1st day 
and then increased by 
0.5g each day), for 14 
days 
N/A ↓ Lipid peroxidation levels 
≈ Glutathione levels 




SPI 20% of the daily diet 
(8g of food the 1st day 
and then increased by 
0.5g each day), for 14 
days 
N/A ↓ TBARS levels 
↓ GSSG/GSH ratio 





SPI 3.9g /day SPI, 
 for 5 weeks 
↓ NF-κB activation 
↓ Expression of TNF-α, IL-
6 and IL-1β 
↓Expression of VCAM-1 
and MCP-1 
 N/A 




SPI 25g/day SPI, 
 for 6 weeks 











Soy (DrSoy® Bars) 33g/day (3 servings of 
11g) 
N/A ≈ Plasma radical scavenging capacity 
≈ Myeloperoxidase 
Hagen et al. (2009) Male Wistar rats with 
myocardial infarction  
Myocardial 
oxidative stress 
SP + ISF 206 g/kg/day SP + 
189 mg/100g of SP/day 
ISF, 
 for 9 weeks 
N/A ↑ SOD, CAT & GPx activity 
↑ CAT activity 
↓ Protein carbonyls 
↓ Lipid peroxidation 
 





SP + ISF 20g/kg/day SP 
 for 8 weeks 
↓ mRNA expression of IL-
6, TNF-α & PAI-1 
↓ Activation of JNK & IKKβ 
↓ nuclear NF-kB levels 
↓ 4-HNE & 3-NT in liver 
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SP + ISF 26g/day SP +  
44mg/day ISF, 
 for 6 weeks 
↔ CRP 
↔ E-selectin 
↔  VCAM-1 & ICAM-1 
N/A 
Tormala et al. (2008) Postmenopausal women 




SP + ISF 52g/day ISF + 
112mg/day ISF,  





Archarjee et al. (2015)  Postmenopausal women 
(54 years), with or 




to CHD risk 
SP + ISF  
(soy nut) 
25g/day SP + 
101mg/day ISF, 









SP + ISF  
(soy nut) 
37.5g/day SP + 
340mg/day ISF, 






Nasca et al. (2008) Postmenopausal women 




SP + ISF  
(soy nut) 
25g/day SP + 
101mg/day ISF, 





↔   MMP-9 
N/A 
Fanti et al. (2006) Adult ESRD patients (60 
± 3,4 years) 
Chronic 
inflammation 
SP + ISF  25g/day SP + 
54 mg/day ISF, 
 3 times/week, 
 &  
11g/day SP + 
26 mg/day ISF, 
 4 times/week, 
for 8 weeks 
↓ CRP N/A 
Mangano et al. (2013) Healthy women 
(> 70 years) with  
Baseline CRP: 5.24 pg/ml 
Baseline IL-6: 2.76 pg/ml 
Systemic 
inflammation 
SP + ISF 18g/day SP + 
105mg/day ISF,  
for 1 year 
↓ IL-6 N/A 
Vega-Lopez et al. (2005) Hypercholesterolemic 
individuals (> 50 years) 
Antioxidant 
protection related 
to elevated LDL 
cholesterol  
SP + ISF 17% of total energy SP 
+ 1.25mg ISF / 
1000kcal / day,  
for 42 days 
N/A ↔ LDL oxidizability 
↔ Urinary F2-isoprostanes 
↔ MDA 
↔ Protein carbonyls (native plasma) 
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↓ Protein carbonyls (oxidized 
plasma) 
Vega-Lopez et al. (2005) Hypercholesterolemic 
individuals (> 50 years) 
Antioxidant 
protection related 
to elevated LDL 
cholesterol  
SP + ISF 16% of total energy SP 
+ 46.21mg ISF / 
1000kcal / day, 
 for 42 days 
N/A ↔ LDL oxidizability 
↔ Urinary F2-isoprostanes 
↔ MDA 
↔ Protein carbonyls  





SP + ISF 40g/day SP 
 for 24 weeks 
(ISF content not described) 
N/A ↓?  Total antioxidant status 





Soymilk 6g SP/serving, 
 3 servings/day,  




↔ SOD activity 
↔ GPx activity 
Miraghajani et al. (2012) Type 2 diabetic patients 
with nephropathy () 
Inflammation and 
oxidative stress 












Soymilk 1L soymilk/day, 
 for 4 weeks 
N/A ↓ DNA damage 
Jenkins et al. (2002) Hypercholesterolemic 
men postmenopausal 






50g/day SP + 
73mg/day ISF,  
for 1 month 
↔ TNF-α 
↔ CRP 
↑ IL-6 (in women only)  
 
Jenkins et al. (2002) Hypercholesterolemic 
men postmenopausal 






52g/day SP + 
10mg/day ISF, 




1↑: Indicates increase, 2↓: Indicates decrease, 3↔: Indicates no effect, 4≈ : Indicates maintenance, 5CAT: Catalase, 6CHD: Coronary heart disease, 7CRP: C-reactive protein, 
8GPx: Glutathione peroxidase, 9hs-CRP: High sensitivity C-reactive protein, 104-HNE: 4-hydroxy-2,3-nonenal, 11ICAM-1: Intracellular adhesion molecule-1, 12IKKβ: IκB Kinase, 
13IL-1β: Interleukine-1β,  14IL-6: Interleukine-6, 15IL-18: Interleukine-18, 16ISF: Isoflavones, 17JNK: c-Jun N-terminal kinase, 18MDA: malondialdehyde, 19MCP-1: Monocyte 
chemotactic protein-1,  20MMP-9: Matrix metalloproteinase, 213-NT: 3-Nitrotyrosine, 22NF-κB: nuclear factor kappa-B, 23PAI-1: plasminogen-activator inhibitor-1, 24sICAM-1: 
soluble intracellular adhesion molecule-1, 25sIL-2: soluble interleukine-2 receptor, 26sVCAM-1: soluble vascular cell adhesion molecule-1, 27SOD: superoxide dismutase, 28SP: 
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Soy protein. Soy protein represents 35–40% of soybean content and is considered to be a 
protein source of high nutritional quality, because it contains all the essential amino acids and, in 
particular, it has less saturated fat than dairy foods and is cholesterol-free [139]. However, soy 
protein in its isolated form, to our knowledge, has been poorly investigated by researchers looking 
for protein supplements and protein-rich diets to counteract inflammation and oxidative stress.  
When SPI (20% of the daily diet; 8 g of food on day 1, increased by 0.5 g each day for the 
remaining 13 d) was administered to rats exposed to paraquat-induced oxidative stress, an 
attenuation of lipid peroxidation and enhanced reduced glutathione concentrations was observed 
[140, 141]. A recent study showed that a 5-wk supplementation with SPI in hyperlipidemic mice 
counteracted the NF-kB–dependent inflammatory response manifested as reduced activation of 
NF-kB and expression of TNF-a, IL-6, IL-1b, vascular cell adhesion molecule 1 (VCAM-1), and 
monocyte chemoattractant protein 1 because of inhibition of IkB phosphorylation [81]. Therefore, 
given that in chronic inflammatory conditions the increased activation of the NF-kB signaling 
pathway leads to protein degradation through the 20S proteasome subunit [32, 34, 36, 98] soy 
protein may be a potent nutritional intervention against chronic inflammation and its associated 
skeletal muscle loss. In contrast to animal studies, in what is, as far as we know, the only human 
study that tested a 6-wk supplementation with SPI (25 g/d) in postmenopausal women, 
supplementation did not alter inflammatory markers such as soluble IL-2 receptor, E-selectin and 
P-selectin, VCAM-1, and intercellular adhesion molecule 1 [142]. However, the efficacy of SPI 
in inhibiting chronic inflammation should be further investigated in human clinical trials in order 
to come to a clear conclusion.  
Soy foods also contain phytoestrogens named isoflavones that can be removed when these 
foods are washed with alcohol [139, 143]. Genistin, daidzin, and glycitein are the primary 
bioactive isoflavones in soybeans and soy foods [139]. Research on the antioxidative role of 
isoflavones has shown reduced oxidative stress levels, improved antioxidant enzyme activity, and 
attenuated oxidative damage in animal models [144-147], as well as in humans [148, 149]. 
Specifically, the incorporation of 206 g SPI/kg body weight (based on the AIN-93G diet), 
combined with 189 mg isoflavones/100 g SPI, in the daily diet for a 9-wk period attenuated 
myocardial oxidative stress levels in rats that suffered from myocardial infarction and underwent 
heart surgery [150, 151]. Another study investigated the antioxidative action of an isoflavone-
enriched soy protein compared with a casein-based diet on fructose-induced oxidative and 
inflammatory responses in rats, suggesting that, in contrast to casein, soy protein is able not only 
to suppress oxidative stress, but also to elicit an anti-inflammatory response [152]. As previously 
reported for SPI [81], soy isoflavones and mainly genistein also have been shown to hamper the 
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activation of NF-kB and TNF-a in aged mdx mice [153]. Therefore, the effect of isoflavone-
enriched soy protein on inflammation may be attributed to its isoflavone content and amino acid 
composition that seem to prevent the nuclear translocation and subsequent activation of NF-kB, 
which activates the expression of proinflammatory cytokines such as TNF-a and IL-6 [81, 152, 
153].  
In postmenopausal women, the administration of 26 g soy protein/d enriched with 44 mg 
isoflavones/d for 6 wk did not affect circulating concentrations of CRP and various adhesion 
molecules [154]. Tormala et al. [155] increased the amount of supplemented soy protein to 52 
g/d and the amount of isoflavones to 112 mg/d, and also extended the supplementation period to 
8 wk, but they did not observe any anti-inflammatory action either. In contrast, consumption of 
soy nuts containing either 25 g soy protein/d and 101 mg isoflavones/d or 37.5 g soy protein/d 
and 340 mg isoflavones/d for 8 wk led to significant reductions in blood CRP, soluble intercellular 
adhesion molecule 1, E-selectin, TNF-a, and IL-18 in postmenopausal women with metabolic 
syndrome [82, 156], as well as in VCAM-1 in hypertensive postmenopausal women [157]. 
However, discrepancies between these studies may be related to the different supplementation 
protocols applied, as well as to the clinical status of the participants (e.g., in the study by Tormala 
et al. [155], subjects were tibolone users). Moreover, the anti-inflammatory potential of soy nuts 
may be attributed to the fact that nuts contain all the bioactive compounds of a soybean, including 
soy protein, fat, and phytoestrogens, whereas supplemented proteins are isolated and in some 
cases are combined with isoflavones only [139, 158, 159]. Interestingly, in patients with end-
stage renal disease, which is characterized by systemic inflammation (CRP > 10.0 mg/L), the 
administration of SPI that retained its isoflavone content led to a marked elevation of circulating 
isoflavone concentrations that was inversely correlated with inflammatory markers [160]. 
Moreover, in a 1-y clinical study, the intake of 18 g soy protein/d along with 105 mg isoflavone/d 
reduced blood concentrations of IL-6 in healthy older (>70 y of age) women with baseline CRP 
and IL-6 values of 5.24 pg/mL and 2.76 pg/mL, respectively [161]. To the best of our knowledge, 
this is the only human study that used a population with characteristics of inflammaging, and it 
suggested that a combination of sufficient quantities of soy protein and isoflavones may have the 
potential to prevent or alleviate inflammation. Although this study did not look into skeletal 
muscle responses, it supports a rationale for soy protein use as an anti-inflammatory intervention. 
Two studies that examined the antioxidant potential of soy proteins provided some positive 
evidence. In a crossover design, administration of either a soy protein (17% of total energy and 
1.25 mg isoflavones/1000 kcal) or an isoflavone-enriched soy protein (16% of total energy and 
46.21 mg isoflavones/1000 kcal) diet for 42 d had no significant impact on markers of oxidative 
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stress, but improved TAC by 10% [162]. Swain et al. [163] also reported that supplementation 
with soy protein in perimenopausal women improved TAC. Collectively, these studies suggest 
that soy protein with isoflavones may represent a potent anti-inflammatory and antioxidant agent, 
further supporting the rational for its use in proinflammatory conditions such as inflammaging. 
Although this data supports an anti-inflammatory role for soy protein, to our knowledge, no data 
exist regarding its effectiveness in promoting muscle mass and function in inflammaging. When 
dairy and soy protein were compared in healthy aged adults, the 2 types of proteins were equally 
effective in improving body composition and functionality, but the former was more effective in 
increasing muscle strength [164].  
Studies that investigated the effects of soy protein and isoflavone-enriched soy protein on 
inflammatory and oxidative stress responses are presented in Table 2.2. 
2.4. Conclusions 
In conclusion, oxidative stress and inflammation interact in a vicious cycle, creating a chronic 
state of systemic inflammation that in the elderly is known as inflammaging. Many health-related 
dysfunctions and chronic diseases, as well as loss of muscle mass and consequently independence 
in the elderly, have been associated with inflammaging; therefore, it is crucial to develop 
nutritional, exercise-based, and pharmaceutical strategies to counteract its detrimental effects. 
Dairy and soy products contain high-quality proteins of high nutritional value because of their 
amino acid composition and absorption kinetics. Whey protein exhibits antioxidative properties 
that are attributed to its ability to increase glutathione availability and enhance the activity of the 
antioxidative enzymes SOD, catalase, and glutathione peroxidase. Evidence from animal models 
and cell lines indicate that whey protein may regulate multiple intracellular pathways related to 
ROS production. However, future studies should explore the TNF-a/NF-kB/ubiquitin–
proteasome pathway and its crosstalk with Akt-related signaling in skeletal muscle in 
inflammaging in response to various protein feeding protocols. Whey administration may 
attenuate exercise-induced oxidative stress and inflammation, aswell as inflammation resulting 
from clinical complications and obesity. Soy protein is a promising nutritional strategy against 
chronic inflammation, with it having been shown that either in its isolated form or isoflavone-
enriched, it is able to inhibit the activation of the NF-kB and subsequently the upregulation of 
proinflammatory cytokines, such as TNF-a, IL-6, and IL-1b, as well as other mediators, such as 
VCAM-1 and monocyte chemoattractant protein 1. Although this mechanism of action is evident 
in animal models only, soy protein supplementation has been associated with reduced 
concentrations of chronic low-grade inflammation in the elderly as well. There is a great need for 
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well-controlled experimental trials to determine whether an increase in protein consumption may 
aid MPS and muscle function in older adults with elevated systemic inflammation. Well-
controlled randomized trials should compare dairy with plant protein feeding with or without an 
anabolic type of exercise in aged adults with a proinflammatory profile with the use of long-term 
supplementation protocols, as well as an assessment of muscle function and mass. A schematic 
representation of potential mechanisms through which protein supplementation may offset 







Figure 2.2. Mechanistic links between protein feeding and inflammaging. CAT: catalase, CRP: C-reactive protein, 
GSH: reduced glutathione, IkB: inhibitor of NF-κB, ROS: reactive oxygen species, SOD: superoxide dismutase, ?: 
lack of evidence regarding the ability of these proteins to stimulate muscle protein synthesis in inflamed elderly, →: 
increase or activation, ─●: decline or inhibition. 
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Disparate Habitual Physical Activity and Dietary Intake Profiles of Elderly Men 
with Low and Elevated Systemic Inflammation 
Draganidis D, Jamurtas AZ, Stampoulis T, Laschou V, Deli CK, Georgakouli K, Papanikolaou 
K, Chatzinikolaou A, Michalopoulou M, Papadopoulos C, Tsimeas P, Chondrogianni N, 
Koutedakis Y, Karagounis LG, Fatouros IG 
Abstract 
The development of chronic, low-grade systemic inflammation in the elderly (inflammaging) has 
been associated with increased incidence of chronic diseases, geriatric syndromes, and functional 
impairments. The aim of this study was to examine differences in habitual physical activity (PA), 
dietary intake patterns, and musculoskeletal performance among community-dwelling elderly 
men with low and elevated systemic inflammation. Nonsarcopenic older men free of chronic 
diseases were grouped as ‘low’ (LSI: N = 17; 68.2 ± 2.6 years; hs-CRP: <1 mg/L) or ‘elevated’ 
(ESI: N = 17; 68.7 ± 3.0 years; hs-CRP: >1 mg/L) systemic inflammation according to their serum 
levels of high-sensitivity CRP (hs-CRP). All participants were assessed for body composition via 
Dual Emission X-ray Absorptiometry (DEXA), physical performance using the Short Physical 
Performance Battery (SPPB) and handgrip strength, daily PA using accelerometry, and daily 
macro- and micronutrient intake. ESI was characterized by a 2-fold greater hs-CRP value than 
LSI (p < 0.01). The two groups were comparable in terms of body composition, but LSI displayed 
higher physical performance (p < 0.05), daily PA (step count/day and time at moderate-to-
vigorous PA (MVPA) were greater by 30% and 42%, respectively, p < 0.05), and daily intake of 
the antioxidant vitamins A (6590.7 vs. 4701.8 IU/day, p < 0.05), C (120.0 vs. 77.3 mg/day, p < 
0.05), and E (10.0 vs. 7.5 mg/day, p < 0.05) compared to ESI. Moreover, daily intake of vitamin 
A was inversely correlated with levels of hs-CRP (r = −0.39, p = 0.035). These results provide 
evidence that elderly men characterized by low levels of systemic inflammation are more 
physically active, spend more time in MVPA, and receive higher amounts of antioxidant vitamins 
compared to those with increased systemic inflammation. 
Keywords: aging, chronic low-grade systemic inflammation, physical activity, nutrition, 
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Chronic exposure to antigens as well as to chemical, physical, and nutritional stressors that the 
immune system has to cope with, in combination with the dramatic increase in life expectancy, 
result in the overstimulation of the immune system with advancing age and the development of a 
chronic and persistent pro-inflammatory state [1, 4]. This age-associated, low-grade, chronic 
inflammatory status has been termed as “inflammaging” [4] and is clinically assessed by 
measuring systemic concentrations of cytokines and acute-phase proteins, including interleukin-
6 (IL-6), tumor necrosis factor-α (TNF-α), and C-reactive protein (CRP) [5]. Inflammaging 
represents a significant risk factor for age-related frailty, morbidity, and mortality [1, 13] as many 
chronic diseases and geriatric syndromes such as cardiovascular diseases, atherosclerosis, 
metabolic syndrome, type 2 diabetes mellitus, neurodegenerative diseases, cancer, and chronic 
obstructive pulmonary disease have been associated with chronic inflammation [8-11]. Moreover, 
increased levels of IL-6, TNF-α, and CRP in the elderly have been associated with lower muscle 
mass and physical performance [25-27] as well as with increased risk for sarcopenia and 
osteoporosis [15, 22, 88]. Thus, the concept of inflammaging appears to be a key determinant of 
successful aging and longevity and as such a valuable tool to counteract age-related pathologies 
[1]. 
To date, inflammaging is defined as a complex and multifactorial process whose origin cannot 
be simply attributed to a specific number of factors/mechanisms, as a complete understanding of 
the extent to which different tissues, organs, and biological systems contribute to its 
pathophysiology is lacking [5, 16]. However, both physical activity (PA) and nutrition are 
considered powerful lifestyle factors that may, cooperatively or independently, influence both 
healthy aging and lifespan in humans [39, 40]. Specifically, being physically active substantially 
reduces the risk of developing cardiovascular [39, 40] and metabolic diseases [39, 41], obesity 
[39, 44], frailty [39, 45, 46], sarcopenia [47], osteoporosis [40, 48], cognitive impairment [42], 
and mental health disorders [40, 43] in a dose-response manner [165, 166]. Numerous studies 
reported that higher volume of habitual PA is related to lower levels of IL-6, CRP, and TNF-α in 
older adults [23, 49-60]. Most of these studies, though, are based on self-reported PA estimations 
[49-54, 57, 58, 60] that may result in increased risk of recall bias [167] and therefore do not 
provide an objective determination of different intensity levels (i.e., light, moderate, vigorous, or 
very vigorous PA). However, to our knowledge, four studies have utilized accelerometry to 
provide an objective assessment of PA [23, 55, 56, 59]. In two of them, an inverse relationship 
between PA and disease-related (chronic obstructive pulmonary disease and obesity) systemic 
inflammation was revealed in middle-aged adults [55, 56]. Similarly, two other studies reported 
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that time spent in MVPA is negatively associated with markers of systemic inflammation in the 
healthy elderly [23, 59]. Although these data clearly suggest that habitual PA is inversely 
associated with mediators of systemic inflammation in older adults, a direct comparison of 
objectively assessed PA, sedentary time, and PA-related energy expenditure among the elderly 
with low and increased systemic inflammation is still lacking. 
Ideally, this comparison would be more conclusive by the concurrent examination of habitual 
PA/inactivity and dietary intake levels, since both factors may impact systemic inflammation. In 
fact, available data suggest that the role of nutrition and dietary pattern is pivotal for immune 
function and low-grade systemic inflammation [61-63]. Both macronutrient and micronutrient 
intake may interfere with immune responses, triggering either a pro-inflammatory or an anti-
inflammatory effect [64]. Excessive consumption of glucose and saturated fatty acids (SFA) 
(particularly long-chain SFA) are reported to activate pro-inflammatory markers in insulin-
sensitive tissues [64, 67] and may result in systemic inflammation [16], while high phospholipid 
consumption, especially that of polyunsaturated fatty acids (PUFA) and monounsaturated fatty 
acids (MUFA), elicit antiinflammatory properties and reduce the risk of chronic inflammation 
and its associated chronic diseases [68]. On the other hand, consumption of either plant- or dairy-
based protein or amino acids may offer anti-inflammatory effects by reducing levels of 
inflammatory mediators [64, 69]. Furthermore, adequate intake of antioxidants and trace 
elements, particularly vitamins A, C, E, and selenium, also enhances immunity and elicits a 
protective effect against chronic inflammatory conditions [63]. However, to our knowledge, the 
literature lacks evidence regarding differences in dietary habits among older healthy adults with 
low and high systemic inflammation.  
Given the pivotal role of both PA and macronutrient/micronutrient intake in mediating 
immunity and chronic inflammatory responses, a direct comparison of them among older adults 
exhibiting low and elevated systemic inflammation may identify which parameters of these 
lifestyle factors function as discriminants of healthy aging and inflammaging. Therefore, the aim 
of the present study was to compare levels of objectively assessed habitual PA and dietary 
macronutrient/micronutrient intake, among otherwise healthy elderly men of low and increased 
systemic inflammation. 
3.2. Materials and Methods 
3.2.1 Experimental Design and Participants 
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A total of fifty community-dwelling elderly men aged 65–75 years were recruited from the 
surrounding area of Thessaly (Greece) through postings, newspaper, and media advertisements. 
All volunteers completed a health history questionnaire and were also examined by a physician. 
In order to be included in the study, volunteers had to initially meet all of the following 
inclusion/exclusion criteria: (a) nonsmokers; (b) independently living; (c) absence of chronic 
disease (i.e., cancer, metabolic, cardiovascular, neurological, pulmonary, or kidney disease); (d) 
absence of inflammatory disease (i.e., osteoarthritis, rheumatoid arthritis); (e) absence of type 2 
diabetes, and (f) no recent or current use of antibiotics or other medication that could affect 
inflammatory status (i.e., corticosteroids). Subsequently, those who fulfilled these criteria 
underwent assessment of body height, body weight, body composition, handgrip strength, and 
physical performance (via the SPPB) testing to estimate their weight status and stage of 
sarcopenia according to the European Working Group on Sarcopenia in Older People (EWGSOP) 
[168]. Volunteers who were characterized as presarcopenic/sarcopenic were excluded from the 
study at this stage, since substantial loss of skeletal muscle mass is accompanied by significant 
performance decline [168], resulting in lower levels of habitual PA [169]. Volunteers who were 
classified as obese were also excluded since obesity is linked to metaflammation, an adipose-
tissue-mediated chronic inflammatory state that differs in terms of pathophysiology from 
inflammaging [8, 16]. Accordingly, thirty-four volunteers who fulfilled the eligibility criteria 
participated in the study. The determination of inflammatory status was based on two consecutive 
measurements of high-sensitivity CRP (hs-CRP) and participants were grouped as “low systemic 
inflammation” (LSI: hs-CRP <1 mg/L) or “elevated systemic inflammation” (ESI: hs-CRP >1 
mg/L) according to a previous report [170]. Participants were then provided with accelerometers 
and food diaries to monitor their habitual PA and daily macronutrient/micronutrient intake, 
respectively, over a 7-day period. They were fully informed about the aim and the experimental 
procedures of the study, as well as about the benefits involved, before obtaining written consent. 
The Institutional Review Board of the University of Thessaly approved the study and all 
procedures were in accordance with the 1975 Declaration of Helsinki (as revised in 2000). 
3.2.2. Body Composition 
Standing body mass and height were measured on a beam balance with stadiometer (Beam 
Balance-Stadiometer, SECA, Vogel & Halke, Hamburg, Germany) with participants wearing 
light clothing and no shoes as described previously [171]. Body composition [including fat mass, 
fat-free mass (FFM), percent of fat, lean body mass (LBM)] was assessed by dual emission X-
ray absorptiometry (DXA, GE Healthcare, Lunar DPX NT, Diegem, Belgium) with participants 
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in supine position as described before [172]. Appendicular lean mass (ALM) and skeletal muscle 
mass index (SMI) were calculated as the sum of muscle mass (kg) of the four limbs (based on 
DXA scan) and as ALM divided by height by meters squared (kg/m2), respectively [168], while 
sarcopenia status was determined according to the criteria established by EWGSOP [168]. 
3.2.3. Physical Activity 
Physical activity was monitored by using the accelerometers ActiGraph, GT3X+ (ActiGraph, 
Pensacola, FL, USA) over a 7-day period. Accelerometers were attached to elastic, adjustable 
belts and did not provide any feedback to the participants. Participants were taught how to wear 
the belt around the waist with the monitor placed on the right hip and they were asked to wear it 
throughout the day, except for bathing or swimming and sleep, for seven consecutive days. To be 
included in the analysis, participants had to have ≥four days with ≥10 wear hours/day (i.e., four 
valid days) [173]. Nonwear time was calculated using the algorithms developed by Choi et al. 
[174] for vector magnitude (VM) data and defined as periods of 90 consecutive minutes of zero 
counts per minute (cpm), including intervals with nonzero cpm that lasted up to 2 min and were 
followed by 30 consecutive minutes of zero cpm. Daily activity and sedentary time were 
estimated according to VM data and expressed as steps/day and time in sedentary (<199 cpm), 
light (200–2689 cpm), moderate (2690–6166 cpm), vigorous (6167–9642 cpm), and moderate-
to-vigorous (≥2690 cpm) PA [175]. The manufacturer software ActiLife 6 was utilized to 
initialize accelerometers and download data using 60-s epoch length.  
3.2.4. Dietary Assessment 
Participants were taught by a registered dietitian how to estimate food servings and sizes of 
different food sources and how to complete food diaries. They were allowed to weigh out food 
servings, so that they could precisely report the amount of specific food portions, while they were 
also provided with colored photographs depicting different portion sizes that they could use to 
compare their food weights. Furthermore, complete instructions on how to describe portion sizes 
based on household measures or other standard units were also administered to our participants. 
Participants recorded their daily dietary intake for seven consecutive days, describing, in as much 
detail as possible all portions of food and drinks/water. For commercially available products, the 
name of the manufacturer, fat content (i.e., 1%. 2% etc), and other related information had to be 
noted. The Science Fit Diet 200 A (Science Technologies, Athens, Greece) dietary software was 
utilized to analyze diet recalls and data regarding total energy (kJ), protein (g/kg/day & g/day), 
leucine (g/day), branched chain amino acids (BCAA, g/day), carbohydrates (g/day), fat (g/day), 
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vitamin A (IU/day), vitamin C (mg/day), vitamin E (mg/day), selenium (μg/day), polyunsaturated 
fatty acids (PUFA), and monounsaturated fatty acids (MUFA). 
3.2.5. Systemic Inflammation 
Blood samples were collected early in the morning between 07:00 and 09:00 am, after an 
overnight fasting. Participants were asked to avoid alcohol and abstain from intense physical 
activity for ≥48 h before blood sampling. Blood was drawn from an antecubital arm vein via a 
10-gauge disposable needle equipped with a Vacutainer tube holder (Becton Dickinson) with 
participants seated. To separate serum, blood samples were allowed to clot at room temperature 
and then centrifuged (15,000 g, 15 min, 4 °C). The supernatant was dispensed in multiple aliquots 
(into Eppendorf tubes) and stored at −80 °C for later analysis of hs-CRP. Serum hs-CRP was 
quantitatively measured in duplicate using the C-Reactive Protein (Latex) High Sensitivity assay 
(CRP LX High Sensitive, Cobas®) on a Cobas Integra® 400 plus analyzer (Roche) with a 
detectable limit of 0.01 mg/dL and an inter-assay coefficient of one standard deviation (1 SD). 
3.2.6. Statistical Analyses 
All data are presented as means ± SD. The normality of data was examined using the Shapiro–
Wilk test (N = 17/group). Because our data sets in most of our variables differed significantly 
from normal distribution, we rejected the hypothesis of normality and applied nonparametric 
tests. To test differences in body composition, daily PA-related parameters, and dietary 
macronutrient/micronutrient intake among the two groups (LSI vs. HSI) a Kruskal–Wallis test 
was applied. Pearson’s correlation analysis was used to examine the relation of dietary antioxidant 
vitamins intake, number of steps, and time in MVPA per day with serum levels of hs-CRP. 
Correlation coefficients of r < 0.2, 0.2 < r < 0.7 and r > 0.7 were defined as small, moderate, and 
high, respectively. Effect sizes (ES) and confidence intervals (CI) were also calculated for all 
dependent variables using the Hedge’s g method corrected for bias. ES was interpreted as none, 
small, medium-sized, and large for values 0.00–0.19, 0.20–0.49, 0.50–0.79, and ≥0.8, 
respectively. The level of statistical significance was set at p < 0.05. Statistical analyses were 
performed using the SPSS 20.0 software (IBM SPSS Statistics). The G * Power program (G * 
Power 3.0.10) was utilized to perform power analysis. With our sample size of 17/group we 
obtained a statistical power greater than 0.80 at an α error of 0.05. 
3.3. Results 
Participants’ characteristics are presented in Table 3.1. Participants were healthy and had no 
pathological levels of hs-CRP. The two groups, though, differed significantly in respect to hs-
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CRP values (ESI: 2.1 ± 0.8 vs. LSI: 0.7 ± 0.2 mg/dL, p = 0.00), with ESI displaying a 2-fold 
elevation in serum hs-CRP compared to LSI. Averaged BMI values in LSI and ESI were 27.3 ± 
3.1 kg/m2 and 27.9 ± 2.5 kg/m2, respectively, which classifies them as nonobese according to the 
criteria established by the World Health Organization (WHO) [176]. Moreover, all participants 
were characterized as nonsarcopenic, since they exhibited SMI >7.26 kg/m2, handgrip strength 
>30 kg, and physical performance score in SPPB >8. No differences were detected in respect to 
BMI, fat mass, percent of fat, FFM, LBM, ALM, SMI, and handgrip strength among groups. 
However, significant differences were observed in physical performance, with LSI achieving a 
higher SPPB score compared to ESI (LSI: 11.9 ± 0.2 vs. ESI: 11.2 ± 1.0; χ2 = 6.436, p = 0.016; 
ES = 0.90; 95% CI = −1.63, −0.17). 
Table 3.1. Participants’ characteristics. 
Parameter LSI (n = 17) ESI (n = 17) 
Age (years) 68.2 ± 2.6 68.7 ± 3.0 
Body Height (m) 1.71 ± 0.07 1.73 ± 0.04 
Body Weight (kg) 82.3 ± 8.5 85.2 ± 7.5 
BMI (kg/m2) 27.3 ± 3.1 27.9 ± 2.5 
Fat Mass (kg) 24.1 ± 7.0 26.3 ± 4.1 
Fat (%) 29.5 ± 6.6 31.8 ± 2.1 
Fat-Free Mass (kg) 56.3 ± 4.6 58.4 ± 5.2 
Lean Body Mass (kg) 53.3 ± 4.5 55.3 ± 5.1 
ALM (kg) 23.2 ± 2.4 24.4 ± 2.1 
SMI (kg/m2) 8.12 ± 0.7 8.13 ± 0.6 
Grip Strength (kg) 34.3 ± 5.5 36.7 ± 6.6 
SPPB (score) 11.9 ± 0.2 11.2 ± 1.0 1 
Sarcopenia Status Non-Sarcopenic Non-Sarcopenic 
hs-CRP (mg/L) 0.7 ± 0.2 2.1 ± 0.8 2 
Data are presented as mean ± SD. ALM: Appendicular Lean Mass; SMI: Skeletal Muscle Mass 
Index; SPPB: Short Physical Performance Battery; hs-CRP: High-Sensitivity CRP. 1 significant 
difference between groups, p < 0.05, 2 significant difference between groups, p < 0.01. 
Results comparing sedentary time and PA among groups are shown in Figure 3.1. The two 
groups were comparable in sedentary time throughout the day (LSI: 378.2 ± 98.7 vs. ESI: 370.5 
± 95.9 min/day; χ2 = 0.008, p = 0.927) and in the time they spent in light PA/day (LSI: 342.9 ± 
93.1 vs. ESI: 331.7 ± 98.2 min/day; χ2 = 0.357, p = 0.550), while a trend for significantly more 
time spent in moderate PA/day by the LSI group was also observed (LSI: 59.5 ± 16.7 vs. ESI: 
44.1 ± 18.2 min/day; χ2 = 3.637, p = 0.057). Interpretation of the level of moderate PA by group 
means examined in relation to the PA guidelines adopted by the WHO revealed that both groups 
met the recommendation for at least 150 min of moderate-intensity PA throughout the week. 
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Figure 3.1. (A) Sedentary time, (B) time spent in light, (C) moderate, (D) vigorous, (E) moderate-
to-vigorous (MVPA) PA, and (F) total step count throughout the day, in low (LSI) and elevated 
(ESI) systemic inflammation groups. Values are presented as mean ± SD. * denotes significant 
difference between groups at p < 0.05. 
By performing an individual examination in both groups, we found that all participants in LSI 
and approximately 86% of participants in ESI met this criterion. Significant differences between 
LSI and ESI were observed in MVPA and daily step count, with LSI spending more time in 
MVPA throughout the day (LSI: 65.2 ± 21.5 vs. ESI: 45.9 ± 19.8 min/day; χ2 = 3.997, p = 0.044; 
ES = 0.91; 95% CI = −1.68, −0.13) and performing more steps (LSI: 9000.1 ± 2496 vs. ESI: 
6968.3 ± 2075 steps/day; χ2 = 4.087, p = 0.043; ES = 0.86; 95% CI = −1.63, −0.08) than ESI, by 
42% and 30%, respectively. The average step count/day for LSI was 9000.1 steps, which is close 
to the upper recommended limit for older adults (7100–10,000 steps/day) [177] while the ESI did 
not meet these recommendations, performing 6968.3 steps/day. Almost 86% of participants in 
the LSI group performed >7100 steps daily while slightly more than half (53%) of participants in 
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the ESI group did so. A longitudinal analysis combining both groups revealed a trend for an 
inverse correlation between hs-CRP level and daily step count (r = −0.37, p = 0.055). Time in 
vigorous PA/day did not differ among groups (LSI: 5.3 ± 6.9 vs. ESI: 1.0 ± 2.6 min/day; χ2 = 
2.315, p = 0.128), probably because of a high interindividual variability. Moreover, the two 
groups demonstrated similar PA-related energy expenditure throughout the day, as no differences 
observed in terms of kJ/day (LSI: 2554.3 ± 1033.5 vs. ESI: 2654.3 ± 1041.8 kJ/day, p = 0.798) 
and METs/day (LSI: 1.28 ± 0.1 vs. ESI: 1.23 ± 0.1 METs/day, p = 0.203) (Figure 3.2). 
 
Figure 3.2. Daily PA-related energy expenditure expressed as (A) kJ and (B) METs in low (LSI) 
and elevated (ESI) systemic inflammation groups. Values are presented as mean ± SD. 
LSI and ESI demonstrated similar total energy and macronutrient intake throughout the day 
(Table 3.2). The two groups had a daily energy intake of 6949.6–6794.8 kJ, constituted by 15–
16% protein, 38% carbohydrate, and 42% fat. The mean protein intake in both groups was 0.8 
g/kg body weight/day, which represents the recommended daily allowance (RDA) that meets 
97.5% of the population [178]. However, approximately 46% of participants in both groups had 
a daily protein intake of 0.5–0.7 g/kg body weight/day. Separate analysis in leucine and BCAA 
intake revealed that both LSI and ESI received 0.6 g of leucine/kg body weight/day and 0.13–
0.14 g of BCAAs/kg body weight/day, which meets the current recommendations for amino acid 
intake in adults [178]. The two groups, though, differed significantly in respect to daily 
antioxidant vitamin intake, with the LSI group receiving higher amounts of vitamin A (LSI: 
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6590.7 ± 2219 vs. ESI: 4701.8 ± 1552.6 IU/day; χ2 = 5.616, p = 0.018; ES = 0.95; 95% CI = 1.72, 
0.18), vitamin C (LSI: 120.0 ± 55.5 vs. ESI: 77.3 ± 39.1 mg/day; χ2 = 5.421, p = 0.020; ES = 
0.87; 95% CI = 1.63, 0.11), and vitamin E (LSI: 10.0 ± 2.9 vs. ESI: 7.5 ± 3.0 mg/day; χ2 = 4.496, 
p = 0.034; ES = 0.75; 95% CI = 1.50, 0.01) than ESI, by 37%, 59%, and 33%, respectively. 
Moreover, by performing a longitudinal analysis of both groups we observed that daily vitamin 
A intake was inversely correlated with levels of hs-CRP (r = −0.39, p = 0.035) (Figure 3.3). On 
the contrary, daily intake of selenium (LSI: 93.2 ± 29.8 vs. ESI: 96.1 ± 29.7 μg/day, p = 0.793), 
PUFA (LSI: 10.1 ± 2.4 vs. ESI: 8.9 ± 2.6 g/day, p = 0.215), and MUFA (LSI: 43.7 ± 10.8 vs. ESI: 
37.9 ± 10.9 g/day, p = 0.168) was comparable in the two groups. 
 
Table 3.2. Dietary macronutrient and micronutrient intake in LSI and ESI groups. 
Parameter LSI (n = 17) ESI (n = 17) p Value χ2 
Total Energy (kJ/day) 6952.9 ± 1241.8 6797.8 ± 1136.8 0.771 0.085 
Protein     
g/day 63.8 ± 20.3 66.9 ± 14.6 0.183 1.770 
g/kg BM/day 0.8 ± 0.3 0.8 ± 0.2 0.817 0.054 
% of total calories 15 ± 2.7 16 ± 3.0   
Leucine (g/day) 4.89 ± 1.7 5.13 ± 1.2 0.430 0.624 
BCAAs (g/day) 11.38 ± 3.6 11.53 ± 2.4 0.533 0.389 
Carbohydrates     
g/day 156.2 ± 37.6 154.9 ± 52.7  0.901 0.016 
% of total calories 37.7 ± 6.9 37.5 ± 8.4   
Fat     
g/day 79.3 ± 12.5 73.7 ± 17.0 0.318 0.996 
% of total calories 42.0 ± 4.0 41.7 ± 7.1   
PUFA (g/day) 10.1 ± 2.4 8.9 ± 2.6 0.275 1.191 
MUFA (g/day) 43.7 ± 10.8 37.9 ± 10.9 0.359 0.840 
Vitamin A (IU/day) 6590.7 ± 2219.6 4701.8 ± 1552.6 1 0.018 5.616 
Vitamin C (mg/day) 120.0 ± 55.5 77.3 ± 39.1 1 0.020 5.421 
Vitamin E (mg/day) 10.0 ± 2.9 7.5 ± 3.0 1 0.034 4.496 
Selenium (μg/day) 93.2 ± 29.8 96.1 ± 29.7 0.589 0.292 
Data are presented as mean ± SD. BM: Body mass; BCAA: Branched chain amino acids; PUFA: 
Polyunsaturated fatty acids; MUFA: Monounsaturated fatty acids. 1 Significant difference between 
groups. 
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Figure 3.3. The relationship between serum hs-CRP level and daily dietary intake of Vitamin A. 
 
3.4. Discussion 
The present study is the first, to our knowledge, to compare the levels of habitual PA, sedentary 
time, and dietary intake between healthy elderly men with low and elevated low-grade systemic 
inflammation (inflammaging). Our findings suggest that older adults characterized by low levels 
of systemic inflammation perform more steps and spent more time in MVPA throughout the day 
and they receive higher amounts of dietary antioxidant vitamins (i.e., vitamins A, C, and E) on a 
daily basis compared to their counterparts with elevated systemic inflammation. 
Participants were categorized as having either “low” or “elevated” low-grade systemic 
inflammation according to their serum levels of hs-CRP. This acute-phase protein is considered 
a valid and informative marker of inflammaging [179] and has been previously used as a single 
marker to identify levels of systemic inflammation in older adults [170]. The term inflammaging, 
first introduced by Franceschi and his colleagues [4], refers to the development of a chronic, low-
grade inflammation phenotype with advancing age. However, the presence of obesity, either in 
young or older individuals, results in elevated systemic inflammation, which has been defined as 
metaflammation (metabolic inflammation) and is primarily mediated by the adipose tissue [8]. 
Although the underpinning mechanisms of inflammaging and metaflammation may be different, 
these two chronic inflammatory conditions may overlap [16]. Therefore, in an attempt to focus 
on inflammaging in this study, we included only nonobese elderly men (according to WHO 
criteria). Moreover, LSI and ESI groups were very homogeneous in terms of body composition, 
since they did not differ in body weight, fat mass, percent of fat, FFM, and LBM. All participants 
were also nonsarcopenic according to the criteria established by the EWGSOP [168], since the 
existence of sarcopenia could act as a covariate in our investigation, interfering with their ability 
to habitually perform PA [169]. 
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Previous cross-sectional studies have investigated the association between habitual PA and 
inflammatory biomarkers in middle-aged and older adults [23, 49-52, 54-60]. However, only two 
utilized accelerometry to quantify not only the quantity but also the quality (intensity) of habitual 
PA in the otherwise healthy elderly with physiological and elevated chronic, low-grade systemic 
inflammation [23, 59]. This study attempted to extend the current literature by providing insights 
concerning the differences in PA and dietary intake profile among elderly men with low and 
elevated low-grade systemic inflammation. The use of accelerometry to objectively assess the 
quantity and intensity of habitual PA is a strength of our study, as most of the previously cited 
studies [49-52, 54, 57, 58, 60] are based on questionnaires, self-reports, or interviews. The use of 
accelerometers over a 7-day period to assess PA and sedentary time has been reported to be a 
valid and reproducible methodological approach in the elderly [180]. 
Although sedentary time and time spent in light- and moderate-intensity activities throughout 
the day were similar between LSI and ESI, we noted that overall the LSI group performed more 
steps and spent more time in MVPA on a daily basis. This suggests that not only the volume of 
habitual PA but also the intensity in which daily physical activities are performed may interfere 
with the development of chronic, low-grade systemic inflammation in older individuals. Our 
findings further build on previous reports that higher volume of habitual PA is associated with 
lower levels of pro-inflammatory mediators in healthy elderly individuals [50, 54, 57] and COPD 
patients [55]. Moreover, this inverse association between PA and inflammation is suggested to 
be dose-dependent, so that the more physically active an individual is, the lower the chronic 
inflammatory milieu [50, 52, 60]. Although only a trend (r = −0.37, p = 0.055) for an inverse 
correlation between hs-CRP level and daily step number was observed in our study, possibly 
because of an interindividual variability in daily step counts of our participants (we used 
accelerometers whereas questionnaires were utilized by others), these findings collectively 
suggest that habitual PA may be associated with inflammaging in an inverse, dose-response 
pattern. Furthermore, it has been recently reported that the impact of PA on chronic low-grade 
inflammation is not only dose-dependent but also intensity-dependent, as moderate-to-vigorous 
activities induce greater improvements in the inflammatory profile of older adults while light- or 
moderate-intensity physical activities are accompanied by no changes in inflammatory mediators 
[181]. Indeed, Wahlin-Larsson et al. [23] found that in recreationally active elderly women, the 
time spent in MVPA is inversely associated with serum levels of CRP, a finding also reported in 
younger individuals [182]. The mechanism/s through which PA reduces or prevents low-grade 
systemic inflammation in the elderly remains to be elucidated. Observational, cross-sectional 
studies are not designed to identify the mechanisms that underline the effects of systematic PA 
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on chronic inflammation and as such, more intervention studies are needed [167, 181]. Based on 
the fact that inflammaging is tightly regulated by the balance between pro- and anti-inflammatory 
mediators [183], a possible mechanism could be that PA, and especially MVPA, suppresses the 
production of pro-inflammatory cytokines and molecules that trigger the inflammatory milieu, 
and enhances the production of anti-inflammatory mediators [167, 181, 184]. Moreover, the 
process of inflammaging may be further affected by the age-associated increase in the production 
of reactive oxygen and nitrogen species (RONS) that lead to redox balance disturbances and 
subsequent activation of the redox-sensitive NF-κB signaling pathway that stimulates the 
expression of numerous pro-inflammatory mediators such as TNF-α, IL-6, IL-1β, and CRP [69, 
83]. As such, a vicious cycle of RONS and pro-inflammatory molecule production is propagated, 
driving a chronic, systemic pro-inflammatory phenotype [17, 69]. Regular participation in 
moderate-to-vigorous intensity exercise has been shown to attenuate both basal and exercise-
induced levels of oxidative damage, enhance the antioxidant capacity, and improve the DNA 
repair machinery in healthy, elderly individuals [185, 186]. Thus, it can be proposed that 
systematic MVPA may prevent the development of inflammaging by lowering the production of 
RONS and levels of oxidative damage in the elderly. 
LSI and ESI also differed significantly in terms of physical performance. More specifically, 
LSI exhibited higher performance in the SPPB test compared to ESI and this observation is in 
line with previous findings reporting that older adults with elevated systemic inflammation 
demonstrate lower physical performance [24, 187]. Although the underlying mechanism leading 
from chronic inflammation to functional decline has not been clarified yet, it has been reported 
that systemic inflammation may impact physical performance by decreasing skeletal muscle mass 
[22, 69]. However, in this study, the two groups demonstrated similar LBM, ALM, and SMI, 
indicating that the observed difference in physical performance was not muscle-mass-dependent. 
A previous report, though, by Wahlin-Larsson and colleagues [23] provided evidence that 
increased systemic inflammation influences muscle regeneration by decreasing the proliferation 
rate of myoblasts. In addition, increased inflammation and cytokine production may also reduce 
the quiescent satellite cells pool and attenuate their differentiation capacity [22]. Therefore, it can 
be assumed that elevated systemic inflammation may contribute to physical performance 
deterioration by attenuating the regeneration potential of the aged skeletal muscle. 
We also utilized 7-day recalls to perform a thorough screening of the dietary intake in the LSI 
and ESI groups, focusing on macronutrients and micronutrients that have been shown to elicit 
either a pro- or an anti-inflammatory effect, and could be therefore characterized as ‘key 
modifiers’ in the process of inflammaging. LSI and ESI demonstrated similar energy and 
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macronutrient intake, consuming 6794.8–6949.6 kJ/day composed of 15–16% protein, 38% 
carbohydrates, and 42% fat. Our group recently conducted a literature review suggesting that 
protein intake, especially that of whey protein and soy or isoflavone-enriched soy protein, may 
indirectly offer antioxidative and anti-inflammatory benefits beyond its ability to stimulate 
skeletal muscle protein synthesis [69]. Also, Zhou et al. [188] performed a meta-analysis on the 
effects of whey protein supplementation on levels of CRP, concluding that increased whey protein 
intake may induce favorable effects on individuals with elevated baseline CRP levels. However, 
in this study, we noted that daily protein intake was similar between LSI and ESI, with both 
groups receiving on average ~0.8 g/kg BM/day, which is in line with WHO RDA for protein 
[178]. BCAA and leucine intake were also compared among groups to provide a qualitative 
determination of daily protein intake. Although leucine is classified as a BCAA, we decided to 
present it separately because its role may differ from that of the other BCAAs, especially in the 
elderly where a higher amount of leucine should be consumed through diet to efficiently stimulate 
muscle protein synthesis and preserve muscle loss [189, 190]. In our present work, we observed 
that LSI and ESI had a similar daily intake of BCAAs and leucine, meeting the recommendations 
for amino acid intake in adults [178]. Daily carbohydrate intake was also similar among groups 
(154–156 g/day), indicating that it does not play a prominent role in the development of 
inflammaging. Previous reports have noted that only increased consumption of high glycemic 
index carbohydrates may be associated with increased levels of inflammation [191]. 
Unfortunately, the determination of glycemic index and glycemic load in our participants’ daily 
diets was not feasible. 
Similarly, no differences were observed in total fat consumption among groups, with LSI and 
ESI receiving 79 and 74 g/day, respectively, which corresponds in both groups to 42% of daily 
energy intake. Although previous reports have indicated that increased fat consumption is 
associated with elevated systemic markers of inflammation [191, 192], this was not the case here. 
High fat diets, and primarily SFA, have been reported to induce substantial alterations in the gut 
microbial flora (i.e., increases gut mucosa permeability, epithelial brier disruption) that result in 
enhanced translocation of lipolysaccharide (LPS) in the circulation, thus promoting the 
development of low-grade systemic inflammation [192, 193]. However, it should be highlighted 
here that not all SFA demonstrate equal properties and consumption of specific SFA (i.e., C14:0, 
C15:0, C17:0, CLA, and trans-palmitoleic) has been associated with positive effects on 
cardiovascular health [194]. On the other hand, increased intake of MUFA and/or PUFA has been 
proposed to counteract the pro-inflammatory cascade by reducing the translocation of LPS in the 
circulation [192] and suppressing the eicosanoid and PAF inflammatory pathways [68]. Indeed, 
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many studies have revealed an inverse association between higher intake of dietary PUFA and/or 
MUFA and levels of pro-inflammatory mediators such as hs-CRP and IL-6 [191]. In this study, 
although no statistically meaningful differences were observed in dietary MUFA and PUFA 
intake between groups, LSI displayed a higher intake of MUFA and PUFA, by 15% and 13.5%, 
respectively, compared to ESI. 
Interestingly, we noted significant differences between LSI and ESI in terms of antioxidant 
vitamin intake. More specifically, daily dietary intake of vitamins A, C, and E in LSI was higher 
by 37%, 59%, and 33%, respectively, as compared to ESI. These vitamins play a major role in 
immune function, so that adequate intake enhances innate, cell-mediated, and humoral antibody 
immunity while deficiency promotes the opposite effects [63, 195]. With aging, the production 
of reactive oxygen and nitrogen species and that of pro-inflammatory cytokines rises 
significantly, propagating a vicious cycle of oxidative stress and inflammation that promotes a 
chronic low-grade inflammatory state [17, 69]. Vitamin A has been shown to promote a T-helper 
type 2 immune response by reducing the expression of pro-inflammatory cytokines (i.e., 
interferon-γ, TNF-α and IL-12) and adipocytokines (i.e., leptin) [63, 195] while it may also inhibit 
the activation of the redox-sensitive nuclear factor-kappa B (NF-κB) [63, 195], a principal 
mediator of the bidirectional interaction between oxidative stress and inflammation [69]. 
Moreover, the pivotal role of vitamin A in chronic inflammation is further supported by the fact 
that a deficit in vitamin A intake is associated with a pronounced pro-inflammatory state and 
inability to cope with pathogens, as well as with reduced phagocytic capacity of macrophages 
[63]. Vitamin C also reduces the production of pro-inflammatory cytokines through inhibition of 
the transcription factor NF-κB [63]. The anti-inflammatory effect of this micronutrient is further 
supported by a previous investigation where vitamin C intake was inversely associated with levels 
of CRP and tissue plasminogen activator (t-PA) antigen in elderly men [196]. Furthermore, 
vitamin C acts as a potent antioxidant, protecting cells from ROS-mediated oxidative damage, 
while it may also boost the synthesis of other antioxidants such as vitamin E [63]. Likewise, 
vitamin E is able to confer protection against oxidative stress by increasing the concentration of 
endogenous antioxidant enzymes, such as SOD, CAT, and GPX, and it also prevents oxidative 
damage in the cell membrane [63, 197]. Evidence based on human studies indicates that vitamin 
E supplementation in older adults improves immune function [63] and is associated with a lower 
concentration of pro-inflammatory mediators [198]. Collectively, these data corroborate the 
higher antioxidant vitamin intake observed in LSI in the present study, indicating that vitamins 
A, C, and E may contribute to the control of low-grade systemic inflammation in the elderly. By 
contrast, no differences were observed in selenium intake between LSI and ESI, although 
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selenium is also considered a micronutrient that may efficiently influence both innate and 
acquired immune function and may enhance the antioxidative defense system [63]. 
3.5. Conclusions 
We found that elderly men with low levels of systemic inflammation are characterized by 
higher quality and quantity of habitual PA and ingested higher amounts of antioxidant vitamins 
A, C, and E through normal diet when compared to those with increased systemic inflammation. 
To the best of our knowledge, this is the first study to directly compare elderly men of low and 
increased low-grade systemic inflammation in respect to habitual PA and dietary profile. PA and 
antioxidant vitamin intake appear to be discriminant factors of inflammaging and healthy aging. 
Future research should further explore the cause and effect as well as the dose-response 
relationship between PA and/or antioxidant vitamins and inflammaging. 
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Comparison of elderly men with low and elevated chronic systemic inflammation in 
indices of strength, oxidative stress and inflammation 
Draganidis D, Poulios A, Laschou V, Tzatzakis T, Papanikolaou K, Kritikos S, Deli CK, 
Georgakouli K, Avloniti A, Pappas A, Jamurtas AZ, Fatouros IG. 
Abstract 
The aim of the study was to examine differences among elderly men with low and elevated 
chronic systemic inflammation (CSI) in indices of the immune system, oxidative stress, 
antioxidant capacity and strength of the upper and lower body. A total of thirty-three, healthy, 
elderly men aged 65-75 years were included in the study and grouped as either ″low‶ CSI (LCSI: 
n=16; hs-CRP: < 1 mg/L) or ″elevated‶ CSI (ECSI: n=17; hs-CRP: > 1 mg/L) according to their 
serum levels of high-sensitivity CRP (hs-CRP). All participants were assessed for 
anthropometrics, body composition via Dual Emission X-ray Absorptiometry (DXA), handgrip 
strength and lower limb muscle strength on a leg extension machine. Blood samples were also 
collected for the determination of white blood cells (WBC), granulocytes (GRA), monocytes 
(MON) and lymphocytes (LYM) concentration as well as for the measurement of protein 
carbonyls (PC) and total antioxidant capacity (TAC) in serum. ECSI was characterized by almost 
a 4-fold greater hs-CRP value compared to LCSI (ECSI: hs-CRP = 0.6±0.1 mg/L vs LCSI: hs-
CRP = 2.3±0.8 mg/L, p=0.00). ECSI and LCSI were comparable in terms of anthropometric 
characteristics, body mass index, fat percent, fat mass, fat free mass, lean body mass as well as in 
handgrip and lower limb muscle strength. Moreover, no differences were observed among groups 
in WBC, GRA, MON and LYM counts and in PC concentration. In contrast, significant 
differences observed between groups in TAC, with LCSI displaying a greater antioxidant capacity 
than ECSI by 60% (p<0.05). In conclusion, white blood cell counts and protein carbonyl 
concentration as well as muscle strength of the lower and upper body are not different among 
elderly men with ″low‶ CSI and ″elevated‶ CSI. However, those with low levels of CSI are 
characterized by a greater antioxidant capacity compared to their counterparts with elevated CSI. 
Keywords: chronic systemic inflammation, white blood cells, protein carbonyl, muscle strength 
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Σύγκριση ηλικιωμένων ανδρών με χαμηλή και υψηλή χρόνια συστημική φλεγμονή 
σε δείκτες δύναμης, οξειδωτικού στρες και φλεγμονής 
Δραγανίδης Δ, Πούλιος Α, Λάσχου Β, Τζατζάκης Θ, Παπανικολάου Κ, Κρητικός Σ, Δελή Χ, 
Γεωργακούλη Κ, Αυλωνίτη Α, Παππάς Α, Τζιαμούρτας Α, Φατούρος Ι 
Περίληψη 
Σκοπός της μελέτης ήταν να διερευνήσει την ύπαρξη διαφορών μεταξύ ηλικιωμένων ανδρών με 
χαμηλή και υψηλή χρόνια συστημική φλεγμονή (ΧΣΦ), σε δείκτες ανοσοποιητικού συστήματος, 
οξειδωτικού στρες, αντιοξειδωτικής ικανότητας και δύναμης άνω και κάτω άκρων. Στη μελέτη 
έλαβαν μέρος συνολικά 33 υγιείς, άνδρες εθελοντές ηλικίας 65-75 ετών, οι οποίοι 
κατηγοριοποιήθηκαν με βάση τα επίπεδα της C-αντιδρώσας πρωτεΐνης υψηλής ευαισθησίας (hs-
CRP) σε δύο ομάδες: α) ομάδα χαμηλής ΧΣΦ (hs-CRP < 1 mg/L) και β) ομάδα υψηλής ΧΣΦ 
(hs-CRP > 1 mg/L). Όλοι οι συμμετέχοντες υποβλήθηκαν σε αξιολόγηση των σωματομετρικών 
τους χαρακτηριστικών, της σύστασης σώματος με μηχάνημα διπλής ενεργειακής απορρόφησης 
ακτινών Χ (DXA), της μέγιστης δύναμης χειρολαβής και των 10ΜΕ κάτω άκρων στο μηχάνημα 
εκτάσεις γονάτων. Επιπλέον υποβλήθηκαν σε αιμοληψία για τη βιοχημική αξιολόγηση των 
λευκοκυττάρων και των υποπληθυσμών τους, των πρωτεϊνικών καρβονυλίων, που είναι δείκτης 
οξείδωσης των πρωτεϊνών, και της συνολικής αντιοξειδωτικής ικανότητας στον ορό. Η μέση 
συγκέντρωση hs-CRP στην ομάδα υψηλής ΧΣΦ ήταν περίπου 4 φορές μεγαλύτερη από εκείνη 
στην ομάδα χαμηλής ΧΣΦ (υψηλής ΧΣΦ: hs-CRP=0.6±0.1 mg/L / χαμηλής ΧΣΦ: hs-
CRP=2.3±0.8 mg/L, p=0.00). Οι δύο ομάδες δεν διέφεραν μεταξύ τους όσον αφορά τα 
σωματομετρικά χαρακτηριστικά, το δείκτη μάζας σώματος, το ποσοστό λίπους, τη λιπώδη μάζα, 
την άλιπη μάζα, τη μυϊκή μάζα καθώς και τη δύναμη χειρολαβής και κάτω άκρων. Επίσης δεν 
εντοπίστηκαν διαφορές μεταξύ των ομάδων στη συγκέντρωση λευκοκυττάρων και πρωτεϊνικών 
καρβονυλίων. Αντίθετα, σημαντικές διαφορές εντοπίστηκαν στη συνολική αντιοξειδωτική 
ικανότητα, με την ομάδα χαμηλής ΧΣΦ να παρουσιάζει κατά 60% υψηλότερη αντιοξειδωτική 
ικανότητα από την ομάδα υψηλής ΧΣΦ (p<0.05). Συμπερασματικά, η συγκέντρωση 
λευκοκυττάρων και πρωτεϊνικών καρβονυλίων αλλά και τα επίπεδα δύναμης δεν 
διαφοροποιούνται μεταξύ ηλικιωμένων ανδρών με χαμηλή ΧΣΦ και υψηλή ΧΣΦ. Ωστόσο, τα 
άτομα με χαμηλή ΧΣΦ χαρακτηρίζονται από υψηλότερη αντιοξειδωτική ικανότητα. 
Λέξεις κλειδιά: χρόνια συστημική φλεγμονή, λευκοκύτταρα, πρωτεϊνικά καρβονύλια, μυϊκή 
δύναμη 
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Σε υγιή άτομα τρίτης ηλικίας συχνά παρατηρείται η ανάπτυξη χρόνιας συστημικής φλεγμονής 
(ΧΣΦ), η οποία χαρακτηρίζεται από αυξημένα επίπεδα προ-φλεγμονώδη κυτταροκινών στην 
κυκλοφορία κατά 2 έως 3 φορές σε σχέση με τις φυσιολογικές τους τιμές [5]. Η εκδήλωση της 
ΧΣΦ αποδίδεται στη μακροχρόνια έκθεση του ανοσοποιητικού συστήματος σε αντιγόνα και 
στρεσογόνους παράγοντες (χημικούς, φυσικούς ή/και διατροφικούς) που σε συνδυασμό με την 
σημαντική αύξηση στο προσδόκιμο ζωής προάγουν την παρατεταμένη ενεργοποίηση του 
ανοσοποιητικού [1, 4]. Το φαινόμενο αυτό στη διεθνή βιβλιογραφία αναφέρεται ως 
″inflammaging‶, βασισμένο στα δύο συνθετικά ″inflammation‶ (= φλεγμονή) και ″aging‶ (= 
γήρανση) [4], ενώ για τη διάγνωσή του οι κύριες μεταβλητές που αξιολογούνται είναι η 
συγκέντρωση των κυτταροκινών ιντερλευκίνη-6 (IL-6) και ιντερλευκίνη-1 (IL-1), του 
παράγοντα νέκρωσης όγκων-α (TNF-α) καθώς και η συγκέντρωση της C-αντιδρώσας πρωτεΐνης 
(CRP), στο πλάσμα [5]. Η ΧΣΦ αποτελεί μια απειλητική για την υγεία κατάσταση καθώς η 
ύπαρξή της έχει συνδεθεί με την παθογένεση αρκετών χρόνιων ασθενειών και γηριατρικών 
συνδρόμων όπως το μεταβολικό σύνδρομο, ο διαβήτης τύπου 2, η αθηροσκλήρωση, οι 
καρδιαγγειακές και νευροεκφυλιστικές παθήσεις και η χρόνια αποφρακτική πνευμονοπάθεια [8, 
10, 11]. 
Σύμφωνα με τη θεωρεία της ″μοριακής φλεγμονής‶ στη γήρανση, η οποία αναπτύχθηκε στις 
αρχές της δεκαετίας του 2000 από τους Chung και συνεργάτες [83], τα κύτταρα του 
ανοσοποιητικού συνυπάρχουν σε έναν φαύλο κύκλο με δραστικά είδη οξυγόνου και αζώτου 
(ΔΕΟΑ) κατά τον οποίο μια σημαντική αύξηση στα τελευταία πυροδοτεί την αυξημένη 
κινητοποίηση στα πρώτα καταλήγοντας στην εμφάνιση της ΧΣΦ. Πιο συγκεκριμένα, η αυξημένη 
παραγωγή ΔΕΟΑ λόγω της γήρανσης σε συνδυασμό με τη μειωμένη αντιοξειδωτική ικανότητα 
στα άτομα αυτά, προκαλεί οξειδωτικό στρες και αυξημένο οξειδωτικό τραυματισμό σε 
μακρομόρια όπως το DNA, οι πρωτεΐνες και τα λιπίδια [7, 19]. Αυτό έχει ως αποτέλεσμα τη 
διαταραχή της οξειδοαναγωγικής ισορροπίας και την ενεργοποίηση του ρυθμιζόμενου από την 
οξειδοαναγωγική κατάσταση μεταγραφικού παράγοντα NF-κB (nuclear factor kappa B) μέσω 
του οποίου διεγείρεται η ενεργοποίηση προ-φλεγμονώδη μορίων της φλεγμονής, κυρίως των 
κυτταροκινών IL-6, IL-1, TNF-α και της CRP [32, 84]. Καθώς η διαδικασία της φλεγμονής 
εξελίσσεται, αυξάνεται η κινητοποίηση των μονοκυττάρων και μακροφάγων τα οποία με τη 
σειρά τους εκκρίνουν περαιτέρω ΔΕΟΑ παρατείνοντας με αυτόν τον τρόπο τον φαύλο αυτό 
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κύκλο [17]. Ωστόσο, η συγκεκριμένη θεωρεία βασίζεται κυρίως σε ερευνητικά δεδομένα 
προερχόμενα από μελέτες σε πειραματόζωα και κύτταρα, ενώ  η διερεύνησή της σε ηλικιωμένα 
άτομα είναι ελλιπής. Επίσης άγνωστο παραμένει εάν τα ηλικιωμένα άτομα με υψηλή ΧΣΦ 
παρουσιάζουν διαφορετικά επίπεδα οξειδωτικού στρες, αντιοξειδωτικής ικανότητας και 
κυττάρων του ανοσοποιητικού από τα αντίστοιχα άτομα με χαμηλή ΧΣΦ. 
Επιπλέον, ερευνητικά δεδομένα υποδεικνύουν ότι ηλικιωμένα άτομα με υψηλή ΧΣΦ 
παρουσιάζουν αυξημένο κίνδυνο για ταχύτερη απώλεια μυϊκής μάζας και δύναμης καθώς και για 
ανάπτυξη σαρκοπενίας [25-27, 69]. Συγκεκριμένα, σε μελέτη στην οποία συμμετείχαν συνολικά 
986 άνδρες και γυναίκες με μέση ηλικία 74,6 έτη διαπιστώθηκε ότι όσοι χαρακτηρίζονταν από 
αυξημένα επίπεδα IL-6 και CRP παρουσίασαν κατά 2 έως 3 φορές μεγαλύτερο κίνδυνο απώλειας 
> 40% της μυϊκής τους μάζας τρία χρόνια αργότερα, συγκριτικά με εκείνους που 
χαρακτηρίζονταν από χαμηλές συγκεντρώσεις  των συγκεκριμένων κυτταροκινών [27]. 
Παρομοίως, σε δείγμα 2177 ηλικιωμένων ανδρών και γυναικών (70-79 έτη) η υψηλότερη 
συγκέντρωση TNF-α στην αρχική μέτρηση συσχετίστηκε με μεγαλύτερη απώλεια μυϊκής μάζας 
και δύναμης πέντε χρόνια αργότερα [26]. Παρ’ όλα αυτά, η σύγκριση μεταξύ ηλικιωμένων 
ατόμων με χαμηλή ΧΣΦ και υψηλή ΧΣΦ σε λειτουργικά τεστ δύναμης άνω και κάτω άκρων δεν 
έχει διερευνηθεί. 
Συνεπώς, ο σκοπός της συγκεκριμένης μελέτης ήταν να συγκρίνει ηλικιωμένους άνδρες με 
χαμηλή ΧΣΦ και υψηλή ΧΣΦ: i) στους δείκτες του ανοσοποιητικού συστήματος: α) 
λευκοκύτταρα, β) κοκκιοκύτταρα, γ) μονοπύρηνα και δ) λεμφοκύτταρα, ii) στον δείκτη 
οξείδωσης των πρωτεϊνών: πρωτεϊνικά καρβονύλια, iii) στην συνολική αντιοξειδωτική 
ικανότητα του ορού, καθώς και iv) στη δύναμη άνω και κάτω άκρων μέσω αξιολόγησης της 
δύναμης χειρολαβής και της μέγιστης δύναμης στο μηχάνημα εκτάσεις γονάτων, αντίστοιχα. 
4.2. Μέθοδος και Διαδικασία 
4.2.1. Συμμετέχοντες 
Για την εύρεση εθελοντών στην ευρύτερη περιοχή της Θεσσαλίας μοιράστηκαν ενημερωτικά 
φυλλάδια και πραγματοποιήθηκαν ενημερωτικές ομιλίες σε χώρους όπου συχνάζουν άτομα 
τρίτης ηλικίας (π.χ. Κ.Α.Π.Η., κέντρα άθλησης και αναψυχής). Η αρχική προϋπόθεση ήταν οι 
εθελοντές να είναι άνδρες ηλικίας 65-75 ετών. Περίπου 55-60 εθελοντές προσήλθαν στη 
Σ.Ε.Φ.Α.Α. του Π.Θ., στο χώρο του SMART Lab, όπου συμπλήρωσαν έναν έντυπο ιατρικού 
ιστορικού και εξετάστηκαν επίσης από ιατρό. Προκειμένου να συμπεριληφθούν στη μελέτη, οι 
εθελοντές έπρεπε να πληρούν τα παρακάτω κριτήρια: α) να είναι μη καπνιστές, β) να είναι 
ανεξάρτητοι στην καθημερινότητά τους, γ) να μην πάσχουν από οποιαδήποτε χρόνια πάθηση 
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(π.χ. μεταβολική, καρδιαγγειακή, νευρολογική, αναπνευστική ή νεφρική), δ) να μην πάσχουν από 
φλεγμονώδεις παθήσεις (π.χ. οστεοαρθρίτιδα, ρευματοειδής αρθρίτιδα), ε) να μην πάσχουν από 
διαβήτη τύπου 2 και ζ) να μην χρησιμοποιούν ή έχουν χρησιμοποιήσει πρόσφατα αντιβιοτικά ή 
άλλου είδους φαρμακευτικά σκευάσματα τα οποία θα μπορούσαν να επηρεάσουν τα επίπεδα 
συστημικής φλεγμονής. Ακολούθως, 33 εθελοντές οι οποίοι πληρούσαν τα παραπάνω κριτήρια 
συμπεριλήφθηκαν τελικά στη μελέτη και πραγματοποίησαν τρεις ακόμη επισκέψεις. Στην πρώτη 
επίσκεψη, υποβλήθηκαν σε αξιολόγηση των σωματομετρικών τους χαρακτηριστικών, της 
σύστασης σώματος και της δύναμης άνω και κάτω άκρων. Στις επόμενες δύο διαδοχικές 
επισκέψεις (μια εβδομάδα μετά την πρώτη επίσκεψη), οι εθελοντές προσέρχονταν νωρίς το πρωί, 
μετά από ολονύκτια νηστεία και υποβάλλονταν σε μια αιμοληψία (~8-10 ml) για τον 
προσδιορισμό των δεικτών του ανοσοποιητικού, του οξειδωτικού στρες, της αντιοξειδωτικής 
ικανότητας και του επιπέδου ΧΣΦ. Η ΧΣΦ αξιολογήθηκε με βάση τις τιμές της hs-CRP (high-
sensitivity CRP), όπου ο μέσος όρος των τιμών της hs-CRP από τις δυο μετρήσεις 
χρησιμοποιήθηκε ως η τελική τιμή για το κάθε άτομο, και η κατηγοριοποίηση των εθελοντών σε  
″χαμηλή" ΧΣΦ  και ″υψηλή" ΧΣΦ έγινε ως εξής: ″χαμηλή" ΧΣΦ = hs-CRP < 1 mg/L και 
″υψηλή‶ ΧΣΦ = hs-CRP > 1 mg/L, σύμφωνα με προηγούμενη μελέτη [199]. Οι εθελοντές 
ενημερώθηκαν πλήρως για τον σκοπό της συγκεκριμένης μελέτης αλλά και για τα πιθανά οφέλη 
από τη συμμετοχής τους και στη συνέχεια υπέγραψαν έντυπο συναίνεσης. Η μελέτη έλαβε 
έγκριση από την  Εσωτερική Επιτροπή Δεοντολογίας του Πανεπιστημίου Θεσσαλίας. 
4.2.2. Διαδικασία μέτρησης 
Σωματομετρικά χαρακτηριστικά και σύσταση σώματος: To σωματικό βάρος και ύψος των 
συμμετεχόντων μετρήθηκε με ακρίβεια μισού κιλού (0,5 kg) και μισού εκατοστού (0,5 cm) 
αντίστοιχα, σε μηχανικό ζυγό με αναστημόμετρο (Beam Balance-Stadiometer, SECA, Vogel & 
Halke, Hamburg, Germany). Οι εξεταζόμενοι φορώντας ελαφρύ ρουχισμό και χωρίς παπούτσια 
πραγματοποίησαν την μέτρηση από όρθια θέση στο κέντρο του ζυγού, έχοντας τις φτέρνες 
ενωμένες και τα πέλματα να σχηματίζουν γωνία περίπου 60ο, σύμφωνα με προηγούμενη μελέτη 
[171]. Η σύσταση σώματος αξιολογήθηκε σε μηχάνημα διπλής ενεργειακής απορρόφησης 
ακτινών Χ (DXA, GE Healthcare, Lunar DPX NT, Diegem, Belgium), με τον εξεταζόμενο σε 
ξαπλωτή θέση, όπως έχει περιγραφεί σε προηγούμενη μελέτη [172]. 
Δύναμη άνω και κάτω άκρων: Για την αξιολόγηση της δύναμης άνω άκρων μετρήθηκε η 
μέγιστη δύναμη χειρολαβής με τη χρήση φορητού υδραυλικού χειροδυναμόμετρου Jamar (Jamar 
5030J1, Jamar Technologies, Horsham, Pennsylvania, USA). Οι δοκιμαζόμενοι εκτέλεσαν την 
μέτρηση από καθιστή θέση, με τον αγκώνα να σχηματίζει γωνία 90ο και τον καρπό σε ουδέτερη 
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θέση κρατώντας το δυναμόμετρο στη θέση 2 [200]. Από αυτή τη θέση πραγματοποιήθηκαν 3 
προσπάθειες σε κάθε χέρι με διάλειμμα 60 δευτερολέπτων, όπου στην κάθε προσπάθεια  
εκτελέστηκε μέγιστη ισομετρική σύσπαση για 5 δευτερόλεπτα. Ως τελική επίδοση καταγράφηκε  
η μεγαλύτερη τιμή σε χιλιόγραμμα (kg). Η αξιολόγηση της δύναμης των κάτω άκρων εκτιμήθηκε 
μέσω της εκτέλεσης 10 μέγιστων επαναλήψεων (10 ΜΕ) στο μηχάνημα έκτασης γονάτων. Οι 
εξεταζόμενοι, μετά από κατάλληλη προθέρμανση εκτελούσαν το πρώτο σετ και σε περίπτωση 
που ήταν σε θέση να εκτελέσουν περισσότερες από 10 επαναλήψεις, ο εξεταστής τους 
σταματούσε και τους έδινε διάλειμμα 2 λεπτών. Έπειτα αυξάνονταν τα κιλά και επιχειρούσαν 
δεύτερη προσπάθεια. Αν και πάλι ήταν σε θέση να εκτελέσουν περισσότερες από 10 
επαναλήψεις, ο εξεταστής επαναλάμβανε την ίδια διαδικασία. Η διαδικασία αυτή συνεχιζόταν 
μέχρι οι εξεταζόμενοι να εκτελέσουν 10 μέγιστες επαναλήψεις (περίπου 3-4 σετ). 
Αιμοληψίες και διαχείριση των δειγμάτων: Σε κάθε αιμοληψία λαμβάνονταν 8-10 ml 
αρτηριοφλεβικού αίματος από τη μεσοβασιλική φλέβα και ενώ ο εξεταζόμενος βρισκόταν σε 
καθιστή θέση. Περίπου 2 ml διοχετεύονταν σε σωλήνα με αντιπηκτικό (EDTA) και στη συνέχεια 
τοποθετούνταν στον αυτόματο αναλυτή αίματος (Mythic 18, Orphee SA, Geneva, Switzerland) 
για να πραγματοποιηθεί η γενική ανάλυση αίματος. Τα υπόλοιπα 6-8 ml μοιράζονταν σε δυο 
σωληνάρια με κενό αέρος, τα οποία παρέμεναν για 20 λεπτά σε θερμοκρασία δωματίου και στη 
συνέχεια φυγοκεντρούνταν στις 3500 στροφές για 10 λεπτά στους 4οC. Αμέσως μετά τη 
φυγοκέντρηση το υπερκείμενο υγρό (ορός) συλλέγονταν και μοιραζόταν σε σωληνάκια 
eppendorf και στη συνέχεια αποθηκεύονταν στους -80οC, για την ανάλυση των πρωτεϊνικών 
καρβονυλίων, της συνολικής αντιοξειδωτικής ικανότητας και της hs-CRP.  
Πρωτεϊνικά καρβονύλια: Για τη μέτρηση των πρωτεϊνικών καρβονυλίων πραγματοποιήθηκε 
η βιοχημική αντίδραση του κάθε δείγματος με 2,4- dinitrophenylhydrazine (DNPH) που επέφερε 
τη μετατροπή του σε 2,4-dinitrophenylhydrazone (DNP-hydrazone). Ο προσδιορισμός της 
συγκέντρωσης του 2,4- DNP-hydrazone, πραγματοποιήθηκε με τη μέτρηση της απορρόφησης 
του κάθε δείγματος στο φωτόμετρο, στα 375 nm. Η τελική συγκέντρωση των πρωτεϊνικών 
καρβονυλίων υπολογιζόταν σύμφωνα με την εξίσωση: PC (nmol/mL) = (Absδείγμα – Αbsτυφλό) / 
0,022 × 1000/50 [201]. 
Συνολική αντιοξειδωτική ικανότητα: Η συνολική αντιοξειδωτική ικανότητα του ορού 
αξιολογήθηκε μέσω της βιοχημικής αντίδρασης των αντιοξειδωτικών συστατικών του ορού με 
τη ρίζα 1,1-diphenyl-2-picrylhydrazyl (DPPH), κατά την οποία τα αντιοξειδωτικά δρουν ως δότες 
υδρογόνου προκαλώντας την αναγωγή της συγκεκριμένης ρίζας, μειώνοντας με αυτό τον τρόπο 
τη συγκέντρωσή της. Η τελική συγκέντρωση της ρίζας DPPH υπολογίστηκε μετρώντας την 
απορρόφηση του δείγματος στα 520 nm. Τα αποτελέσματα εκφράστηκαν ως μmol DPPH που 
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καθαρίστηκαν ανά ml ορού, χρησιμοποιώντας την εξίσωση: [(%Αbs μείωσης / 100) x 50 x 50] / 
100 [201]. 
hs-CRP: Πραγματοποιήθηκε ποσοτική ανάλυση της hs-CRP στον ορό, με τη μέθοδο της 
θολοσιμετρικής ανάλυσης ενισχυμένης με τη χρήση σωματιδίων λάτεξ (CRP LX High Sensitive, 
Cobas®), σε αναλυτή Cobas Integra 400 plus (Roche). Το κατώτατο όριο ανίχνευσης της 
ανάλυσης ήταν 0,1 mg/L και ο συντελεστής διακύμανσης μεταξύ των αναλύσεων ήταν μία 
τυπική απόκλιση (1 SD) [199]. 
4.2.3. Στατιστική ανάλυση 
O έλεγχος της κανονικότητας των δεδομένων πραγματοποιήθηκε με βάση το Shapiro-Wilk 
τεστ. Για τη διερεύνηση των διαφορών μεταξύ των δυο ομάδων (χαμηλή ΧΣΦ και υψηλή ΧΣΦ) 
στις εξαρτημένες μεταβλητές χρησιμοποιήθηκε το T-Test για ανεξάρτητα δείγματα. Το μέγεθος 
της επίδρασης (ΜτΕ) καθώς και τα διαστήματα εμπιστοσύνης (ΔΕ) για τις εξαρτημένες 
μεταβλητές υπολογίστηκαν με τη μέθοδο του Hedge’s g. Το ΜτΕ χαρακτηρίστηκε ως κανένα, 
μικρό, μεσαίου μεγέθους και μεγάλο για τιμές 0.00-0.19, 0.20-0.49, 0.50-0.79 και ≥ 0.8, 
αντίστοιχα. Το επίπεδο σημαντικότητας ορίστηκε στο p<0.05. Όλα τα δεδομένα παρουσιάζονται 
ως μέσος όρος ± τυπική απόκλιση. Για τις στατιστικές αναλύσεις χρησιμοποιήθηκε το στατιστικό 
πακέτο SPSS 20.0 (IBM SPSS Statistics). 
4.3. Αποτελέσματα 
Τα περιγραφικά χαρακτηριστικά των δύο ομάδων παρουσιάζονται στον Πίνακα 4.1. Οι δύο 
ομάδες δεν διέφεραν μεταξύ τους στα σωματομετρικά χαρακτηριστικά και σε παραμέτρους της 
σύστασης σώματος. Ωστόσο, σημαντική ήταν η διαφορά τους στα επίπεδα ΧΣΦ με την ομάδα 
υψηλής ΧΣΦ να παρουσιάζει σχεδόν κατά 3 φορές υψηλότερες τιμές hs-CRP συγκριτικά με την 
ομάδα χαμηλής ΧΣΦ (χαμηλή ΧΣΦ: 0.6±0.1 / υψηλή ΧΣΦ: 2.3±0.8, p=0.00, ΜτΕ=2.86, ΔΕ=-
3.84, -1.89). 
 
Πίνακας 4.1. Περιγραφικά χαρακτηριστικά των δύο ομάδων. 
Παράμετρος Χαμηλή ΧΣΦ (N=16)  Υψηλή ΧΣΦ (N=17) 
Ηλικία (έτη) 69.1 ± 2.8 68.8 ± 2.9 
Σωματικό ύψος (μ) 1.70 ± 0.07 1.72 ± 0.05 
Σωματικό βάρος (κιλά) 81.4 ± 7.6 84.7 ± 5.5 
ΔΜΣ (κιλά/μ2) 26.92 ± 2.77 27.86 ± 2.51 
Λιπώδης μάζα (κιλά) 23.20 ± 6.26 25.54 ± 3.14 
Λίπος (%) 29.41 ± 4.14 31.25 ± 1.72 
Άλιπη μάζα (κιλά) 56.89 ± 4.26 57.70 ± 4.35 
Μυϊκή μάζα (κιλά) 53.86 ± 4.13 55.12 ± 5.11 
Μυϊκή μάζα άκρων (κιλά) 23.32 ± 2.43 24.15 ± 1.83 
Δείκτης μυϊκής μάζας (κιλά/μ2) 8.03 ± 0.78 8.11 ± 0.64 
hs-CRP (mg/L) 0.6 ± 0.1 2.3 ± 0.8* 
* : Υποδηλώνει σημαντική διαφορά μεταξύ των ομάδων, p < 0.01.  
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Τα αποτελέσματα έδειξαν ότι στην αξιολόγηση της δύναμης, τόσο στη μέγιστη δύναμη 
χειρολαβής (t(30)=1.139, p>0.05) όσο και στις 10 ΜΕ κάτω άκρων στο μηχάνημα  έκτασης 
γονάτων (t(30)=-0.526, p>0.05), δεν υπήρξαν στατιστικά σημαντικές διαφορές μεταξύ των δυο 
ομάδων (Σχήμα 4.1). 
 
Σχήμα 4.1. 10ΜΕ κάτω άκρων στο μηχάνημα εκτάσεις γονάτων (1Α) και μέγιστη δύναμη 
χειρολαβής (1Β) στις δυο ομάδες.  
 
Επίσης από τη σύγκριση των ομάδων χαμηλή ΧΣΦ και υψηλή ΧΣΦ ως προς του δείκτες του 
ανοσοποιητικού συστήματος διαπιστώθηκε ότι δεν υπήρχε στατιστικά σημαντική διαφορά 
μεταξύ τους στα επίπεδα λευκοκυττάρων (t(30)=-1.088, p>0.05), κοκκιοκυττάρων (t(30)=-0.963, 
p>0.05), μονοπύρηνων (t(30)=-0.916, p>0.05) και λεμφοκυττάρων (t(30)=-0.433, p>0.05) 
(Σχήμα 4.2). 
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Σχήμα 4.2. Συστημικά επίπεδα Λευκοκυττάρων (2Α), Κοκκιοκυττάρων (2Β), Λεμφοκυττάρων 
(2Γ) και Μονοπύρηνων (2Δ) στις δύο ομάδες.  
 
Από τη σύγκριση των δύο ομάδων σε δείκτες οξειδωτικό στρες και αντιοξειδωτικής 
ικανότητας, προέκυψε ότι η συγκέντρωση πρωτεϊνικών καρβονυλίων δεν διέφερε μεταξύ των 
ομάδων (t(28)=0.334, p>0.05), ωστόσο, οι δυο ομάδες παρουσίασαν σημαντική διαφορά στη 
συνολική αντιοξειδωτική ικανότητα του ορού, με την ομάδα χαμηλή ΧΣΦ να παρουσιάζει 
υψηλότερη αντιοξειδωτική ικανότητα από τη ομάδα υψηλή ΧΣΦ (t(28)=-2.275, p=0.03, 
ΜτΕ=0.96, ΔΕ=0.24, 1.69) (Σχήμα 4.3). 
 
Σχήμα 4.3. Συγκέντρωση πρωτεϊνικών καρβονυλίων (3Α) και συνολική αντιοξειδωτική ικανότητα  
(3Β) στις δυο ομάδες. 
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Στη συγκεκριμένη μελέτη εξετάστηκε η ύπαρξη διαφορών μεταξύ ηλικιωμένων ανδρών με 
χαμηλή και υψηλή ΧΣΦ, σε δείκτες του ανοσοποιητικού συστήματος, οξειδωτικού στρες, 
αντιοξειδωτικής ικανότητας και της δύναμης των άνω και κάτω άκρων. Για το σκοπό αυτό 
πραγματοποιήθηκε βιοχημική αξιολόγηση για τον προσδιορισμό της συγκέντρωσης των 
λευκοκυττάρων, των κοκκιοκυττάρων, των μονοπύρηνων και των λεμφοκυττάρων στην 
κυκλοφορία καθώς και της συγκέντρωσης πρωτεϊνικών καρβονυλίων και της συνολικής 
αντιοξειδωτικής ικανότητας στον ορό. Όσον αφορά τη δύναμη, αξιολογήθηκε η μέγιστη δύναμη 
χειρολαβής και οι 10ΜΕ στα κάτω άκρα στο μηχάνημα έκτασης γονάτων. Τα αποτελέσματα της 
μελέτης υποδεικνύουν ότι ηλικιωμένα άτομα με χαμηλή ΧΣΦ και υψηλή ΧΣΦ παρουσιάζουν 
παρόμοια συγκέντρωση λευκοκυττάρων, οξειδωτικού στρες και δύναμης, ωστόσο εκείνοι με 
χαμηλή ΧΣΦ χαρακτηρίζονται από υψηλότερη αντιοξειδωτική ικανότητα. 
Οι συμμετέχοντες στη παρούσα μελέτη διαχωρίστηκαν στις δυο ομάδες, χαμηλή ΧΣΦ και 
υψηλή ΧΣΦ, σύμφωνα με τα επίπεδα της hs-CRP στον ορό. Ο συγκεκριμένος δείκτης 
συστημικής φλεγμονής θεωρείται ένας έγκυρος και αξιόπιστος δείκτης ΧΣΦ [179] και έχει 
χρησιμοποιηθεί σε αρκετές μελέτες προκειμένου να κατηγοριοποιήσει ηλικιωμένα άτομα με 
βάση τα επίπεδα φλεγμονής [170, 199]. Οι δυο ομάδες παρουσίασαν παρόμοια σωματομετρικά 
χαρακτηριστικά και σύσταση σώματος, γεγονός που υποδηλώνει ότι το δείγμα ήταν αρκετά 
ομοιογενές και διέφερε μόνο ως προς τα επίπεδα ΧΣΦ. Επιπλέον, σύμφωνα με τα κριτήρια του 
Παγκόσμιου Οργανισμού Υγείας (WHO) για την παχυσαρκία και με βάση τις τιμές του ΔΜΣ 
των συμμετεχόντων, τα άτομα των δυο ομάδων κατατάσσονται ως μη-παχύσαρκα, κάτι που είναι 
σημαντικό για την ερμηνεία των αποτελεσμάτων της συγκεκριμένης μελέτης. Η ύπαρξη 
παχυσαρκίας έχει συνδεθεί με την ανάπτυξη ΧΣΦ, η οποία όμως οφείλεται κατά κύριο λόγο στο 
λιπώδη ιστό (μεταβολική φλεγμονή) [8, 16], και όχι αποκλειστικά στη γήρανση που είναι και ο 
σκοπός της παρούσας μελέτης. 
Μέχρι σήμερα, η αξιολόγηση της ύπαρξης ΧΣΦ αλλά και η σύγκριση των επιπέδων της 
μεταξύ ηλικιωμένων ατόμων βασίζεται κατά κύριο λόγο στη μέτρηση των κυτταροκινών IL-1, 
IL-6, TNF-α και της C-αντιδρώσας πρωτεΐνης [25-27, 170, 199]. Δεν υπάρχουν μελέτες που να 
εξετάζουν εάν η αύξηση στα επίπεδα των κυτταροκινών συνοδεύεται από αυξημένη 
συγκέντρωση λευκοκυττάρων και των υποπληθυσμών τους σε ηλικιωμένα άτομα με ΧΣΦ. Η 
κινητοποίηση των λευκοκυττάρων σε συνθήκες οξείας φλεγμονής, όπως η άσηπτη φλεγμονή που 
προκαλείται από την άσκηση, είναι άμεση και η συγκέντρωσή τους στην κυκλοφορία παραμένει 
αυξημένη για 24-48 ώρες [202]. Τα κοκκιοκύτταρα, τα οποία αποτελούνται από ουδετερόφιλα, 
βασεόφιλα και ηωσινόφιλα, αυξάνονται επίσης αμέσως μετά από άσκηση λόγω της ύπαρξης 
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άσηπτης φλεγμονής και παραμένουν αυξημένα έως και 48 ώρες μετά [203]. Ωστόσο, στην 
παρούσα μελέτη δεν παρατηρήθηκαν διαφορές στα λευκοκύτταρα και τους υποπληθυσμούς τους 
μεταξύ των ομάδων χαμηλή ΧΣΦ και υψηλή ΧΣΦ, υποδεικνύοντας ότι τα συγκεκριμένα κύτταρα 
του ανοσοποιητικού παρουσιάζουν διαφορετικό μοτίβο ενεργοποίησης σε συνθήκες οξείας 
φλεγμονής και ΧΣΦ. 
 Η εκδήλωση ΧΣΦ σε άτομα τρίτης ηλικίας έχει αποδοθεί στη μειωμένη αντιοξειδωτική 
ικανότητα και στην αυξημένη παραγωγή ΔΕΟΑ που έχουν ως αποτέλεσμα την πρόκληση 
οξειδωτικού στρες και οξειδωτικού τραυματισμού σε πρωτεΐνες, λιπίδια και DNA [7, 19]. Η 
παρατεταμένη αύξηση στα επίπεδα οξειδωτικού στρες οδηγεί σε διαταραχή της 
οξειδοαναγωγικής ισορροπίας και την επακόλουθη ενεργοποίηση του μεταγραφικού παράγοντα 
NF-κB ο οποίος με τη σειρά του διεγείρει την ενεργοποίηση προ-φλεγμονώδη κυτταροκινών και 
της CRP [32, 84]. Με αυτό τον τρόπο εξελίσσεται η διαδικασία της φλεγμονής, κατά την οποία 
τα μονοκύτταρα και μακροφάγα εκκρίνουν περαιτέρω ΔΕΟΑ δημιουργώντας έτσι έναν φαύλο 
κύκλο που έχει ως αποτέλεσμα την μακροχρόνια εκδήλωση φλεγμονής [17, 83]. Στη 
συγκεκριμένη μελέτη η συγκέντρωση πρωτεϊνικών καρβονυλίων, που αποτελεί δείκτη 
οξείδωσης των πρωτεϊνών, ήταν παρόμοια στα άτομα με χαμηλή ΧΣΦ και υψηλή ΧΣΦ. Ωστόσο, 
οι δυο ομάδες διέφεραν σημαντικά μεταξύ τους όσον αφορά τη συνολική αντιοξειδωτική 
ικανότητα, με την ομάδα χαμηλής ΧΣΦ να παρουσιάζει κατά 60% μεγαλύτερη αντιοξειδωτική 
ικανότητα συγκριτικά με την ομάδα υψηλής ΧΣΦ. Το συγκεκριμένο εύρημα είναι σε συμφωνία 
με πρόσφατη μελέτη η οποία έδειξε ότι τα ηλικιωμένα άτομα με χαμηλή ΧΣΦ προσλαμβάνουν 
μεγαλύτερες ποσότητες αντιοξειδωτικών βιταμινών μέσω της τροφής και είναι περισσότερο 
δραστήρια κατά τη διάρκεια της ημέρας, συγκριτικά με άτομα ίδιας ηλικίας με υψηλή ΧΣΦ [199]. 
Επομένως, τα παραπάνω ευρήματα αποδεικνύουν πως η διατήρηση της αντιοξειδωτικής 
ικανότητας, μέσω επαρκούς πρόσληψης διαιτητικών αντιοξειδωτικών και φυσικής 
δραστηριότητας, μπορεί να προλάβει την εκδήλωση ΧΣΦ στα άτομα τρίτης ηλικίας. 
Προηγούμενες μελέτες έχουν συσχετίσει τα επίπεδα συστημικής φλεγμονής σε ηλικιωμένα 
άτομα με την απώλεια μυϊκής δύναμης [25-27]. Πιο συγκεκριμένα, άτομα με αυξημένα επίπεδα 
CRP ή/και προφλεγμονώδη κυτταροκινών όπως η IL-6 και ο TNF-α, παρουσίασαν κατά 2 έως 3 
φορές μεγαλύτερη απώλεια δύναμης στα επόμενα 2-5 χρόνια, τόσο στη μέγιστη δύναμη 
χειρολαβής [27] όσο και στη δύναμη κάτω άκρων [25, 26]. Στην παρούσα μελέτη ωστόσο, 
συγκρίνοντας τη μέγιστη δύναμη χειρολαβής και τις 10ΜΕ κάτω άκρων μεταξύ των ομάδων 
χαμηλή ΧΣΦ και υψηλή ΧΣΦ, δεν εντοπίστηκαν στατιστικά σημαντικές διαφορές. Η απώλεια 
μυϊκής δύναμης ως αποτέλεσμα της ΧΣΦ φαίνεται πως επέρχεται μέσω της προκαλούμενης από 
τη ΧΣΦ απώλεια μυϊκής μάζας [25, 69]. Σύμφωνα με πρόσφατη ανασκοπική μελέτη, η ΧΣΦ 
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μπορεί να οδηγήσει σε απώλεια μυϊκής μάζας και λειτουργικής ικανότητας, είτε μέσω αύξησης 
της πρωτεόλυσης ενεργοποιώντας το σύμπλοκο του πρωτεασώματος, είτε μέσω μείωσης της 
δυνατότητας ενεργοποίησης των σηματοδοτικών πρωτεϊνών που επάγουν την πρωτεϊνοσύνθεση 
στο μυ [69]. Επομένως, το γεγονός ότι οι δυο ομάδες στη παρούσα μελέτη δεν διέφεραν ως προς 
τα επίπεδα δύναμης άνω και κάτω άκρων, μπορεί να αποδοθεί στο ότι δεν εντοπίστηκαν μεταξύ 
τους διαφορές στη μυϊκή μάζα. 
4.5. Συμπεράσματα 
Συμπερασματικά, τα ευρήματα της παρούσας μελέτης υποδεικνύουν ότι ηλικιωμένα άτομα με 
χαμηλή ΧΣΦ και υψηλή ΧΣΦ δεν διαφέρουν μεταξύ τους ως προς τα συστημικά επίπεδα 
λευκοκυττάρων και οξείδωσης των πρωτεϊνών, ωστόσο οι συμμετέχοντες με χαμηλή ΧΣΦ 
παρουσιάζουν μεγαλύτερη αντιοξειδωτική ικανότητα από εκείνους με υψηλή ΧΣΦ. Η 
συγκέντρωση των λευκοκυττάρων και των υποπληθυσμών τους στην κυκλοφορία φαίνεται ότι 
δεν επηρεάζεται από την ανάπτυξη ΧΣΦ. Αντίθετα, η καλύτερη αντιοξειδωτική ικανότητα 
εμφανίζεται ως αποτρεπτικός παράγοντας για την εκδήλωση ΧΣΦ. Επιπλέον, άτομα με χαμηλή 
και υψηλή ΧΣΦ δεν παρουσιάζουν διαφορές στη δύναμη άνω και κάτω άκρων εφόσον 
παρουσιάζουν παρόμοια επίπεδα μυϊκής μάζας. 
4.6. Σημασία για την ποιότητα ζωής 
Η εκδήλωση χρόνιας συστημικής φλεγμονής στα άτομα τρίτης ηλικίας είναι μια απειλητική 
για την υγεία κατάσταση καθότι συνδέεται άμεσα με την παθογένεση αρκετών χρόνιων 
ασθενειών και γηριατρικών συνδρόμων, αλλά και με την απώλεια μυϊκής μάζας και λειτουργικής 
ικανότητας. Όλα αυτά συνεπάγονται την επιδείνωση της ποιότητας ζωής αυτών των ατόμων 
έχοντας παράλληλα σοβαρό αντίκτυπο στην οικονομική τους κατάσταση καθότι αυξάνονται 
σημαντικά τα έξοδα νοσηλείας. Η διατήρηση της αντιοξειδωτικής ικανότητας με την αύξηση της 
ηλικίας είναι ένας σημαντικός παράγοντας που μπορεί να προλάβει την εκδήλωση χρόνιας 
συστημικής φλεγμονής και επιτυγχάνεται μέσω επαρκούς πρόσληψης διαιτητικών 
αντιοξειδωτικών και φυσικής δραστηριότητας. 
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Results related to inflammaging, proteasome-mediated proteolysis and anabolic resistance 
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5.1. Inflammaging and proteolysis via the ubiquitin-proteasome system 
5.1.1. Variables measured in skeletal muscle 
Proteasome activity and protein levels: The proteasome is the main proteolytic system in 
skeletal muscle composed by 7 α- and 7 β-subunits. Three of the proteasome β-subunits, β1, β2 
and β5, and the corresponding immunoproteasome βi-subunits, β1i, β2i and β5i, are responsible 
for the proteasome proteolytic activities caspase-like (C-L), trypsin-like (T-L) and chymotrypsin-
like (CT-L), respectively [204]. The proteolytic activities T-L and CT-L were measured though 
a specific proteasome peptidase assay while protein expression levels of proteasome (β5) and 
immunoproteasome (β1i, β2i and β5i) subunits were measured using immunoblot analysis 
(western blotting) as described previously [172]. 
Protein oxidation: Oxidative protein modification was evaluated by measuring the formation 
of protein carbonyl and 3-nitrotyrosine groups in skeletal muscle. Protein carbonyl groups were 
detected via immunoblot analysis (western blotting) using the OxyBlot kit, whereas 3-
nitrotyrosine groups were detected via immunohistochemistry.   
Phosphorylated IKKα/β: The IκB kinase (IKK) is a protein complex composed by two 
catalytic subunits α and β (IKKα and ΙΚΚβ) and a regulatory subunit γ (IKKγ) [32]. 
Phosphorylated IKKα/β (activated) results in degradation of the inhibitors of NF-κB (IκBs) and 
activation of the NF-κB [32]. Phosphorylated levels of IKKα/β were detected using 
immunohistochemistry.  
Nuclear-erythroid factor 2 (Nrf2): Nrf2 is a transcription factor that mediates adaptive 
responses to cellular stress and regulates the antioxidant response system protecting cells from 
oxidative stress [204]. Upon activation, Nrf2 is translocated into the nucleus and results in 
proteasome activation [204]. Nuclei levels of Nrf2 were detected using immunohistochemistry.     
Heme Oxygenase 1 (HO1): HO1 is positively regulated by Nrf2 under conditions of oxidative 
stress, protecting against oxidative damage and ensuring cell survival [205]. Protein expression 
of HO1 was measured using immunoblotting (western blotting). 
5.1.2. Results 
Proteasome activity and protein levels: At baseline, the two groups differed significantly in 
CT-L proteasome activity with HSI eliciting higher activity than LSI by almost 40% (HSI: 256.9 
± 86.5 UF vs LSI: 185.6 ± 51.0 UF; P = 0.044; ES: 0.99; 95% CI: 0.00/1.97) (Figure 5.1A). 
Moreover, a Pearson correlation analysis revealed that baseline levels of CT-L activity are 
significantly correlated with levels of hs-CRP (r = 0.576; P = 0.010) (Figure 5.2A). At 3h 
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following protein supplementation, CT-L activity increased in both HSI (P = 0.015; ES: -1.18; 
95% CI: -2.24/-0.11) and LSI (P = 0.001; ES: -1.74; 95% CI: -2.77/-0.71) by 44% and 86% 
respectively (Figure 5.1A). Although the rise in CT-L activity was greater in LSI by 42%, no 
statistically meaningful differences observed between groups. By performing a longitudinal 
analysis of both groups we observed that the rise in CT-L activity following exercise was 
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No differences observed in T-L proteasome activity between HSI and LSI (HIS: 388.9 ± 173.0 
UF vs LSI: 452.4 ± 198.8 UF) at baseline (Figure 5.1B). T-L activity increased by 24% in HSI 
and by 38% in LSI at 3h following protein supplementation, however only the rise observed in 
LSI was statistically meaningful (P = 0.049; ES: -0.88; 95% CI: -1.85/0.09) (Figure 5.1B). 
Protein expression levels of the catalytic immunoproteasome subunits β1i, β2i and β5i, and the 
proteasomal β5 subunit remained unaltered following protein supplementation in both groups 
(Figure 5.3). No group differences observed at any time point. 
Figure 5.1. Changes in Chymotrypsin-like (A) 
and trypsin-like (B) proteasome activity in HIS 
and LSI.  
Figure 5.2. The correlation of baseline 
Chymotrypsin-like activity with hs-CRP levels (A) 
and percent change of chymotrypsin-like activity 
following protein ingestion (B). 
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Protein oxidation: Concentration of protein carbonyl groups at baseline was higher in HSI 
compared to LSI by 47% (HSI: 23.5 ± 6.2 vs LSI: 15.9 ± 7.6; P = 0.026; ES: 0.79; 95% CI: -
0.20/1.78) (Figure 5.4). In HSI, protein carbonyl concentration declined by 31% at 3h following 
protein supplementation (P = 0.025; ES: 1.23; 95% CI: 0.16/2.29), whereas in LSI it remained 
unaltered (Figure 5.4). No differences observed among groups at 3h post-supplementation (HSI: 
16.2 ± 4.3 vs LSI: 14.7 ± 4.0) (Figure 5.4). 
 
3-Nitrotyrosine levels were unchanged from basal in both groups, independent of muscle fiber 
type (Figure 5.5A-C). In addition, no group differences observed in 3-nitrotyrosine levels at any 
time point. However, in both groups, there was a significantly higher concentration of 3-
nitrotyrosine in type II compared to type I muscle fibers both at baseline (HSI: P = 0.000; ES: -
2.07; 95% CI: -3.29/-0.86 and LSI: P = 0.000; ES: -1.86; 95% CI: -2.91/-0.81) and 3 hours after 
Figure 5.3. Changes in the expression of proteasome and immunoproteasome β-
subunits in HSI and LSI.  
Figure 5.4. Changes in protein carbonyl groups in HSI and LSI. * Indicates significant 
difference from baseline, p<0.05, # Indicates significant difference between groups, p<0.05.  
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protein supplementation (HSI: P = 0.001; ES: -2.65; 95% CI: -4.08/-1.21 and LSI: P = 0.000; ES: 
-1.65; 95% CI: -2.67/-0.64) (Figure 5.5D). 
 
Phosphorylated IKKα/β: At baseline, HSI demonstrated significantly higher amount of 
phosphorylated IKKα/β protein by 37% as compared to LSI (HSI: 14.69 ± 3.2 A.U. vs LSI: 10.70 
± 3.1 A.U.; P = 0.044; ES: 1.18; 95% CI: 0.01/2.36), whereas no group differences were detected 
at 3h post-supplementation (HSI: 11.77 ± 3.2 vs LSI: 10.20 ± 2.6) (Figure 5.6). Phosphorylation 
of IKKα/β following protein supplementation was not statistically changed from baseline in either 
group, despite a 20% reduction observed in HSI (Figure 5.6). 
 
Figure 5.5. Changes in 3-Nitrotyrosine levels in HSI and LSI. 3-Nitrotyrosine levels in type I muscle fibers (A), type 
II muscle fibers (B), mixed fibers (C) and comparison of type I vs type II fibers (D) between HSI and LSI. * Indicates 
significant difference between type I and type II fibers, p<0.05. 
Figure 5.6. Changes in phosphorylated IKKα/β in HSI and LSI. # Indicates 
significant difference between groups, p<0.05.  
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Nuclear-erythroid factor 2 (Nrf2): Nuclei levels of Nrf2 were equal among groups in both the 
basal state (HSI: 42.44 ± 7.8 vs LSI: 38.90 ± 6.5) and following protein supplementation (HSI: 
44.65 ± 5.9 vs LSI: 49.73 ± 10.6) (Figure 5.7). At 3h of the postprandial period, a significant rise 
of the Nrf2 nuclei levels was observed only in LSI by almost 28% (P = 0.012; ES: -1.15; 95% 
CI: -2.28/-0.02) (Figure 5.7). 
 
Heme Oxygenase 1 (HO1): Heme Oxygenase 1 (HO1) protein was comparable among groups 
in both time points (Pre: HSI: 0.43 ± 0.18 vs LSI: 0.43 ± 0.19; Post: HSI: 0.44 ± 0.15 vs LSI: 
0.42 ± 0.19) and remained unaltered from baseline independent of group (Figure 5.8). 
 
5.2. Inflammaging and anabolic resistance  
5.2.1. Variables measured in skeletal muscle 
Ribosomal protein S6 (rpS6): rpS6 is a downstream mediator of the Akt – mTOR signaling 
cascade that upon activation enhances translation initiation leading to increased protein synthesis 
[206]. We measured levels of phosphorylated rpS6 using immunoblotting (western blotting). 
Ribosome biogenesis: Ribosome biogenesis is the process characterizing the synthesis of new 
ribosomes and regulates the translational capacity [206]. The expression of the upstream regulator 
Figure 5.7. Changes in nuclei levels of Nrf2 in HSI and LSI. * Indicates 
significant difference from baseline, p<0.05.   
Figure 5.8. Changes in Heme Oxygenase 1 in HSI and LSI.   
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of ribosome biogenesis, c-Myc and phosphorylation state of the transcription initiation factor 1A 
(TIF-1A) were tested using immunoblotting (western blotting). 
Amino acid transporters: The activity of amino acid transporters in skeletal muscle regulates 
the availability of amino acids and therefore is crucial for muscle protein synthesis [207]. Protein 
expression of the amino acid transporters, L-type amino acid transporter 1 (LAT1) and sodium-
coupled neutral amino acid transporter 2 (SNAT2)/SLC38A2, was measured using 
immunoblotting (western blotting).   
5.2.2. Results 
Ribosomal protein S6 (rpS6): Phosphorylation of rpS6 was significantly increased only in LSI 
following exercise and protein ingestion by 1.5-fold (P = 0.001; ES: -1.44; 95% CI: -2.48/-0.41). 
Moreover, at 3h following protein ingestion phosphorylation of rpS6 was greater in LSI compared 
to HSI (HSI: 1.3 ± 0.4 fold change vs LSI: 2.5 ± 1.4 fold change; P = 0.030; ES: -1.08; 95% CI: 




Ribosome biogenesis: c-Myc protein expression remained unchanged in either group 
following exercise and protein ingestion (P > 0.05) and was similar among groups in both time-
points (Figure 5.10A). Similarly, phosphorylation state of TIF-1A was comparable between LSI 
and HSI in both time points and no significant alteration (P > 0.05) was observed after protein 
ingestion for both groups (Figure 5.10B).  
Figure 5.9. Changes in phosphorylated rpS6 in HSI and LSI.   
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Amino acid transporters: LAT1 protein expression was similar between LSI and HSI in both 
time-points and was not altered significantly (P > 0.05) after protein ingestion in either group 
(Figure 5.11A). Likewise, TIF-1A phosphorylation remained unaltered during the 3h postprandial 
period in both LSI and HSI (P > 0.05) and no differences were observed among groups across 





Figure 5.10. Changes in protein expression of c-Myc (A) and 
phosphorylation state of TIF-1A (B) in HSI and LSI.   
Figure 5.11. Changes in protein expression of LAT1 (A) and 
SNAT2/SLC38A2 (B) in HSI and LSI.   
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By integrating results from previous in vivo and in vitro studies, our literature review identified 
that the main mechanisms through which inflammaging may lead to loss of skeletal muscle mass 
and frailty is the reduced skeletal muscle’s anabolic potential and the increased activation of the 
proteolytic machinery [69]. The former incorporates the reduced activation of the intracellular 
anabolic signaling pathway and the unresponsiveness of muscle protein synthesis to protein 
feeding, while the latter is characterized by increased activation of the transcriptional factor NF-
κB and subsequent upregulation of proteasome activity, leading to proteolysis [69]. Our results 
corroborate these findings providing evidence for first time that the NF-κB/ubiquitin-proteasome 
pathway is activated while the translational efficiency is downregulated in the skeletal muscle of 
aged adults characterized by chronic low-grade systemic inflammation.  
In the fasted state, we observed that older adults with increased systemic inflammation 
exhibited higher chymotrypsin-like proteasome activity accompanied by greater amount of 
phosphorylated IKKα/β and increased concentration of protein carbonyl groups in skeletal 
muscle. Upon activation, the IKKα/β phosphorylates and inactivates the inhibitor of the NF-κB, 
IkB complex, allowing the NF-κB to translocate into the nucleus [35] and activate the UPS [32, 
34]. The UPS is also activated in response to increased oxidative stress and protein oxidation in 
order to maintain redox balance [208]. Under oxidative stress, the transcriptional factor Nrf2 is 
activated and translocate to the nucleus where it regulates the transcription of various protective 
genes such as HO1 and the expression of proteasome genes [208]. However, in the present thesis 
nuclear levels of Nrf2 and HO1 expression in the fasted state were equal among groups. 
Therefore, we suggest that during chronic low-grade systemic inflammation in the elderly, the 
elevated levels of pro-inflammatory mediators and the increased protein oxidation may increase 
proteasome activity in the fasted state, through the redox-sensitive transcriptional factor NF-κB 
(Figure 6.1). Protein expression of the catalytic β (proteasome) and βi (immunoproteasome) 
subunits was similar among groups, indicating that the observed difference in proteasome activity 
was dependent on activity per se and not on the increased amount of proteasome as well. 
Furthermore, we observed a significant correlation between hs-CRP levels and chymotrypsin-like 
activity, providing evidence that inflammaging affects proteasome activation in a dose-response 
manner. 
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At 3h following exercise and protein ingestion, chymotrypsin-like proteasome activity 
increased equally in both groups, supporting previous evidence that following an acute bout of 
resistance exercise the UPS is activated in skeletal muscle of older adults, independently of 
protein ingestion [209, 210]. Protein expression of β and βi subunits remained unaltered in the 
postprandial period in both groups, indicating that acute resistance exercise alters proteasome 
activity but not the proteasome quantity in the aged skeletal muscle, and this effect in not 
dependent on the inflammatory status. Interestingly though, we observed that trypsin-like 
proteasome activity was elevated in the postprandial state only in the LSI group, and this elevation 
was accompanied by increased nuclear levels of Nrf2. Thus, unlike to chymotrypsin-like activity, 
inflammaging may differentially affect the trypsin-like activity following acute exercise and 
protein feeding, via the Nrf2 pathway. However, this observation is a preliminary finding that 
should be further investigated by future studies.  
The concentration of 3-nitrotyrosine in skeletal muscle remained unaffected by exercise and 
protein feeding in both groups. Interestingly, type II skeletal muscle fibers were characterized by 
higher levels of 3-nitrotyrosine compared to type I fibers, independent of the inflammatory status 
and the time-point measured. Protein carbonyls declined significantly in the HSI group at 3h 
following protein ingestion as a response to the increased chymotrypsin-like activity, whereas 
their concentration in LSI group remained unaltered, probably because of the already low levels 
in the fasted state. 
With regard to the skeletal muscle’s anabolic potential, our data also suggest that 
inflammaging may negatively affect the anabolic signaling following exercise and protein 
ingestion. More specifically, we observed that phosphorylation of ribosomal protein S6 increased 
only in older adults characterized by low levels of systemic inflammation, whereas no changes 
Figure 6.1. Schematic representation of the proposed molecular mechanism through 
which inflammaging leads to activation of the ubiquitin-proteasome system. 
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were observed in indices of ribosome biogenesis and amino acid transporters in either group. 
Therefore, we suggest that the previously reported reduced muscle protein synthetic response to 
protein feeding under conditions of chronic inflammation [28, 29], may be primarily driven by 
reduced translational efficiency via attenuated activation of the rpS6 and subsequently lower 
translation initiation rate. Collectively, in the present thesis we provide molecular evidence that 
older adults with increased low-grade systemic inflammation exhibit increased proteasomic 
activity in the fasted state and reduced translational efficiency in response to exercise and protein 
feeding, and as such may be more vulnerable to skeletal muscle wasting and functional 
impairments compared to their healthy counterparts. 
We also investigated levels of habitual physical activity, daily dietary intake and physical 
performance as well as blood markers of oxidative stress and antioxidant status in older adults 
characterized by low and elevated levels of chronic low-grade systemic inflammation. Although 
no significant differences observed in lower and upper limb strength among groups, we noticed 
that elderly individuals with low systemic inflammation exhibited higher functional performance 
and were also more physically active, performing more steps and more intense activities 
throughout the day, as compared to those characterized by increased systemic inflammation. In 
addition, dietary intake of antioxidant vitamins (i.e. vitamins A, C and E) was also higher in those 
with low inflammation and accompanied by higher antioxidant capacity in plasma as well. 
Therefore, higher quality and quantity of habitual physical activity and increased antioxidant 
consumption through diet appear to be discriminant factors of inflammaging and successful 
aging, and thus may considered as promising lifestyle-based interventions to prevent the 
development of chronic low-grade systemic inflammation in the elderly.  
Future studies should further invest on these primary findings by exploring the dose-response 
relationship between PA, antioxidant vitamin intake and inflammaging, in acute and long-term 
interventions. Moreover, there is also great need for well-controlled clinical trials to explore the 
response of the NF-κB/ubiquitin proteasome pathway and the Akt-related signaling pathway to 
chronic interventions aiming at reducing low-grade systemic inflammation in older adults, by 
utilizing various protein supplementation protocols and types of exercise. Plant and animal 
derived protein supplementation, especially that of whey and soy protein, may elicit antioxidative 
and anti-inflammatory properties and may therefore be considered as a promising nutritional 
strategy to offset the inflammaging associated skeletal muscle loss and frailty [69]. However, 
their effectiveness has been only tested in animal models so far, and thus, future studies should 
investigate whether increased consumption of plant- and dairy-based protein may aid muscle 
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protein synthesis and preserve muscle function in elderly individuals characterized by increased 
systemic inflammation.
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Inflammaging and Skeletal Muscle: Can Protein
Intake Make a Difference?1,2
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Abstract
Inflammaging is the chronic low-grade inflammatory state present in the elderly, characterized by increased systemic
concentrations of proinflammatory cytokines. It has been shown that inflammaging increases the risk of pathologic
conditions and age-related diseases, and that it also has been associated with increased skeletal muscle wasting, strength
loss, and functional impairments. Experimental evidence suggests that the increased concentrations of proinflammatory
cytokines and primary tumor necrosis factor a observed in chronic inflammation lead to protein degradation through
proteasome activation and reduced skeletal muscle protein synthesis (MPS) via protein kinase B/Akt downregulation.
Dairy and soy proteins contain all the essential amino acids, demonstrate sufficient absorption kinetics, and include other
bioactive peptides that may offer nutritional benefits, in addition to those of stimulating MPS. Whey protein has
antioxidative effects, primarily because of its ability to enhance the availability of reduced glutathione and the activity of the
endogenous antioxidative enzyme system. Soy protein and isoflavone-enriched soy protein, meanwhile, may counteract
chronic inflammation through regulation of the nuclear transcription factor kB signaling pathway and cytokine production.
Although evidence suggests that whey protein, soy protein, and isoflavone-enriched soy proteins may be promising
nutritional interventions against the oxidative stress and chronic inflammation present in pathologic conditions and aging
(inflammaging), there is a lack of information about the anabolic potential of dietary protein intake and protein supplementation
in elderly peoplewith increased systemic inflammation. The antioxidative and anti-inflammatory effects, as well as the anabolic
potential of protein supplementation, should be further investigated in the future with well-designed clinical trials focusing on
inflammaging and its associated skeletal muscle loss. J Nutr doi: 10.3945/jn.116.230912.
Keywords: inflammaging, oxidative stress, skeletal muscle loss, frailty, whey protein, soy protein
Introduction
The progressive loss of skeletal muscle mass and function (i.e.,
muscle strength and endurance and ability to perform daily physical
activities) with advancing age is a well-documented process (1–3)
that may lead to functional limitations, frailty, and hospitalization
(4, 5). Muscle mass is maintained by a constant equilibrium
between the rates of muscle protein synthesis (MPS)7 and degra-
dation, in which a net increase or a decrease occurs when the
balance is disturbed. Nutritional-, hormonal-, neuropathic-, and
inactivity-related factors all may contribute to deregulation of
the molecular milieu of the aged muscle, resulting in muscle
wasting and loss of independence (5).
In the elderly, the development of low-grade, chronic,
systemic inflammation is often observed with age, characterized
by a 2- to 3-fold elevation in circulating inflammatory media-
tors. This has been termed ‘‘inflammaging’’ (inflamm-aging) (6).
Proinflammatory cytokines are key components in this chronic
inflammatory state; thus, the assessment of inflammaging pri-
marily is based on the measurement of systemic concentrations of
IL-6, IL-1, and TNF-a, their soluble receptors IL-1Ra, TNF
receptor, and soluble IL-6 receptor, respectively, and that of the
acute-phase C-reactive protein (CRP) (6–8). Furthermore,
inflammaging may be assessed at the skeletal muscle tissue
level by the quantification of infiltrating macrophages, cytokine
concentrations, and the examination of inflammatory pathways
(7, 8). Although the molecular mechanisms involved in the
interaction between inflammaging and muscle loss is far from
1 The authors report no funding received for this study.
2 Author disclosures: D Draganidis, LG Karagounis, I Athanailidis, A Chatzinikolaou,
AZ Jamurtas, and IG Fatouros, no conflicts of interest.
*To whom correspondence should be addressed. E-mail: ifatouros@pe.uth.gr.
7 Abbreviations used: Bax, BCL2 associated X, apoptosis regulator; Bcl-2, B-cell
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understood, research carried out in animal models revealed that
augmented low-grade inflammation may favor muscle protein
breakdown and inhibit protein synthesis (9, 10).
Although older adults exhibit anabolic resistance (i.e., a
higher protein amount is required to maximally stimulate MPS
than for young individuals) to protein intake, dietary protein is
still the most potent anabolic stimulus in older adults, because it
has been shown to efficiently activate the skeletal muscle
anabolic response in the postprandial period, at rest, and after
resistance exercise (11, 12). A higher (>1.2 g/(kg body weight  d)
compared with a lower (<1.0 g/(kg body weight  d) protein
intake appears to preserve muscle quality in the aged with high
levels of systemic inflammation (13), suggesting that adequate
protein intake may preserve muscle function under chronic
inflammatory conditions. Dairy proteins that include high
amounts of branched-chain amino acids demonstrate fast
(whey protein) and slow (casein protein) digestion and absorp-
tion kinetics and may efficiently stimulate MPS in healthy aged
skeletal muscle (14–16). Soy protein, on the other hand, which
demonstrates somewhat slower kinetics than whey and faster
digestion rates than casein (14), is also rich in branched-chain
amino acids and able to upregulate MPS (14, 16). Whey and
soy protein also possess antioxidant and anti-inflammatory
properties (17, 18). Thus, both animal and plant protein sources
may represent efficient nutritional strategies to counteract
inflammaging and its detrimental effects on skeletal muscle.
This review aims to provide evidence for an anti-inflammatory
and anticatabolic role of protein supplementation in aged skeletal
muscle by presenting molecular and physiologic data that link
protein consumption and muscle wasting under proinflammatory
conditions.
Inflammaging and Its Association with
Frailty
Chung et al. (19) proposed the molecular inflammation theory,
according to which the age-related increase in reactive oxygen
and nitrogen species concentrations and redox balance distur-
bances may lead to a chronic low-grade inflammatory state by
activating redox-sensitive transcriptional factors. The NF-kB
pathway is the most important redox-sensitive signaling path-
way through which oxidative stress may increase the expression
of numerous proinflammatory molecules, especially cytokines
such as TNF-a, IL-6, IL-1b, and CRP, stimulating inflammation
(20, 21). As the inflammatory response escalates, additional
reactive nitrogen and oxygen species are released from immune
cells (e.g., monocytes and macrophages) resulting in a propaga-
tion of cytokine production (8, 22). Thus, a vicious cycle is
propagated, driving a chronic systemic proinflammatory state
that in the elderly has been termed inflammaging (23) (Figure 1).
Is inflammaging, however, associated with skeletal muscle
wasting and strength loss? Data derived from 3075 men and
women aged 70–79 y in the Health, Aging, and Body Compo-
sition Study (24) showed that those with high concentrations of
IL-6 and TNF-a had smaller skeletal muscle area, less appen-
dicular muscle mass, and reduced strength. Similarly, elderly
subjects with elevated IL-6 and CRP concentrations demonstrated
a 2- to 3-fold greater risk of losing >40% of their muscle strength
(25). Moreover, according to a 5-y follow-up study in 2177 men
and women aged 70–79 y, increased baseline concentrations of
TNF-a and its soluble receptor were linked to a greater decline in
muscle mass and strength (26). Although the underlying molec-
ular pathway leading from inflammation to functional decline
has not been clarified yet, increased IL-6 concentrations in the
elderly contribute to the development of disability and functional
dependence (27–31) via direct interactions with key growth
factors in skeletal muscle (32, 33). These findings accord well with
the observation that orally administered cyclo-oxygenase inhibi-
tors in older adults engaged in resistance exercise lead to increased
skeletal muscle mass and strength gains by reducing the production
of IL-6 andmuscle ring-finger-1 in skeletal muscle (34). Therefore,
these studies provide compelling evidence of an association
between inflammaging and a deterioration of skeletal muscle
size and function.
In vivo and in vitro studies indicate that inflammaging-
related muscle wasting may be attributed to a TNF-a mediated
upregulation of the NF-kB pathway and the subsequent activa-
tion of the ubiquitin–proteasome system (UPS) (21, 35, 36).
Increased concentrations of proinflammatory cytokines, i.e.,
TNF-a and/or IL-6, have been shown to activate the inhibitor of
NF-kB (IkB) kinase, which phosphorylates the IkB complex and
results in its degradation, thereby allowing the translocation of
the NF-kB complex into the nucleus (37). The 20S proteasome is
the catalytic part of the UPS, performing the degradation and
removal of abnormal, misfolded, and denatured proteins, and it
also may remove healthy proteins under certain circumstances
(38–42). Under conditions of chronic inflammation, increased
NF-kB expression activates the UPS, resulting in protein degra-
dation by the 20S proteasome subunit and muscle wasting (21,
35, 43, 44). In experimental animals, infusion or injection of
TNF-a resulted in a pronounced loss of skeletal muscle and
body mass (45, 46), probably in a concentration-dependent
manner (47). Moreover, infusion of IL-6 has been shown to al-
ter amino acid turnover and decrease the phosphorylation of
signaling proteins involved in the anabolic pathway, suggesting
that increased IL-6 concentrations contribute to skeletal muscle
atrophy (48, 49).
An interaction between the NF-kB-related proteolytic cas-
cade and anabolic pathways also has been observed in human
skeletal muscle. Older humans exhibited a blunted MPS response
to feeding compared with their younger counterparts that was
attributed to NF-kB overexpression in their skeletal muscles (50).
Later studies revealed that the increased TNF-a–dependent
NF-kB expression attenuates the activation of anabolic signaling
molecules such as Akt and S6K1, leading to reduced MPS and
insulin resistance (51, 52). Thus, chronic inflammation may not
only lead to NF-kB–related skeletal muscle wasting, but it also
may hamper anabolic signaling pathways in skeletal muscle. Anti-
inflammatory treatment with ibuprofen in aged rats reduced
systemic inflammation, increased the rate of MPS and activation
of anabolic intracellular signaling pathways, and significantly
suppressed muscle protein breakdown (10). Although the verifi-
cation of this mechanism (Figure 1) in humans is still missing, this
study clearly shows that inflammaging should be targeted by
nutritional, exercise, and pharmaceutical interventions aimed at
the limitation of sarcopenia and skeletal muscle loss. The
molecular mechanisms regulating the TNF-a/NF-kB/ubiquitin–
proteasome pathway and its crosstalk with Akt-related signaling
in the skeletal muscle of aged adults warrants further investiga-
tion. Although exercise-induced inflammation has been shown to
activate muscle satellite cell content as part of the regeneration or
remodeling process (53, 54), there are limited data on the impact
that age-related chronic inflammation has on satellite cells.
Beenakker et al. (55) show that there is no association between
chronic systemic inflammation and satellite cell number in
patients with rheumatoid arthritis. Future investigations need to
examine whether inflammaging affects satellite cell responses,
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and, if so, what the impact is of anabolic approaches, such as
protein feeding and/or resistance exercise training on these
responses.
A Rationale for Protein Supplementation
for Inflammaging
Protein ingestion is a nutritional strategy that has been studied
extensively as a means of attenuating age-dependent muscle loss
and therefore maintain quality of life (56). This mainly is due to
the resulting postprandial aminoacidemia, which is known in
the short term (hours) to stimulate MPS (57, 58), especially
when combined with resistance-type exercise (59–61). Evidence
indicates that MPS is less sensitive to protein intake in elderly
patients than it is in young individuals; thus, higher relative
amounts of protein may be required in each meal to stimulate
MPS maximally in the aged (61–63).
Although the RDA for protein intake in adults is 0.8 g/(kg
body weight  d), consumption of protein above the RDA has
been proposed to more efficiently prevent muscle wasting and
offer health benefits to the aged (12, 64, 65). Higher protein
intake in community-dwelling adults has been associated with
an attenuation of skeletal muscle loss over a 3-y follow-up (66),
whereas protein intake has been negatively associated with
skeletal muscle strength loss in inflammaging (13). Apart from
the anabolic potential of protein, higher intake in the elderly also
has been proposed in order to boost glutathione synthesis by
providing greater availability of cysteine, which is a precursor
amino acid (67). Because the glutamate cysteine ligase Michaelis
constant for cysteine is close to intracellular cysteine concentra-
tions, increased cysteine intake from dietary protein or other
cysteine-rich sources may lead to substantial glutathione syn-
thesis, especially when intracellular concentrations of glutathi-
one are relatively low (67). Glutathione acts as a potent antioxidant
in the intracellular environment, because it counteracts the pro-
duced reactive oxygen and nitrogen species and also downregulates
signaling pathways mediating immune cell mobilization. There-
fore, there is a potential link between protein intake and skeletal
muscle health in older adults with low-grade inflammation.
Recently, researchers have attempted to shed light on the antiox-
idant and anti-inflammatory properties of dairy and plant proteins
by using both in vivo and in vitro experimental models. Therefore,
the interaction between inflammaging and protein intake will be
presented separately for each protein type in the following
paragraphs. For each protein type, existing evidence will be
reviewed in respect to the effect of proteins on 1) both systemic and
local (skeletal muscle) anti-inflammatory and antioxidant poten-
tial, and 2) their ability to affect skeletal muscle loss and function.
Dairy proteins.Over the last 5 y there has been growing interest
in the antioxidant and anti-inflammatory role of dairy proteins,
primarily that of whey. In vitro models, although they use an
artificial environment, have offered valuable insight in this area.
When C2C12 myoblasts were incubated with whey protein
(80.05 g/100 g) and various concentrations (0.1–0.4 g/L) of
hydrogen peroxide, it was revealed that whey protein was able
to prevent hydrogen peroxide–induced toxicity, reduce lipid
peroxidation, and enhance the activity of several antioxidant
enzymes (68). Similarly, whey protein hydrolysates (WPHs;
100 mg/mL and 200 mg/mL pre- and postincubation, respec-
tively) protected PC12 cells exposed to hydrogen peroxide from
oxidative damage by reducing intracellular concentrations of
Ca2+, suppressing mitochondrial apoptotic pathways (by 14%),
FIGURE 1 Potential pathway linking inflammag-
ing and frailty. CRP, C-reactive protein; MPS,
muscle protein synthesis; RNOS, reactive oxygen
and nitrogen species; [, increase; Y, decrease.
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and maintaining the membrane potential of the mitochondrial
membrane, thereby improving mitochondrial function (69). In
line with the results from Xu et al. (68) in C2C12 myoblasts,
WPH supplementation in PC12 cells (69) upregulated the
activity of antioxidant enzymes, such as catalase and superoxide
dismutase (SOD). The antioxidant properties of whey protein
were illustrated further when C2C12 muscle cell lines were
treated with sheep whey protein (0.78–6.24 mg) by increasing
reduced glutathione concentrations and reducing TBARs and
reactive oxygen species (ROS) (70). Therefore, it appears that
whey protein supplementation in the muscle and other cell lines
prevents the onset of oxidative stress by enhancing the activity of
endogenous antioxidant enzymes and increasing reduced gluta-
thione availability, as well as maintaining mitochondria integ-
rity. These results were corroborated in findings reported by
studies that used rodent models (71–73).
Intraperitoneal [4 mg/(kg body weight  d)] or oral [8 mg/(kg
body weight  d)] ingestion of WPH in albino mice with
hepatonephrotoxicity attenuated the elevation of serum markers
of oxidative damage, such as glutathione pyruvate transaminase,
alkaline phosphatase, creatinine, and TBARs, upregulated the
activities of antioxidant enzymes, and preserved serum urea
nitrogen at normal concentrations, suggesting that WPH also
has the ability to enhance the endogenous antioxidant system in
vivo under pathologic conditions (71). When the antioxidant
properties of diets containing various amounts of whey and
casein protein (20% casein compared with 10% casein and 10%
whey protein) were compared under conditions of elevated
oxidative stress induced by iron overloading, it was shown that
rats fed the diet including whey protein had greater levels of
reduced glutathione and SOD activity in erythrocytes and
reduced lipid peroxidation and DNA damage in leukocytes
and colonocytes compared with those that received casein only,
suggesting that whey was primarily responsible for the enhanced
antioxidant defense (72). Furthermore, diabetic rats supple-
mented with 100 mg whey protein/kg body weight exhibited
considerable reductions in malondialdehyde, NO, and ROS
concentrations and also preserved their glutathione concentra-
tions (73). These in vivo results, although derived from tissues
other than skeletal muscle, are in agreement with those reported
from in vitro studies (68–70) in which whey protein was
systematically shown to possess antioxidant properties despite
varying doses and supplementation protocols applied. This
antioxidant profile of whey protein is attributed primarily to
enhanced antioxidant enzyme activity and increased reduced
glutathione concentrations.
Although human supplementation studies in inflammaging are
lacking, human protein feeding studies under proinflammatory
conditions offer valuable information. The anti-inflammatory role
of protein supplementation in humans has been tested in the
context of exercise (74–79), as well as in various clinical
proinflammatory conditions, such as cystic fibrosis and obesity
(80–84). Exercise, especially eccentric or unaccustomed, has been
associated with microtrauma of skeletal muscle fibers and an
intense aseptic type of inflammation that is characterized by
immune cell activation, excessive ROS generation, perturbation of
redox status, and deterioration of muscle performance (85–87).
During a 6-d block of intense training, athletes receiving a daily
supplement containing protein, leucine, carbohydrate, and fat at
20, 7.5, 89, and 22 g/h, respectively, for 1–3 h postexercise over
6 d demonstrated increased counts of circulating neutrophil and
respiratory burst activity on day 6 compared with those receiving
only a carbohydrate control beverage (74). However, in this case,
we could not determine whether the effect was attributable to
leucine, protein, or a combination of the supplements ingredients.
In another study, well-trained cyclists performed 3 high-intensity
ride sessions over 4 d (day 3 was a rest day), with supplementation
on days 1 and 2 with a protein blend [whey protein isolate,
calcium caseinate, and soy protein isolate (SPI)] at a dosage of
0.8 g protein/(kg fat-free mass  h) during a 4-h postexercise
recovery period (75). A protein effect was observed in the
postexercise period, leading to reduced creatine kinase concen-
trations, but no significant alterationswere observed for any of the
oxidative stress and inflammatory markers measured (75). Sim-
ilarly, during a 9-wk weight-training period, consumption of 33 g
whey protein/d (3 servings of 11 g/d, in a bar form) did not
prevent exercise-induced oxidative stress, whereas an equal
amount of soy protein (33 g/d, 3 servings of 11 g/d, in a bar
form) preserved postexercise antioxidative capacity, as evidenced
by free-radical scavenging capacity and plasma myeloperox-
idase response (76). In contrast to these findings, acute anti-
inflammatory and antioxidative properties have been attributed
to whey protein after a cycling session to exhaustion (77, 78).
When whey protein [4 dosages of 0.28 g/(kg body weight  h)]
was consumed immediately postexercise and daily during the re-
covery period after an exhaustive cycling trial that induced a
marked inflammatory and oxidative stress response, an attenuation
of IL-6, plasma TBARs, and CRP was observed during the first 4 h
after exercise, whereas plasma total antioxidant capacity (TAC),
protein carbonyls, and erythrocyte reduced glutathione and
catalase concentrations remained unaltered (77, 78). Similar
findings (i.e., attenuated elevation of TBARs and protein car-
bonyls, and increased reduced glutathione availability) have been
reported for whey protein in ultramarathon runners receiving
daily 2 whey protein bars (14.3 g whey protein/100 g bar) for 2
mo (79). Therefore, most of these human exercise studies support
an anti-inflammatory and antioxidant role for whey protein.
Nevertheless, these studies involved healthy young individuals,
and data on skeletal muscle performance and molecular responses
are lacking. We must mention, however, that one previous study
suggested that antioxidant supplementation (i.e., vitamins C and
E) may offset some positive adaptations induced by exercise
training (88). These findings were reported for young athletes,
but, to our knowledge, no data exist for inflammaging.
To our knowledge, only a small number of studies examined
the effects of a nutritional intervention of dairy-based protein
diets in aged adults on chronic inflammation and oxidative
stress. Either acute (a bolus of 45 g of protein) or chronic (54 g of
protein/d for a 12-wk period) consumption of whey protein
isolate did not alter the responses of circulating proinflammatory
markers such as IL-6, TNF-a, and CRP in overweight postmen-
opausal women and overweight adults aged 18–65 y, respectively
(80, 81). Similarly, when obese individuals received a soy-based
protein diet, after a wash-out period, no changes in inflammatory
and oxidative stress markers were observed (82). In contrast,
whenwhey isolate and calcium caseinate (45 g of each protein in a
crossover design) were consumed in combination with a fat-rich
meal by obese, nondiabetic individuals in the context of an acute
clinical trial, an acute suppression of markers of low-grade
inflammation was observed (83). The anti-inflammatory potential
of whey protein also was evident in cystic fibrosis patients who
consumed 20 g whey protein/d for 3 mo (84). These few human
studies provided valuable insight regarding the anti-inflammatory
role of protein in the presence of low-grade inflammation and
partly verify the in vitro and in vivo results described earlier. Both
dairy proteins seem to have a protective effect against low-grade
inflammation, with whey eliciting a slightly greater attenuation
of proinflammatory cytokines than does casein (83). Thus, the
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rationale for using dairy proteins to counteract low-grade
inflammation and oxidative stress and prevent sarcopenia may
be valid, and future investigations should explore this prospect in
human skeletal muscle in inflammaging.
Studies that investigated the effects of dairy protein on
inflammatory and oxidative stress responses are presented in
Table 1.
Soy protein. Soy protein represents 35–40% of soybean
content and is considered to be a protein source of high
nutritional quality, because it contains all the essential amino
acids and, in particular, it has less saturated fat than dairy
foods and is cholesterol-free (89). However, soy protein in its
isolated form, to our knowledge, has been poorly investigated
by researchers looking for protein supplements and protein-
rich diets to counteract inflammation and oxidative stress.
When SPI (20% of the daily diet; 8 g of food on day 1,
increased by 0.5 g each day for the remaining 13 d) was
administered to rats exposed to paraquat-induced oxidative
stress, an attenuation of lipid peroxidation and enhanced
reduced glutathione concentrations was observed (90, 91). A
recent study showed that a 5-wk supplementation with SPI in
hyperlipidemic mice counteracted the NF-kB–dependent inflam-
matory response manifested as reduced activation of NF-kB and
expression of TNF-a, IL-6, IL-1b, vascular cell adhesion
molecule 1 (VCAM-1), and monocyte chemoattractant protein
1 because of inhibition of IkB phosphorylation (17). Therefore,
given that in chronic inflammatory conditions the increased
activation of the NF-kB signaling pathway leads to protein
degradation through the 20S proteasome subunit (21, 35, 43,
44), soy protein may be a potent nutritional intervention against
chronic inflammation and its associated skeletal muscle loss.
In contrast to animal studies, in what is, as far as we know, the
only human study that tested a 6-wk supplementation with SPI
(25 g/d) in postmenopausal women, supplementation did not alter
inflammatory markers such as soluble IL-2 receptor, E-selectin
and P-selectin, VCAM-1, and intercellular adhesionmolecule 1 (92).
However, the efficacy of SPI in inhibiting chronic inflammation
should be further investigated in human clinical trials in order to
come to a clear conclusion.
Soy foods also contain phytoestrogens named isoflavones
that can be removed when these foods are washed with alcohol
(89, 93). Genistin, daidzin, and glycitein are the primary
bioactive isoflavones in soybeans and soy foods (89). Research
on the antioxidative role of isoflavones has shown reduced
oxidative stress levels, improved antioxidant enzyme activity,
and attenuated oxidative damage in animal models (94–97), as
well as in humans (98, 99). Specifically, the incorporation of
206 g SPI/kg body weight (based on the AIN-93G diet),
combined with 189 mg isoflavones/100 g SPI, in the daily diet
for a 9-wk period attenuated myocardial oxidative stress levels
in rats that suffered from myocardial infarction and underwent
heart surgery (100, 101). Another study investigated the
antioxidative action of an isoflavone-enriched soy protein
compared with a casein-based diet on fructose-induced oxida-
tive and inflammatory responses in rats, suggesting that, in
contrast to casein, soy protein is able not only to suppress
oxidative stress, but also to elicit an anti-inflammatory response
(102). As previously reported for SPI (17), soy isoflavones and
mainly genistein also have been shown to hamper the activation
of NF-kB and TNF-a in aged mdx mice (103). Therefore, the
effect of isoflavone-enriched soy protein on inflammation may be
attributed to its isoflavone content and amino acid composition
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activation of NF-kB, which activates the expression of proin-
flammatory cytokines such as TNF-a and IL-6 (17, 102, 103).
In postmenopausal women, the administration of 26 g soy
protein/d enriched with 44 mg isoflavones/d for 6 wk did not
affect circulating concentrations of CRP and various adhesion
molecules (104). T€orm€al€a et al. (105) increased the amount of
supplemented soy protein to 52 g/d and the amount of
isoflavones to 112 mg/d, and also extended the supplementation
period to 8 wk, but they did not observe any anti-inflammatory
action either. In contrast, consumption of soy nuts containing
either 25 g soy protein/d and 101 mg isoflavones/d or 37.5 g soy
protein/d and 340 mg isoflavones/d for 8 wk led to significant
reductions in blood CRP, soluble intercellular adhesion molecule
1, E-selectin, TNF-a, and IL-18 in postmenopausal women with
metabolic syndrome (18, 106), as well as in VCAM-1 in
hypertensive postmenopausal women (107). However, discrep-
ancies between these studies may be related to the different
supplementation protocols applied, as well as to the clinical
status of the participants [e.g., in the study by T€orm€al€a et al.
(105), subjects were tibolone users]. Moreover, the anti-
inflammatory potential of soy nuts may be attributed to the
fact that nuts contain all the bioactive compounds of a soybean,
including soy protein, fat, and phytoestrogens, whereas supple-
mented proteins are isolated and in some cases are combined
with isoflavones only (89, 108, 109). Interestingly, in patients
with end-stage renal disease, which is characterized by systemic
inflammation (CRP > 10.0 mg/L), the administration of SPI that
retained its isoflavone content led to a marked elevation of
circulating isoflavone concentrations that was inversely corre-
lated with inflammatory markers (110). Moreover, in a 1-y
clinical study, the intake of 18 g soy protein/d along with 105 mg
isoflavone/d reduced blood concentrations of IL-6 in healthy
older (>70 y of age) womenwith baseline CRP and IL-6 values of
5.24 pg/mL and 2.76 pg/mL, respectively (111). To the best of
our knowledge, this is the only human study that used a
population with characteristics of inflammaging, and it suggested
that a combination of sufficient quantities of soy protein and
isoflavones may have the potential to prevent or alleviate
inflammation. Although this study did not look into skeletal
muscle responses, it supports a rationale for soy protein use as an
anti-inflammatory intervention. Two studies that examined the
antioxidant potential of soy proteins provided some positive
evidence. In a crossover design, administration of either a soy
protein (17% of total energy and 1.25 mg isoflavones/1000 kcal)
or an isoflavone-enriched soy protein (16% of total energy and
46.21 mg isoflavones/1000 kcal) diet for 42 d had no significant
impact onmarkers of oxidative stress, but improved TAC by 10%
(112). Swain et al. (113) also reported that supplementation with
soy protein in perimenopausal women improved TAC. Collec-
tively, these studies suggest that soy protein with isoflavones may
represent a potent anti-inflammatory and antioxidant agent, further
supporting the rational for its use in proinflammatory condi-
tions such as inflammaging. Although this data supports an anti-
inflammatory role for soy protein, to our knowledge, no data exist
regarding its effectiveness in promoting muscle mass and function
in inflammaging. When dairy and soy protein were compared in
healthy aged adults, the 2 types of proteins were equally effective in
improving body composition and functionality, but the former was
more effective in increasing muscle strength (114).
Studies that investigated the effects of soy protein and
isoflavone-enriched soy protein on inflammatory and oxidative
stress responses are presented in Table 2.
Conclusions
In conclusion, oxidative stress and inflammation interact in a
vicious cycle, creating a chronic state of systemic inflammation
that in the elderly is known as inflammaging.Many health-related
FIGURE 2 Mechanistic links between protein feeding and inflammaging. CAT, catalase; CRP, C-reactive protein; GSH, reduced glutathione;
IkB, inhibitor of NF-kB; ROS, reactive oxygen species; SOD, superoxide dismutase; ?, lack of evidence regarding the ability of these proteins to
stimulate muscle protein synthesis in inflamed elderly;/, increase or activation; —C, decline or inhibition.
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dysfunctions and chronic diseases, as well as loss of muscle mass
and consequently independence in the elderly, have been associ-
ated with inflammaging; therefore, it is crucial to develop
nutritional, exercise-based, and pharmaceutical strategies to
counteract its detrimental effects. Dairy and soy products contain
high-quality proteins of high nutritional value because of their
amino acid composition and absorption kinetics. Whey protein
exhibits antioxidative properties that are attributed to its ability
to increase glutathione availability and enhance the activity of
the antioxidative enzymes SOD, catalase, and glutathione perox-
idase. Evidence from animal models and cell lines indicate that
whey protein may regulatemultiple intracellular pathways related
to ROS production. However, future studies should explore the
TNF-a/NF-kB/ubiquitin–proteasome pathway and its crosstalk
with Akt-related signaling in skeletal muscle in inflammaging in
response to various protein feeding protocols. Whey administra-
tion may attenuate exercise-induced oxidative stress and inflam-
mation, aswell as inflammation resulting from clinical complications
and obesity. Soy protein is a promising nutritional strategy against
chronic inflammation, with it having been shown that either in its
isolated form or isoflavone-enriched, it is able to inhibit the
activation of the NF-kB and subsequently the upregulation of
proinflammatory cytokines, such as TNF-a, IL-6, and IL-1b,
as well as other mediators, such as VCAM-1 and monocyte
chemoattractant protein 1. Although this mechanism of action is
evident in animal models only, soy protein supplementation has
been associatedwith reduced concentrations of chronic low-grade
inflammation in the elderly as well. There is a great need for well-
controlled experimental trials to determine whether an increase in
protein consumption may aid MPS and muscle function in older
adults with elevated systemic inflammation. Well-controlled
randomized trials should compare dairy with plant protein
feeding with or without an anabolic type of exercise in aged
adults with a proinflammatory profile with the use of long-term
supplementation protocols, as well as an assessment of muscle
function and mass. A schematic representation of potential mech-
anisms through which protein supplementation may offset in-
flammation and boost muscle anabolism and performance in
the elderly is presented in Figure 2.
Acknowledgments
We thank Alexandra Avloniti and Theodoros Stamboulis for
their valuable assistance with the preparation of this manu-
script. DD, LGK, IA, AC, AZJ, and IGF wrote parts of the
manuscript; and DD, LGK, and IGF had primary responsibility
for the final content. All authors read and approved the final
manuscript.
References
1. Waters DL, Baumqartner RN, Garry PJ, Vellas B. Advantages of
dietary, exercise-related, and therapeutic interventions to prevent and
treat sarcopenia in adult patients: an update. Clin Interv Aging
2010;5:259–70.
2. Morley JE, Abbatecola AM, Argiles JM, Baracos V, Bauer J, Bhasin S,
Cederholm T, Coats AJ, Cummings SR, Evans WJ, et al. Sarcopenia
with limited mobility: an international consensus. J Am Med Dir
Assoc 2011;12:403–9.
3. Rennie MJ, Selby A, Atherton P, Smith K, Kumar V, Glover EL, Philips
SM. Facts, noise and wishful thinking: muscle protein turnover in
aging and human disuse atrophy. Scand J Med Sci Sports 2010;20:5–9.
4. McLean RR, Kiel DP. Developing consensus criteria for sarcopenia: an
update. J Bone Miner Res 2015;30:588–92.
5. Narici MV, Maffulli N. Sarcopenia: characteristics, mechanisms and
functional significance. Br Med Bull 2010;95:139–59.
6. Calc¸ada D, Vianello D, Giampieri E, Sala C, Castellani G, de Graaf A,
Kremer B, van Ommen B, Feskens E, Santoro A, et al. The role of low-
grade inflammation and metabolic flexibility in aging and nutritional
modulation thereof: a systems biology approach. Mech Ageing Dev
2014;136–137:138–47.
7. Beyer I, Mets T, Bautmans I. Chronic low-grade inflammation and age-
related sarcopenia. Curr Opin Clin Nutr Metab Care 2012;15:12–22.
8. Kregel KC, Zhang HJ. An integrated view of oxidative stress in aging:
basic mechanisms, functional effects, and pathological considerations.
Am J Physiol Regul Integr Comp Physiol 2007;292:R18–36.
9. Balage M, Averous J, Remond D, Bos C, Pujos-Guillot E, Papet I,
Mosoni L, Combaret L, Dardevet D. Presence of low grade inflam-
mation impaired postprandial stimulation of muscle protein synthesis
in old rats. J Nutr Biochem 2010;21:325–31.
10. Rieu I, Magne H, Savary-Auzeloux I, Averous J, Bos C, Payron
MA, Combaret L, Dardevet D. Reduction of low grade inflamma-
tion restores blunting of postprandial muscle anabolism and limits
sarcopenia in old rats. J Physiol 2009;587:5483–92.
11. Volpi E, Kobayashi H, Sheffield-Moore M, Mittendorfer B, Wolfe RR.
Essential amino acids are primarily responsible for the amino acid
stimulation of muscle protein anabolism in healthy elderly adults. Am
J Clin Nutr 2003;78:250–8.
12. Wolfe RR, Miller S, Miller K. Optimal protein intake in the elderly.
Clin Nutr 2008;27:675–84.
13. Bartali B, Frongillo EA, Stipanuk MH, Bandinelli S, Salvini S, Palli D,
Morais JA, Volpato S, Guralnik JM, Ferrucci L. Protein intake and
muscle strength in older persons: does inflammation matter? J Am
Geriatr Soc 2012;60:480–4.
14. Tang JE, Moore DR, Kujbida GW, Tarnopolsky MA, Phillips SM.
Ingestion of whey hydrolysate, casein, or soy protein isolate: effects on
mixed muscle protein synthesis at rest and following resistance
exercise in young men. J Appl Physiol 2009;107:987–92.
15. West DW, Burd NA, Coffey VG, Baker SK, Burke LM, Hawley JA,
Moore DR, Stellingwerff T, Phillips SM. Rapid aminoacidemia enhances
myofibrillar protein synthesis and anabolic intramuscular signaling
responses after resistance exercise. Am J Clin Nutr 2011;94:795–803.
16. Burd NA, Yang Y, Moore DR, Tang JE, Tarnopolsky MA, Phillips SM.
Greater stimulation of myofibrillar protein synthesis with ingestion of
whey protein isolate v. micellar casein at rest and after resistance
exercise in elderly men. Br J Nutr 2012;108:958–62.
17. Burris RL, Ng HP, Nagarajan S. Soy protein inhibits inflammation-
induced VCAM-1 and inflammatory cytokine induction by inhibiting
the NF-kB and AKT signaling pathway in apolipoprotein E-deficient
mice. Eur J Nutr 2014;53:135–48.
18. Azadbakht L, Kimiagar M, Mehrabi Y, Esmaillzadeh A, Hu FB,
Willett WC. Soy consumption, markers of inflammation, and endo-
thelial function: a cross-over study in postmenopausal women with the
metabolic syndrome. Diabetes Care 2007;30:967–73.
19. Chung HY, Kim HJ, Kim JW, Yu BP. The inflammation hypothesis of
aging: molecular modulation by calorie restriction. Ann N Y Acad Sci
2001;928:327–35.
20. Powers SK, Kavazis AN, McClung JM. Oxidative stress and disuse
muscle atrophy. J Appl Physiol 2007;102:2389–97.
21. Li H, Malhorta S, Kumar A. Nuclear factor-kappa B signaling in
skeletal muscle atrophy. J Mol Med (Berl) 2008;86:1113–26.
22. Baylis D, Bartlett DB, Patel HP, Roberts HC. Understanding how we
age: insights into inflammaging. Longev Healthspan 2013;2:8.
23. Franceschi C, Bonafe M, Valensin S, Olivieri F, De Luca M, Ottaviani
E, De Benedictis G. Inflamm-aging. An evolutionary perspective on
immunosenescence. Ann N Y Acad Sci 2000;908:244–54.
24. Visser M, Pahor M, Taaffe DR, Goodpaster BH, Simonsick EM,
Newman AB, Nevitt M, Harris TB. Relationship of interleukin-6 and
tumor necrosis factor-alpha with muscle mass and muscle strength in
elderly men and women: the Health ABC Study. J Gerontol A Biol Sci
Med Sci 2002;57:M326–32.
25. Schaap LA, Pluijm SM, Deeg DJ, Visser M. Inflammatory markers
and loss of muscle mass (sarcopenia) and strength. Am J Med
2006;119:526.e9–17.
26. Schaap LA, Pluijm SM, Deeg DJ, Harris TB, Kritchevsky SB, Newman
AB, Colbert LH, Pahor M, Rubin SM, Tylavsky FA, et al. Higher
inflammatory marker levels in older persons: associations with 5-year
change in muscle mass and muscle strength. J Gerontol A Biol Sci Med
Sci 2009;64:1183–9.













Institutional Repository - Library & Information Centre - University of Thessaly
07/06/2020 16:34:36 EEST - 137.108.70.13
27. Alema´n H, Esparza J, Ramirez FA, Astiazaran H, Payette H.
Longitudinal evidence on the association between interleukin-6 and
C-reactive protein with the loss of total appendicular skeletal muscle in
free-living older men and women. Age Ageing 2011;40:469–75.
28. Payette H, Roubenoff R, Jacques PF, Dinarello CA, Wilson PW, Abad
LW, Harris T. Insulin-like growth factor-1 and interleukin 6 predict
sarcopenia in very old community-living men and women: the
Framingham heart study. J Am Geriatr Soc 2003;51:1237–43.
29. Rohleder N, Kudielka BM, Hellhammer DH, Wolf JM, Kirschbaum
C. Age and sex steroid-related changes in glucocorticoid sensitivity of
proinflammatory cytokine production after psychosocial stress.
J Neuroimmunol 2002;126:69–77.
30. Ferrucci L, Harris TB, Guralnik JM, Tracy RP, Corti MC, Cohen HJ,
Penninx B, Pahor M, Wallace R, Havlik RJ. Serum IL-6 level and the
development of disability in older persons. J Am Geriatr Soc
1999;47:639–46.
31. de Gonzalo-Calvo D, de Luxan-Delgado B, Rodriguez-Gonzalez S,
Garcia-Macia M, Suarez FM, Solano JJ, Rodriguez-Colunga MJ,
Coto-Montes A. Interleukin 6, soluble tumor necrosis factor receptor I
and red blood cell distribution width as biological markers of
functional dependence in an elderly population: a translational
approach. Cytokine 2012;58:193–8.
32. Barbieri M, Ferrucci L, Ragno E, Corsi A, Bandinelli S, Bonafe M,
Olivieri F, Giovagnetti S, Franceschi C, Guralnik JM, et al. Chronic
inflammation and the effect of IGF-1 on muscle strength and power in
older persons. Am J Physiol Endocrinol Metab 2003;284:E481–7.
33. Bodell PW, Kodesh E, Haddad F, Zaldivar FP, Cooper DM, Adams
GR. Skeletal muscle growth in young rats is inhibited by chronic
exposure to IL-6 but preserved by concurrent voluntary endurance
exercise. J Appl Physiol 2009;106:443–53.
34. Trappe TA, Liu SZ. Effects of prostaglandins and COX-inhibiting
drugs on skeletal muscle adaptations to exercise. J Appl Physiol
2013;115:909–19.
35. Li YP, Reid MB. NF-kappa B mediates the protein loss induced by
TNFalpha in differentiated skeletal muscle myotubes. Am J Physiol
Regul Integr Comp Physiol 2000;279:R1165–70.
36. Saini A, Al-Shanti N, Stewart CE. Waste management – cytokines,
growth factors and cachexia. Cytokine Growth Factor Rev
2006;17:475–86. Corrected and republished from: Cytokine Growth
Factor Rev 2007;18(3–4):345.
37. Peterson JM, Bakkar N, Guttridge DC. NF-kB signaling in skeletal
muscle health and disease. Curr Top Dev Biol 2011;96:85–119.
38. Chondrogianni N, Fragoulis EG, Gonos ES. Protein degradation
during aging: the lysosome- and the proteasome-dependent cellular
proteolytic systems. Biogerontology 2002;3:121–3.
39. Chondrogianni N, Stratford FL, Trougakos IP, Friguet B, Rivett AJ,
Gonos ES. Central role of the proteasome in senesce human
fibroblasts: induction of a senescence-like phenotype upon its inhibi-
tion and resistance to stress upon its activation. J Biol Chem
2003;278:28026–37.
40. Chondrogianni N, Gonos ES. Proteasome inhibition induces a
senescence-like phenotype in primary human fibroblasts cultures.
Biogerontology 2004;5:55–61.
41. Tanaka K, Kasahara M. The MHC class I ligand-generating system:
roles of immunoproteasomes and the interferon-gamma inducible
proteasome activator PA28. Immunol Rev 1998;163:161–76.
42. Voges D, Zwickl P, Baumeister W. The 26S proteasome: a molecular
machine designed for controlled proteolysis. Annu Rev Biochem
1999;68:1015–68.
43. Sandri M. Protein breakdown in muscle wasting: role of autophagy-
lysosome and ubiquitin-proteasome. Int J Biochem Cell Biol
2013;45:2121–9.
44. L€ow P. The role of ubiquitin-proteasome system in ageing. Gen Comp
Endocrinol 2011;172:39–43.
45. Llovera M, Lopez-Soriano FJ, Argiles JM. Effects of tumor necrosis
factoralpha on muscle-protein turnover in female Wistar rats. J Natl
Cancer Inst 1993;85:1334–9.
46. Ling PR, Schwartz JH, Bistrian BR. Mechanisms of host wasting
induced by administration of cytokines in rats. Am J Physiol
1997;272:E333–9.
47. Mayot G, Breuille D, Jarret AR, Obled C, Papet I. Systemic low-grade
inflammation does not decrease skeletal muscle mass and protein
synthesis in old rats. J Musculoskelet Neuronal Interact 2008;8:410–7.
48. Haddad F, Zaldivar F, Cooper DM, Adams GR. IL-6-induced skeletal
muscle atrophy. J Appl Physiol 2005;98:911–7.
49. van Hall G, Steensberg A, Fischer C, Keller C, Moller K, Moseley P,
Pedersen BK. Interleukin-6 markedly decreases skeletal muscle protein
turnover and increases nonmuscle amino acid utilization in healthy
individuals. J Clin Endocrinol Metab 2008;93:2851–8.
50. Cuthbertson D, Smith K, Babraj J, Leese G, Waddell T, Atherton P,
Wackerhage H, Taylor PM, Rennie MJ. Anabolic signaling deficits
underline amino acid resistance of wasting, aging muscle. FASEB J
2005;19:422–4.
51. Rivas DA, Morris EP, Haran PH, Pasha EP, Morais Mda S,
Dolnikowski GG, Phillips EM, Fielding RA. Increased ceramide
content and NFkB signaling may contribute to the attenuation of
anabolic signaling after resistance exercise in aged males. J Appl
Physiol 2012;113:1727–36.
52. Plomgaard P, Bouzakri K, Krogh-Madsen R, Mittendorfer B, Zierath
JR, Pedersen BK. Tumor necrosis factor-a induces skeletal muscle
insulin resistance in healthy human subjects via inhibition of Akt
substrate 160 phosphorylation. Diabetes 2005;54:2939–45.
53. Hyldahl RD, Olson T, Welling T, Groscost L, Parcell AC. Satellite cell
activity is differentially affected by contraction mode in human muscle
following a work-matched bout of exercise. Front Physiol 2014;5:485.
54. Farup J, Rahbek SK, Knudsen IS, de Paoli F, Mackey AL, Vissing K.
Whey protein supplementation accelerates satellite cell proliferation
during recovery from eccentric exercise. Amino Acids 2014;46:2503–16.
55. Beenakker KG, Duijnisveld BJ, Van Der Lindeen HM, Visser CP,
Westendorp RG, Butler-Brown G, Nelissen RG, Maier AB. Muscle
characteristics in patients with chronic inflammation. Muscle Nerve
2012;46:204–9.
56. Wolfe RR. The role of dietary protein in optimizing muscle mass,
function and health outcomes in older individuals. Br J Nutr
2012;108:S88–93.
57. Pennings B, Groen B, de Lange A, Gijsen AP, Zorenc AH, Senden
JMG, van Loon LJC. Amino acid absorption and subsequent muscle
protein accretion following graded intakes of whey protein in elderly
men. Am J Physiol Endocrinol Metab 2012;302:E992–9.
58. Tipton KD, Rasmussen BB, Miller SL, Wolfe SE, Owens-Stovall SK,
Petrini BE, Wolfe RR. Timing of amino acid-carbohydrate ingestion
alters anabolic response of muscle to resistance exercise. Am J Physiol
Endocrinol Metab 2001;281:E197–206.
59. Koopman R, Gleeson BG, Gijsen AP, Groen B, Senden JM, Rennie MJ,
van Loon LJ. Post-exercise protein synthesis rates are only marginally
higher in type I compared with type II muscle fibers following
resistance-type exercise. Eur J Appl Physiol 2011;111:1871–8.
60. Moore DR. Keeping older muscle ‘‘young’’ through dietary protein
and physical activity. Adv Nutr 2014;5:599S–607S.
61. Morley JE, Argiles JM, Evans WJ, Bhasin S, Cella D, Deutz NE,
Doehner W, Fearon KC, Ferrucci L, Hellerstein MK, et al. Nutritional
recommendations for the management of sarcopenia. J Am Med Dir
Assoc 2010;11:391–6.
62. Moore DR, Churchward-Venne TA, Witard O, Breen L, Burd NA,
Tipton KD, Phillips SM. Protein ingestion to stimulate myofibrillar
protein synthesis requires greater relative protein intakes in
healthy older versus younger men. J Gerontol A Biol Sci Med Sci
2015;70:57–62.
63. Wall BT, Gorissen SH, Pennings B, Koopman R, Groen BB, Verdijk
LB, van Loon LJ. Aging is accompanied by a blunted protein synthetic
response to protein ingestion. PLoS One 2015;11:e0140903.
64. Morley JE. Sarcopenia: diagnosis and treatment. J Nutr Health Aging
2008;12:452–6.
65. Volpi E, Campbell WW, Dwyer JT, Johnson MA, Jensen GL, Morley
JE, Wolfe RR. Is the optimal level of protein intake for older adults
greater than the recommended dietary allowance? J Gerontol A Biol
Sci Med Sci 2013;68:677–81.
66. Houston DK, Nicklas BJ, Ding J, Harris TB, Tylavsky FA, Newman
AB, Lee JS, Sahyoun NR, Visser M, Kritchevsky SB, et al. Dietary
protein intake is associated with lean mass change in older, community-
dwelling adults: the Health, Aging, and Body Composition (Health
ABC) Study. Am J Clin Nutr 2008;87:150–5.
67. McCarty MF, DiNicolantonio JJ. An increased need for dietary
cysteine in support of glutathione synthesis may underline the
increased risk for mortality associated with low protein intake in the
elderly. Age (Dordr) 2015;37:96.













Institutional Repository - Library & Information Centre - University of Thessaly
07/06/2020 16:34:36 EEST - 137.108.70.13
68. Xu R, Liu N, Xu X, Kong B. Antioxidant effects of whey protein on
peroxide-induced cytotoxicity. J Dairy Sci 2011;94:3739–46.
69. Jin MM, Zhang L, Yu HX, Meng J, Sun Z, Lu RR. Protective effect of
whey protein hydrolysates on H2O2-induced PC12 cells oxidative stress
via a mitochondrial-mediated pathway. Food Chem 2013;141:847–52.
70. Kerasioti E, Stagos D, Priftis A, Aivazidis S, Tsatsakis AM, Hayes AW,
Kouretas D. Antioxidant effects of whey protein on muscle C2C12
cells. Food Chem 2014;155:271–8.
71. Athira S, Mann B, Sharma R, Kumar R. Ameliorative potential of
whey protein hydrolysate against paracetamol-induced oxidative
stress. J Dairy Sci 2013;96:1431–7.
72. Kim J, Paik HD, Yoon YC, Park E. Whey protein inhibits iron
overload-induced oxidative stress in rats. J Nutr Sci Vitaminol (Tokyo)
2013;59:198–205.
73. Ebaid H, Salem A, Sayed A, Metwalli A. Whey protein enhances
normal inflammatory responses during cutaneous wound healing in
diabetic rats. Lipids Health Dis 2011;10:235.
74. Nelson AR, Jackson L, Clarke J, Stellingwerff T, Broadbent S,
Rowlands DS. Effect of post-exercise protein-leucine feeding on
neutrophil function, immunomodulatory plasma metabolites and
cortisol during a 6-day block of intense cycling. Eur J Appl Physiol
2013;113:2211–22.
75. Rowlands DS, Rossler K, Thorp RM, Graham DF, Timmons BW,
Stannard SR, Tarnopolsky MA. Effect of dietary protein content
during recovery from high-intensity cycling on subsequent perfor-
mance and markers of stress, inflammation, and muscle damage in
well-trained men. Appl Physiol Nutr Metab 2008;33:39–51.
76. Brown EC, DiSilvestro RA, Babaknia A, Devor ST. Soy versus whey
protein bars: effects on exercise training impact on lean body mass and
antioxidant status. Nutr J 2004;3:22.
77. Kerasioti E, Kiskini A, Veskoukis A, Jamurtas A, Tsitsimpikou C,
Tsatsakis AM, Koutedakis Y, Stagos D, Kouretas D, Karathanos V. Effect
of a special carbohydrate-protein cake on oxidative stress markers after
exhaustive cycling in humans. Food Chem Toxicol 2012;50:2805–10.
78. Kerasioti E, Stagos D, Jamurtas A, Kiskini A, Koutedakis Y, Goutzoulas
N, Pournaras S, Tsatsakis AM, Kouretas D. Anti-inflammatory effects
of a special carbohydrate-whey protein cake after exhaustive cycling in
humans. Food Chem Toxicol 2013;61:42–6.
79. Samaras A, Tsarouhas K, Paschalidis E, Giamouzis G, Triposkiadis F,
Tsitsimpikou C, Becker AT, Goutzourelas N, Kouretas D. Effect of a
special carbohydrate-protein bar and tomato juice supplementation on
oxidative stress markers and vascular endothelial dynamics in ultra-
marathon runners. Food Chem Toxicol 2014;69:231–6.
80. Pal S, Ellis V. The chronic effects of whey proteins on blood pressure,
vascular function, and inflammatory markers in overweight individ-
uals. Obesity (Silver Spring) 2010;18:1354–9.
81. Pal S, Ellis V. Acute effects of whey protein isolate on blood pressure,
vascular function and inflammatory markers in overweight postmen-
opausal women. Br J Nutr 2011;105:1512–9.
82. Zemel MB, Sun X, Sobhani T, Wilson B. Effects of dairy compared
with soy on oxidative and inflammatory stress in overweight and
obese subjects. Am J Clin Nutr 2010;91:16–22.
83. Holmer-Jensen J, Karhu T, Mortensen LS, Pedersen SB, Herzig KH,
Hermansen K. Differential effects of dietary protein sources on
postprandial low-grade inflammation after a single high fat meal in
obese non-diabetic subjects. Nutr J 2011;10:115.
84. Grey V, Mohammed SR, Smountas AA, Bahlool R, Lands LC.
Improved glutathione status in young adult patients with cystic
fibrosis supplemented with whey protein. J Cyst Fibros 2003;2:195–8.
85. Michailidis Y, Karagounis LG, Terzis G, Jamurtas AZ, Spengos K,
Tsoukas D, Chatzinikolaou A, Mandalidis D, Stefanetti RJ, Papassotiriou
I, et al. Thiol-based antioxidant supplementation alters human skeletal
muscle signaling and attenuates its inflammatory response and recovery
after intense eccentric exercise. Am J Clin Nutr 2013;98:233–45.
86. Chatzinikolaou A, Christoforidis C, Avloniti A, Draganidis D,
Jamurtas AZ, Stampoulis T, Ermidis G, Sovatzidis A, Papassotiriou
I, Kambas A, et al. A microcycle of inflammation following a team
handball game. J Strength Cond Res 2014;28:1981–94.
87. Barbas I, Fatouros IG, Douroudos II, Chatzinikolaou A, Michailidis Y,
Draganidis D, Jamurtas AZ, Nikolaidis MG, Parotsidis C, Theodorou
AA, et al. Physiological and performance adaptations of elite Greco-
Roman wrestlers during a one-day tournament. Eur J Appl Physiol
2011;111:1421–36.
88. Morrison D, Hughes J, Della Gatta PA, Mason S, Lamon S, Russell
AP, Wadley GD. Vitamin C and E supplementation prevents some of
the cellular adaptations to endurance-training in humans. Free Radic
Biol Med 2015;89:852–62.
89. Xiao CW. Health effects of soy protein and isoflavones in humans.
J Nutr 2008;138:1244S–9S.
90. Aoki H, Otaka Y, Igarashi K, Takenaka A. Soy protein reduces
paraquat-induced oxidative stress in rats. J Nutr 2002;132:2258–62.
91. Takenaka A, Annaka H, Kimura Y, Aoki H, Igarashi I. Reduction of
paraquat-induced oxidative stress in rats by dietary soy peptide. Biosci
Biotechnol Biochem 2003;67:278–83.
92. Blum A, Lang N, Peleg A, Vigder F, Israeli P, Gumanovsky M,
Lupovitz S, Elgazi A, Ben-Ami M. Effects of oral soy protein on
markers of inflammation in postmenopausal women with mild
hypercholesterolemia. Am Heart J 2003;145:e7.
93. Anthony MS, Clarkson TB, Hughes CL, Morgan TM, Burke GL.
Soybean isoflavones improve cardiovascular risk factors without
affecting the reproductive system of peripubertal rhesus monkeys.
J Nutr 1996;126:43–50.
94. Yoon GA, Park S. Antioxidant action of soy isoflavones on oxidative
stress and antioxidant enzyme activities in exercised rats. Nutr Res
Pract 2014;8:618–24.
95. Sankar P, Zachariah B, Vickneshwaran V, Jacob SE, Sridhar MG.
Amelioration of oxidative stress and insulin resistance by soy isoflavones
(from Glycine max) in ovariectomized Wistar rats fed with high fat diet:
the molecular mechanisms. Exp Gerontol 2015;63:67–75.
96. Park E, Shin JI, Park OJ, Kang MH. Soy isoflavone supplementation
alleviates oxidative stress and improves systolic blood pressure in male
spontaneously hypertensive rats. J Nutr Sci Vitaminol (Tokyo)
2005;51:254–9.
97. Hsieh HM, Wu WM, Hu ML. Soy isoflavones attenuate oxidative
stress and improve parameters related to aging and Alzheimers disease
in C57BL/6J mice treated with D-galactose. Food Chem Toxicol
2009;47:625–32.
98. Djuric Z, Chen G, Doerge DR, Heilbrum LK, Kucuk O. Effect of soy
isoflavone supplementation on markers of oxidative stress in men and
women. Cancer Lett 2001;172:1–6.
99. Ryan-Borchers TA, Park JS, Chew BP, McGuire MK, Fournier LR,
Beerman KA. Soy isoflavones modulate immune function in healthy
postmenopausal women. Am J Clin Nutr 2006;83:1118–25.
100. Reeves PG, Nielsen FH, Fahey GC. AIN-93 purified diets for
laboratory rodents: final report of the American Institute of Nutrition
ad hoc writing committee on the reformulation of the AIN-76 rodent
diet. J Nutr 1993;123:1939e51.
101. Hagen MK, Lehenbauer-Luke AR, Paludo AC, Schenkel P, Goncalves
L, Fernandes TG, Caron R, Llesuy S, Mill JG, Bello-Klein A. Diet with
isolated soy protein reduces oxidative stress and preserves ventricular
function in rats with myocardial infarction. Nutr Metab Cardiovasc
Dis 2009;19:91–7.
102. Sreeja S, Geetha R, Priyadarshini E, Bhavani K, Anuradha CV.
Substitution of soy protein for casein prevents oxidative modification
and inflammatory response induced in rats fed high fructose diet.
ISRN Inflamm 2014;2014:641096.
103. Messina S, Bitto A, Aguennouz M, Vita GL, Polito F, Irrena N,
Altavilla D, Marini H, Migliorato A, Sguadrito F, et al. The soy
isoflavone genistein blunts nuclear factor kappa-B, MAPKs and
TNF-a activation and ameliorates muscle function and morphology
in mdx mice. Neuromuscul Disord 2011;21:579–89.
104. Greany KA, Nettleton JA, Wangen KE, Thomas W, Kurzer MS.
Consumption of isoflavone-rich soy protein does not alter homocys-
teine or markers of inflammation in postmenopausal women. Eur
J Clin Nutr 2008;62:1419–25.
105. T€orm€al€a R, Appt S, Clarkson TB, Mueck AO, Seeger H, Mikkola TS,
Ylikorkala O. Impact of soy supplementation on sex steroids and vascular
inflammation markers in postmenopausal women using tibolone: role of
equol production capability. Climacteric 2008;11:409–15.
106. Acharjee S, Zhou JR, Elajami TK, Welty FK. Effect of soy nuts and
equol status on blood pressure, lipids and inflammation in postmen-
opausal women stratified by metabolic syndrome status. Metabolism
2015;64:236–43.
107. Nasca MM, Zhou JR, Welty FK. Effect of soy nuts on adhesion
molecules and markers of inflammation in hypertensive and normo-
tensive postmenopausal women. Am J Cardiol 2008;102:84–6.













Institutional Repository - Library & Information Centre - University of Thessaly
07/06/2020 16:34:36 EEST - 137.108.70.13
108. Steinberg FM, Guthrie NL, Villablanca AC, Kumar K, Murray MJ.
Soy protein with isoflavones has favorable effects on endothelial function
that are independent of lipid and antioxidant effects in healthy post-
menopausal women. Am J Clin Nutr 2003;78:123–30.
109. Sirtori CR, Lovati MR. Soy proteins and cardiovascular disease. Curr
Atheroscler Rep 2001;3:47–53.
110. Fanti P, Asmis R, Stephenson TJ, Sawaya BP, Franke AA. Positive
effect of dietary soy in ESRD patients with systemic inflammation–
correlation between blood levels of the soy isoflavones and
the acute-phase reactants. Nephrol Dial Transplant 2006;21:
2239–46.
111. Mangano KM, Hutchins-Wiese HL, Kenny AM, Walsh SJ, Abourizk
RH, Bruno RS, Lipcius R, Fall P, Kleppinger A, Kenyon-Pesce L, et al.
Soy proteins and isoflavones reduce interleukin-6 but not serum
lipids in older women: a randomized controlled trial. Nutr Res
2013;33:1026–33.
112. Vega-Lo´pez S, Yeum KJ, Lecker JL, Ausman LM, Johnson EJ, Devaraj
S, Jialal I, Lichtenstein AH. Plasma antioxidant capacity in response to
diets high in soy or animal protein with or without isoflavones. Am
J Clin Nutr 2005;81:43–9.
113. Swain JH, Alekel DL, Dent SB, Peterson CT, Reddy MB. Iron indexes
and total antioxidant status in response to soy protein intake in
perimenopausal women. Am J Clin Nutr 2002;76:165–71.
114. Thomson RL, Brinkworth GD, Noakes M, Buckley JD. Muscle
strength gains during resistance exercise training are attenuated with
soy compared with dairy or usual protein intake in older adults: A
randomized controlled trial. Clin Nutr 2016;35:27–33.
115. Beavers KM, SerraMC, Beavers DP, CookeMB,Willoughby DS. Soymilk
supplementation does not alter plasma markers of inflammation and
oxidative stress in postmenopausal women. Nutr Res 2009;29:616–22.
116. Miraghajani MS, Esmaillzadeh A, Najafabadi MM, Mirlohi M,
Azadbakht L. Soy milk consumption, inflammation, coagulation, and
oxidative stress among type 2 diabetic patients with nephropathy.
Diabetes Care 2012;35:1981–5.
117. Mitchell JH, Collins AR. Effects of a soy milk supplement on plasma
cholesterol levels and oxidative DNA damage in men-a pilot study.
Eur J Nutr 1999;38:143–8.
118. Jenkins DJ, Kendall CW, Connelly PW, Jackson CJ, Parker T, Faulkner
D, Vidgen E. Effects of high- and low-isoflavone (phytoestrogen) soy
foods on inflammatory biomarkers and proinflammatory cytokines in
middle-aged men and women. Metabolism 2002;51:919–24.













Institutional Repository - Library & Information Centre - University of Thessaly
07/06/2020 16:34:36 EEST - 137.108.70.13
nutrients
Article
Disparate Habitual Physical Activity and Dietary
Intake Profiles of Elderly Men with Low and Elevated
Systemic Inflammation
Dimitrios Draganidis 1 ID , Athanasios Z. Jamurtas 1, Theodoros Stampoulis 2,
Vasiliki C. Laschou 1 ID , Chariklia K. Deli 1 ID , Kalliopi Georgakouli 1 ID ,
Konstantinos Papanikolaou 1 ID , Athanasios Chatzinikolaou 2, Maria Michalopoulou 2,
Constantinos Papadopoulos 3, Panagiotis Tsimeas 1, Niki Chondrogianni 4,
Yiannis Koutedakis 1,5,6 ID , Leonidas G. Karagounis 7,8 ID and Ioannis G. Fatouros 1,* ID
1 School of Physical Education and Sport Science, University of Thessaly, Karies, 42100 Trikala, Greece;
dimidraganidis@gmail.com (D.D.); ajamurt@pe.uth.gr (A.Z.J.); lavassia123@gmail.com (V.C.L.);
delixar@pe.uth.gr (C.K.D.); kgeorgakouli@gmail.com (K.G.); guspapa93@gmail.com (K.P.);
ptsimeas@gmail.com (P.T.); y.koutedakis@uth.gr (Y.K.)
2 School of Physical Education and Sports Science, Democritus University of Thrace, 69100 Komotini, Greece;
stampoulistheodoros@gmail.com (T.S.); achatzin@phyed.duth.gr (A.C.); michal@phyed.duth.gr (M.M.)
3 First Department of Neurology, Aeginition Hospital, School of Medicine, National and Kapodistrian
University, 11528 Athens, Greece; constantinospapadopoulos@yahoo.com
4 Institute of Biology, Medicinal Chemistry and Biotechnology, National Hellenic Research Foundation,
116 35 Athens, Greece; nikichon@eie.gr
5 Institute of Human Performance and Rehabilitation, Centre for Research and
Technology—Thessaly (CERETETH), Karies, 42100 Trikala, Greece
6 Faculty of Education Health and Wellbeing, University of Wolverhampton,
Walsall 14287, West Midlands, UK
7 Institute of Nutritional Science, Nestlé Research Centre, 1015 Lausanne, Switzerland;
leonidas.karagounis@rdls.nestle.com
8 Experimental Myology and Integrative Physiology Cluster, Plymouth Marjon University,
Plymouth PL6 8BH, UK
* Correspondence: ifatouros@pe.uth.gr; Tel.: +30-24-310-47-047
Received: 17 April 2018; Accepted: 1 May 2018; Published: 4 May 2018


Abstract: The development of chronic, low-grade systemic inflammation in the elderly (inflammaging)
has been associated with increased incidence of chronic diseases, geriatric syndromes, and functional
impairments. The aim of this study was to examine differences in habitual physical activity (PA),
dietary intake patterns, and musculoskeletal performance among community-dwelling elderly men
with low and elevated systemic inflammation. Nonsarcopenic older men free of chronic diseases
were grouped as ‘low’ (LSI: n = 17; 68.2 ± 2.6 years; hs-CRP: <1 mg/L) or ‘elevated’ (ESI: n = 17;
68.7 ± 3.0 years; hs-CRP: >1 mg/L) systemic inflammation according to their serum levels of
high-sensitivity CRP (hs-CRP). All participants were assessed for body composition via Dual Emission
X-ray Absorptiometry (DEXA), physical performance using the Short Physical Performance Battery
(SPPB) and handgrip strength, daily PA using accelerometry, and daily macro- and micronutrient
intake. ESI was characterized by a 2-fold greater hs-CRP value than LSI (p < 0.01). The two groups
were comparable in terms of body composition, but LSI displayed higher physical performance
(p < 0.05), daily PA (step count/day and time at moderate-to-vigorous PA (MVPA) were greater
by 30% and 42%, respectively, p < 0.05), and daily intake of the antioxidant vitamins A (6590.7 vs.
4701.8 IU/day, p < 0.05), C (120.0 vs. 77.3 mg/day, p < 0.05), and E (10.0 vs. 7.5 mg/day, p < 0.05)
compared to ESI. Moreover, daily intake of vitamin A was inversely correlated with levels of hs-CRP
(r = −0.39, p = 0.035). These results provide evidence that elderly men characterized by low levels of
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systemic inflammation are more physically active, spend more time in MVPA, and receive higher
amounts of antioxidant vitamins compared to those with increased systemic inflammation.
Keywords: aging; chronic low-grade systemic inflammation; physical activity; nutrition; physical
performance; chronic diseases
1. Introduction
Chronic exposure to antigens as well as to chemical, physical, and nutritional stressors that the
immune system has to cope with, in combination with the dramatic increase in life expectancy,
result in the overstimulation of the immune system with advancing age and the development
of a chronic and persistent pro-inflammatory state [1,2]. This age-associated, low-grade, chronic
inflammatory status has been termed as “inflammaging” [1] and is clinically assessed by measuring
systemic concentrations of cytokines and acute-phase proteins, including interleukin-6 (IL-6), tumor
necrosis factor-α (TNF-α), and C-reactive protein (CRP) [3]. Inflammaging represents a significant
risk factor for age-related frailty, morbidity, and mortality [2,4] as many chronic diseases and geriatric
syndromes such as cardiovascular diseases, atherosclerosis, metabolic syndrome, type 2 diabetes
mellitus, neurodegenerative diseases, cancer, and chronic obstructive pulmonary disease have been
associated with chronic inflammation [5–8]. Moreover, increased levels of IL-6, TNF-α, and CRP in the
elderly have been associated with lower muscle mass and physical performance [9–11] as well as with
increased risk for sarcopenia and osteoporosis [12–14]. Thus, the concept of inflammaging appears
to be a key determinant of successful aging and longevity and as such a valuable tool to counteract
age-related pathologies [2].
To date, inflammaging is defined as a complex and multifactorial process whose origin cannot be
simply attributed to a specific number of factors/mechanisms, as a complete understanding of the
extent to which different tissues, organs, and biological systems contribute to its pathophysiology is
lacking [3,15]. However, both physical activity (PA) and nutrition are considered powerful lifestyle
factors that may, cooperatively or independently, influence both healthy aging and lifespan in
humans [16,17]. Specifically, being physically active substantially reduces the risk of developing
cardiovascular [16,17] and metabolic diseases [16,18], obesity [16,19], frailty [16,20,21], sarcopenia [22],
osteoporosis [17,23], cognitive impairment [24], and mental health disorders [17,25] in a dose-response
manner [26,27]. Numerous studies reported that higher volume of habitual PA is related to lower
levels of IL-6, CRP, and TNF-α in older adults [28–40]. Most of these studies, though, are based on
self-reported PA estimations [28–33,36,37,40] that may result in increased risk of recall bias [41] and
therefore do not provide an objective determination of different intensity levels (i.e., light, moderate,
vigorous, or very vigorous PA). However, to our knowledge, four studies have utilized accelerometry
to provide an objective assessment of PA [34,35,38,39]. In two of them, an inverse relationship between
PA and disease-related (chronic obstructive pulmonary disease and obesity) systemic inflammation
was revealed in middle-aged adults [34,35]. Similarly, two other studies reported that time spent in
MVPA is negatively associated with markers of systemic inflammation in the healthy elderly [38,39].
Although these data clearly suggest that habitual PA is inversely associated with mediators of systemic
inflammation in older adults, a direct comparison of objectively assessed PA, sedentary time, and
PA-related energy expenditure among the elderly with low and increased systemic inflammation is
still lacking.
Ideally, this comparison would be more conclusive by the concurrent examination of habitual
PA/inactivity and dietary intake levels, since both factors may impact systemic inflammation. In fact,
available data suggest that the role of nutrition and dietary pattern is pivotal for immune function and
low-grade systemic inflammation [42–44]. Both macronutrient and micronutrient intake may interfere
with immune responses, triggering either a pro-inflammatory or an anti-inflammatory effect [45].
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Excessive consumption of glucose and saturated fatty acids (SFA) (particularly long-chain SFA) are
reported to activate pro-inflammatory markers in insulin-sensitive tissues [45,46] and may result in
systemic inflammation [15], while high phospholipid consumption, especially that of polyunsaturated
fatty acids (PUFA) and monounsaturated fatty acids (MUFA), elicit antiinflammatory properties and
reduce the risk of chronic inflammation and its associated chronic diseases [47]. On the other hand,
consumption of either plant- or dairy-based protein or amino acids may offer antiinflammatory effects
by reducing levels of inflammatory mediators [45,48]. Furthermore, adequate intake of antioxidants
and trace elements, particularly vitamins A, C, E, and selenium, also enhances immunity and elicits
a protective effect against chronic inflammatory conditions [44]. However, to our knowledge, the
literature lacks evidence regarding differences in dietary habits among older healthy adults with low
and high systemic inflammation.
Given the pivotal role of both PA and macronutrient/micronutrient intake in mediating immunity
and chronic inflammatory responses, a direct comparison of them among older adults exhibiting low
and elevated systemic inflammation may identify which parameters of these lifestyle factors function
as discriminants of healthy aging and inflammaging. Therefore, the aim of the present study was to
compare levels of objectively assessed habitual PA and dietary macronutrient/micronutrient intake,
among otherwise healthy elderly men of low and increased systemic inflammation.
2. Materials and Methods
2.1. Experimental Design and Participants
A total of fifty community-dwelling elderly men aged 65–75 years were recruited from the
surrounding area of Thessaly (Greece) through postings, newspaper, and media advertisements. All
volunteers completed a health history questionnaire and were also examined by a physician. In order
to be included in the study, volunteers had to initially meet all of the following inclusion/exclusion
criteria: (a) nonsmokers; (b) independently living; (c) absence of chronic disease (i.e., cancer, metabolic,
cardiovascular, neurological, pulmonary, or kidney disease); (d) absence of inflammatory disease (i.e.,
osteoarthritis, rheumatoid arthritis); (e) absence of type 2 diabetes, and (f) no recent or current use of
antibiotics or other medication that could affect inflammatory status (i.e., corticosteroids). Subsequently,
those who fulfilled these criteria underwent assessment of body height, body weight, body composition,
handgrip strength, and physical performance (via the SPPB) testing to estimate their weight status
and stage of sarcopenia according to the European Working Group on Sarcopenia in Older People
(EWGSOP) [49]. Volunteers who were characterized as presarcopenic/sarcopenic were excluded from
the study at this stage, since substantial loss of skeletal muscle mass is accompanied by significant
performance decline [49], resulting in lower levels of habitual PA [50]. Volunteers who were classified
as obese were also excluded since obesity is linked to metaflammation, an adipose-tissue-mediated
chronic inflammatory state that differs in terms of pathophysiology from inflammaging [5,15].
Accordingly, thirty-four volunteers who fulfilled the eligibility criteria participated in the study. The
determination of inflammatory status was based on two consecutive measurements of high-sensitivity
CRP (hs-CRP) and participants were grouped as “low systemic inflammation” (LSI: hs-CRP < 1 mg/L)
or “elevated systemic inflammation” (ESI: hs-CRP > 1 mg/L) according to a previous report [51].
Participants were then provided with accelerometers and food diaries to monitor their habitual PA
and daily macronutrient/micronutrient intake, respectively, over a 7-day period. They were fully
informed about the aim and the experimental procedures of the study, as well as about the benefits
involved, before obtaining written consent. The Institutional Review Board of the University of
Thessaly approved the study and all procedures were in accordance with the 1975 Declaration of
Helsinki (as revised in 2000).
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2.2. Body Composition
Standing body mass and height were measured on a beam balance with stadiometer (Beam
Balance-Stadiometer, SECA, Vogel & Halke, Hamburg, Germany) with participants wearing light
clothing and no shoes as described previously [52]. Body composition [including fat mass, fat-free mass
(FFM), percent of fat, lean body mass (LBM)] was assessed by dual emission X-ray absorptiometry
(DXA, GE Healthcare, Lunar DPX NT, Diegem, Belgium) with participants in supine position as
described before [53]. Appendicular lean mass (ALM) and skeletal muscle mass index (SMI) were
calculated as the sum of muscle mass (kg) of the four limbs (based on DXA scan) and as ALM divided
by height by meters squared (kg/m2), respectively [49], while sarcopenia status was determined
according to the criteria established by EWGSOP [49].
2.3. Physical Activity
Physical activity was monitored by using the accelerometers ActiGraph, GT3X+ (ActiGraph,
Pensacola, FL, USA) over a 7-day period. Accelerometers were attached to elastic, adjustable belts and
did not provide any feedback to the participants. Participants were taught how to wear the belt around
the waist with the monitor placed on the right hip and they were asked to wear it throughout the day,
except for bathing or swimming and sleep, for seven consecutive days. To be included in the analysis,
participants had to have ≥four days with ≥10 wear hours/day (i.e., four valid days) [54]. Nonwear
time was calculated using the algorithms developed by Choi et al. [55] for vector magnitude (VM)
data and defined as periods of 90 consecutive minutes of zero counts per minute (cpm), including
intervals with nonzero cpm that lasted up to 2 min and were followed by 30 consecutive minutes of
zero cpm. Daily activity and sedentary time were estimated according to VM data and expressed
as steps/day and time in sedentary (<199 cpm), light (200–2689 cpm), moderate (2690–6166 cpm),
vigorous (6167–9642 cpm), and moderate-to-vigorous (≥2690 cpm) PA [56]. The manufacturer software
ActiLife 6 was utilized to initialize accelerometers and download data using 60-s epoch length.
2.4. Dietary Assessment
Participants were taught by a registered dietitian how to estimate food servings and sizes of
different food sources and how to complete food diaries. They were allowed to weigh out food servings,
so that they could precisely report the amount of specific food portions, while they were also provided
with colored photographs depicting different portion sizes that they could use to compare their food
weights. Furthermore, complete instructions on how to describe portion sizes based on household
measures or other standard units were also administered to our participants. Participants recorded
their daily dietary intake for seven consecutive days, describing, in as much detail as possible all
portions of food and drinks/water. For commercially available products, the name of the manufacturer,
fat content (i.e., 1%. 2%, etc.), and other related information had to be noted. The Science Fit Diet 200
A (Science Technologies, Athens, Greece) dietary software was utilized to analyze diet recalls and
data regarding total energy (kJ), protein (g/kg/day & g/day), leucine (g/day), branched chain amino
acids (BCAA, g/day), carbohydrates (g/day), fat (g/day), vitamin A (IU/day), vitamin C (mg/day),
vitamin E (mg/day), selenium (µg/day), polyunsaturated fatty acids (PUFA), and monounsaturated
fatty acids (MUFA).
2.5. Systemic Inflammation
Blood samples were collected early in the morning between 07:00 and 09:00 am, after an overnight
fasting. Participants were asked to avoid alcohol and abstain from intense physical activity for ≥48 h
before blood sampling. Blood was drawn from an antecubital arm vein via a 10-gauge disposable
needle equipped with a Vacutainer tube holder (Becton Dickinson) with participants seated. To separate
serum, blood samples were allowed to clot at room temperature and then centrifuged (15,000× g,
15 min, 4 ◦C). The supernatant was dispensed in multiple aliquots (into Eppendorf tubes) and stored
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at −80 ◦C for later analysis of hs-CRP. Serum hs-CRP was quantitatively measured in duplicate using
the C-Reactive Protein (Latex) High Sensitivity assay (CRP LX High Sensitive, Cobas®) on a Cobas
Integra® 400 plus analyzer (Roche) with a detectable limit of 0.01 mg/dL and an inter-assay coefficient
of one standard deviation (1 SD).
2.6. Statistical Analyses
All data are presented as means ± SD. The normality of data was examined using the
Shapiro–Wilk test (n = 17/group). Because our data sets in most of our variables differed
significantly from normal distribution, we rejected the hypothesis of normality and applied
nonparametric tests. To test differences in body composition, daily PA-related parameters, and
dietary macronutrient/micronutrient intake among the two groups (LSI vs. HSI) a Kruskal–Wallis test
was applied. Pearson’s correlation analysis was used to examine the relation of dietary antioxidant
vitamins intake, number of steps, and time in MVPA per day with serum levels of hs-CRP. Correlation
coefficients of r < 0.2, 0.2 < r < 0.7 and r > 0.7 were defined as small, moderate, and high, respectively.
Effect sizes (ES) and confidence intervals (CI) were also calculated for all dependent variables using
the Hedge’s g method corrected for bias. ES was interpreted as none, small, medium-sized, and large
for values 0.00–0.19, 0.20–0.49, 0.50–0.79, and≥0.8, respectively. The level of statistical significance was
set at p < 0.05. Statistical analyses were performed using the SPSS 20.0 software (IBM SPSS Statistics).
The G * Power program (G * Power 3.0.10) was utilized to perform power analysis. With our sample
size of 17/group we obtained a statistical power greater than 0.80 at an α error of 0.05.
3. Results
Participants’ characteristics are presented in Table 1. Participants were healthy and had no
pathological levels of hs-CRP. The two groups, though, differed significantly in respect to hs-CRP
values (ESI: 2.1 ± 0.8 vs. LSI: 0.7 ± 0.2 mg/dL, p = 0.00), with ESI displaying a 2-fold elevation in
serum hs-CRP compared to LSI. Averaged BMI values in LSI and ESI were 27.3 ± 3.1 kg/m2 and
27.9 ± 2.5 kg/m2, respectively, which classifies them as nonobese according to the criteria established
by the World Health Organization (WHO) [57]. Moreover, all participants were characterized as
nonsarcopenic, since they exhibited SMI > 7.26 kg/m2, handgrip strength > 30 kg, and physical
performance score in SPPB > 8. No differences were detected in respect to BMI, fat mass, percent of
fat, FFM, LBM, ALM, SMI, and handgrip strength among groups. However, significant differences
were observed in physical performance, with LSI achieving a higher SPPB score compared to ESI (LSI:
11.9 ± 0.2 vs. ESI: 11.2 ± 1.0; χ2 = 6.436, p = 0.016; ES = 0.90; 95% CI = −1.63, −0.17).
Table 1. Participants’ characteristics.
Parameter LSI (n = 17) ESI (n = 17)
Age (years) 68.2 ± 2.6 68.7 ± 3.0
Body Height (m) 1.71 ± 0.07 1.73 ± 0.04
Body Weight (kg) 82.3 ± 8.5 85.2 ± 7.5
BMI (kg/m2) 27.3 ± 3.1 27.9 ± 2.5
Fat Mass (kg) 24.1 ± 7.0 26.3 ± 4.1
Fat (%) 29.5 ± 6.6 31.8 ± 2.1
Fat-Free Mass (kg) 56.3 ± 4.6 58.4 ± 5.2
Lean Body Mass (kg) 53.3 ± 4.5 55.3 ± 5.1
ALM (kg) 23.2 ± 2.4 24.4 ± 2.1
SMI (kg/m2) 8.12 ± 0.7 8.13 ± 0.6
Grip Strength (kg) 34.3 ± 5.5 36.7 ± 6.6
SPPB (score) 11.9 ± 0.2 11.2 ± 1.0 1
Sarcopenia Status Non-Sarcopenic Non-Sarcopenic
hs-CRP (mg/L) 0.7 ± 0.2 2.1 ± 0.8 2
Data are presented as mean ± SD. ALM: Appendicular Lean Mass; SMI: Skeletal Muscle Mass Index; SPPB: Short
Physical Performance Battery; hs-CRP: High-Sensitivity CRP. 1 significant difference between groups, p < 0.05,
2 significant difference between groups, p < 0.01.
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Results comparing sedentary time and PA among groups are shown in Figure 1. The two groups
were comparable in sedentary time throughout the day (LSI: 378.2± 98.7 vs. ESI: 370.5± 95.9 min/day;
χ2 = 0.008, p = 0.927) and in the time they spent in light PA/day (LSI: 342.9 ± 93.1 vs. ESI: 331.7
± 98.2 min/day; χ2 = 0.357, p = 0.550), while a trend for significantly more time spent in moderate
PA/day by the LSI group was also observed (LSI: 59.5 ± 16.7 vs. ESI: 44.1 ± 18.2 min/day; χ2 = 3.637,
p = 0.057). Interpretation of the level of moderate PA by group means examined in relation to the
PA guidelines adopted by the WHO revealed that both groups met the recommendation for at least
150 min of moderate-intensity PA throughout the week.
Figure 1. (A) Sedentary time, (B) time spent in light, (C) moderate, (D) vigorous, (E) moderate-to-vigorous
(MVPA) PA, and (F) total step count throughout the day, in low (LSI) and elevated (ESI) systemic
inflammation groups. Values are presented as mean ± SD. * denotes significant difference between
groups at p < 0.05.
By performing an individual examination in both groups, we found that all participants in LSI and
approximately 86% of participants in ESI met this criterion. Significant differences between LSI and
ESI were observed in MVPA and daily step count, with LSI spending more time in MVPA throughout
the day (LSI: 65.2 ± 21.5 vs. ESI: 45.9 ± 19.8 min/day; χ2 = 3.997, p = 0.044; ES = 0.91; 95% CI = −1.68,
−0.13) and performing more steps (LSI: 9000.1 ± 2496 vs. ESI: 6968.3 ± 2075 steps/day; χ2 = 4.087,
p = 0.043; ES = 0.86; 95% CI = −1.63, −0.08) than ESI, by 42% and 30%, respectively. The average
step count/day for LSI was 9000.1 steps, which is close to the upper recommended limit for older
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adults (7100–10,000 steps/day) [58] while the ESI did not meet these recommendations, performing
6968.3 steps/day. Almost 86% of participants in the LSI group performed >7100 steps daily while
slightly more than half (53%) of participants in the ESI group did so. A longitudinal analysis combining
both groups revealed a trend for an inverse correlation between hs-CRP level and daily step count
(r = −0.37, p = 0.055). Time in vigorous PA/day did not differ among groups (LSI: 5.3 ± 6.9 vs.
ESI: 1.0 ± 2.6 min/day; χ2 = 2.315, p = 0.128), probably because of a high interindividual variability.
Moreover, the two groups demonstrated similar PA-related energy expenditure throughout the day,
as no differences observed in terms of kJ/day (LSI: 2554.3 ± 1033.5 vs. ESI: 2654.3 ± 1041.8 kJ/day,
p = 0.798) and METs/day (LSI: 1.28 ± 0.1 vs. ESI: 1.23 ± 0.1 METs/day, p = 0.203) (Figure 2).
Figure 2. Daily PA-related energy expenditure expressed as (A) kJ and (B) METs in low (LSI) and
elevated (ESI) systemic inflammation groups. Values are presented as mean ± SD.
LSI and ESI demonstrated similar total energy and macronutrient intake throughout the day
(Table 2). The two groups had a daily energy intake of 6949.6–6794.8 kJ, constituted by 15–16% protein,
38% carbohydrate, and 42% fat. The mean protein intake in both groups was 0.8 g/kg body weight/day,
which represents the recommended daily allowance (RDA) that meets 97.5% of the population [59].
However, approximately 46% of participants in both groups had a daily protein intake of 0.5–0.7 g/kg
body weight/day. Separate analysis in leucine and BCAA intake revealed that both LSI and ESI
received 0.6 g of leucine/kg body weight/day and 0.13–0.14 g of BCAAs/kg body weight/day, which
meets the current recommendations for amino acid intake in adults [59]. The two groups, though,
differed significantly in respect to daily antioxidant vitamin intake, with the LSI group receiving higher
amounts of vitamin A (LSI: 6590.7 ± 2219 vs. ESI: 4701.8 ± 1552.6 IU/day; χ2 = 5.616, p = 0.018;
ES = 0.95; 95% CI = 1.72, 0.18), vitamin C (LSI: 120.0 ± 55.5 vs. ESI: 77.3 ± 39.1 mg/day; χ2 = 5.421,
p = 0.020; ES = 0.87; 95% CI = 1.63, 0.11), and vitamin E (LSI: 10.0 ± 2.9 vs. ESI: 7.5 ± 3.0 mg/day;
χ2 = 4.496, p = 0.034; ES = 0.75; 95% CI = 1.50, 0.01) than ESI, by 37%, 59%, and 33%, respectively.
Moreover, by performing a longitudinal analysis of both groups we observed that daily vitamin A
intake was inversely correlated with levels of hs-CRP (r = −0.39, p = 0.035) (Figure 3). On the contrary,
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daily intake of selenium (LSI: 93.2 ± 29.8 vs. ESI: 96.1 ± 29.7 µg/day, p = 0.793), PUFA (LSI: 10.1 ± 2.4
vs. ESI: 8.9 ± 2.6 g/day, p = 0.215), and MUFA (LSI: 43.7 ± 10.8 vs. ESI: 37.9 ± 10.9 g/day, p = 0.168)
was comparable in the two groups.
Table 2. Dietary macronutrient and micronutrient intake in LSI and ESI groups.
Parameter LSI (n = 17) ESI (n = 17) p Value χ2
Total Energy (kJ/day) 6952.9 ± 1241.8 6797.8 ± 1136.8 0.771 0.085
Protein
g/day 63.8 ± 20.3 66.9 ± 14.6 0.183 1.770
g/kg BM/day 0.8 ± 0.3 0.8 ± 0.2 0.817 0.054
% of total calories 15 ± 2.7 16 ± 3.0
Leucine (g/day) 4.89 ± 1.7 5.13 ± 1.2 0.430 0.624
BCAAs (g/day) 11.38 ± 3.6 11.53 ± 2.4 0.533 0.389
Carbohydrates
g/day 156.2 ± 37.6 154.9 ± 52.7 0.901 0.016
% of total calories 37.7 ± 6.9 37.5 ± 8.4
Fat
g/day 79.3 ± 12.5 73.7 ± 17.0 0.318 0.996
% of total calories 42.0 ± 4.0 41.7 ± 7.1
PUFA (g/day) 10.1 ± 2.4 8.9 ± 2.6 0.275 1.191
MUFA (g/day) 43.7 ± 10.8 37.9 ± 10.9 0.359 0.840
Vitamin A (IU/day) 6590.7 ± 2219.6 4701.8 ± 1552.6 1 0.018 5.616
Vitamin C (mg/day) 120.0 ± 55.5 77.3 ± 39.1 1 0.020 5.421
Vitamin E (mg/day) 10.0 ± 2.9 7.5 ± 3.0 1 0.034 4.496
Selenium (µg/day) 93.2 ± 29.8 96.1 ± 29.7 0.589 0.292
Data are presented as mean ± SD. BM: Body mass; BCAA: Branched chain amino acids; PUFA: Polyunsaturated
fatty acids; MUFA: Monounsaturated fatty acids. 1 Significant difference between groups.
Figure 3. The relationship between serum hs-CRP level and daily dietary intake of Vitamin A.
4. Discussion
The present study is the first, to our knowledge, to compare the levels of habitual PA, sedentary
time, and dietary intake between healthy elderly men with low and elevated low-grade systemic
inflammation (inflammaging). Our findings suggest that older adults characterized by low levels of
systemic inflammation perform more steps and spent more time in MVPA throughout the day and
they receive higher amounts of dietary antioxidant vitamins (i.e., vitamins A, C, and E) on a daily basis
compared to their counterparts with elevated systemic inflammation.
Participants were categorized as having either “low” or “elevated” low-grade systemic
inflammation according to their serum levels of hs-CRP. This acute-phase protein is considered a
valid and informative marker of inflammaging [60] and has been previously used as a single marker to
identify levels of systemic inflammation in older adults [51]. The term inflammaging, first introduced
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by Franceschi and his colleagues [1], refers to the development of a chronic, low-grade inflammation
phenotype with advancing age. However, the presence of obesity, either in young or older individuals,
results in elevated systemic inflammation, which has been defined as metaflammation (metabolic
inflammation) and is primarily mediated by the adipose tissue [5]. Although the underpinning
mechanisms of inflammaging and metaflammation may be different, these two chronic inflammatory
conditions may overlap [15]. Therefore, in an attempt to focus on inflammaging in this study, we
included only nonobese elderly men (according to WHO criteria). Moreover, LSI and ESI groups
were very homogeneous in terms of body composition, since they did not differ in body weight, fat
mass, percent of fat, FFM, and LBM. All participants were also nonsarcopenic according to the criteria
established by the EWGSOP [49], since the existence of sarcopenia could act as a covariate in our
investigation, interfering with their ability to habitually perform PA [50].
Previous cross-sectional studies have investigated the association between habitual PA and
inflammatory biomarkers in middle-aged and older adults [28–31,33–40]. However, only two
utilized accelerometry to quantify not only the quantity but also the quality (intensity) of habitual
PA in the otherwise healthy elderly with physiological and elevated chronic, low-grade systemic
inflammation [38,39]. This study attempted to extend the current literature by providing insights
concerning the differences in PA and dietary intake profile among elderly men with low and
elevated low-grade systemic inflammation. The use of accelerometry to objectively assess the
quantity and intensity of habitual PA is a strength of our study, as most of the previously cited
studies [28–31,33,36,37,40] are based on questionnaires, self-reports, or interviews. The use of
accelerometers over a 7-day period to assess PA and sedentary time has been reported to be a valid
and reproducible methodological approach in the elderly [61].
Although sedentary time and time spent in light- and moderate-intensity activities throughout
the day were similar between LSI and ESI, we noted that overall the LSI group performed more
steps and spent more time in MVPA on a daily basis. This suggests that not only the volume of
habitual PA but also the intensity in which daily physical activities are performed may interfere
with the development of chronic, low-grade systemic inflammation in older individuals. Our
findings further build on previous reports that higher volume of habitual PA is associated with
lower levels of pro-inflammatory mediators in healthy elderly individuals [29,33,36] and COPD
patients [34]. Moreover, this inverse association between PA and inflammation is suggested to
be dose-dependent, so that the more physically active an individual is, the lower the chronic
inflammatory milieu [29,31,40]. Although only a trend (r = −0.37, p = 0.055) for an inverse correlation
between hs-CRP level and daily step number was observed in our study, possibly because of an
interindividual variability in daily step counts of our participants (we used accelerometers whereas
questionnaires were utilized by others), these findings collectively suggest that habitual PA may
be associated with inflammaging in an inverse, dose-response pattern. Furthermore, it has been
recently reported that the impact of PA on chronic low-grade inflammation is not only dose-dependent
but also intensity-dependent, as moderate-to-vigorous activities induce greater improvements in
the inflammatory profile of older adults while light- or moderate-intensity physical activities are
accompanied by no changes in inflammatory mediators [62]. Indeed, Wahlin-Larsson et al. [39]
found that in recreationally active elderly women, the time spent in MVPA is inversely associated
with serum levels of CRP, a finding also reported in younger individuals [63]. The mechanism/s
through which PA reduces or prevents low-grade systemic inflammation in the elderly remains to
be elucidated. Observational, cross-sectional studies are not designed to identify the mechanisms
that underline the effects of systematic PA on chronic inflammation and as such, more intervention
studies are needed [41,62]. Based on the fact that inflammaging is tightly regulated by the balance
between pro- and anti-inflammatory mediators [64], a possible mechanism could be that PA, and
especially MVPA, suppresses the production of pro-inflammatory cytokines and molecules that trigger
the inflammatory milieu, and enhances the production of anti-inflammatory mediators [41,62,65].
Moreover, the process of inflammaging may be further affected by the age-associated increase in the
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production of reactive oxygen and nitrogen species (RONS) that lead to redox balance disturbances and
subsequent activation of the redox-sensitive NF-κB signaling pathway that stimulates the expression of
numerous pro-inflammatory mediators such as TNF-α, IL-6, IL-1β, and CRP [48,66]. As such, a vicious
cycle of RONS and pro-inflammatory molecule production is propagated, driving a chronic systemic
pro-inflammatory phenotype [48,67]. Regular participation in moderate-to-vigorous intensity exercise
has been shown to attenuate both basal and exercise-induced levels of oxidative damage, enhance the
antioxidant capacity, and improve the DNA repair machinery in healthy, elderly individuals [68,69].
Thus, it can be proposed that systematic MVPA may prevent the development of inflammaging by
lowering the production of RONS and levels of oxidative damage in the elderly.
LSI and ESI also differed significantly in terms of physical performance. More specifically, LSI
exhibited higher performance in the SPPB test compared to ESI and this observation is in line with
previous findings reporting that older adults with elevated systemic inflammation demonstrate lower
physical performance [70,71]. Although the underlying mechanism leading from chronic inflammation
to functional decline has not been clarified yet, it has been reported that systemic inflammation
may impact physical performance by decreasing skeletal muscle mass [14,48]. However, in this
study, the two groups demonstrated similar LBM, ALM, and SMI, indicating that the observed
difference in physical performance was not muscle-mass-dependent. A previous report, though,
by Wahlin-Larsson and colleagues [39] provided evidence that increased systemic inflammation
influences muscle regeneration by decreasing the proliferation rate of myoblasts. In addition, increased
inflammation and cytokine production may also reduce the quiescent satellite cells pool and attenuate
their differentiation capacity [14]. Therefore, it can be assumed that elevated systemic inflammation
may contribute to physical performance deterioration by attenuating the regeneration potential of the
aged skeletal muscle.
We also utilized 7-day recalls to perform a thorough screening of the dietary intake in the LSI and
ESI groups, focusing on macronutrients and micronutrients that have been shown to elicit either a pro-
or an anti-inflammatory effect, and could be therefore characterized as ‘key modifiers’ in the process
of inflammaging. LSI and ESI demonstrated similar energy and macronutrient intake, consuming
6794.8–6949.6 kJ/day composed of 15–16% protein, 38% carbohydrates, and 42% fat. Our group
recently conducted a literature review suggesting that protein intake, especially that of whey protein
and soy or isoflavone-enriched soy protein, may indirectly offer antioxidative and anti-inflammatory
benefits beyond its ability to stimulate skeletal muscle protein synthesis [48]. Also, Zhou et al. [72]
performed a meta-analysis on the effects of whey protein supplementation on levels of CRP, concluding
that increased whey protein intake may induce favorable effects on individuals with elevated baseline
CRP levels. However, in this study, we noted that daily protein intake was similar between LSI and
ESI, with both groups receiving on average ~0.8 g/kg BM/day, which is in line with WHO RDA for
protein [59]. BCAA and leucine intake were also compared among groups to provide a qualitative
determination of daily protein intake. Although leucine is classified as a BCAA, we decided to present
it separately because its role may differ from that of the other BCAAs, especially in the elderly where
a higher amount of leucine should be consumed through diet to efficiently stimulate muscle protein
synthesis and preserve muscle loss [73,74]. In our present work, we observed that LSI and ESI had a
similar daily intake of BCAAs and leucine, meeting the recommendations for amino acid intake in
adults [59]. Daily carbohydrate intake was also similar among groups (154–156 g/day), indicating
that it does not play a prominent role in the development of inflammaging. Previous reports have
noted that only increased consumption of high glycemic index carbohydrates may be associated with
increased levels of inflammation [75]. Unfortunately, the determination of glycemic index and glycemic
load in our participants’ daily diets was not feasible.
Similarly, no differences were observed in total fat consumption among groups, with LSI and
ESI receiving 79 and 74 g/day, respectively, which corresponds in both groups to 42% of daily
energy intake. Although previous reports have indicated that increased fat consumption is associated
with elevated systemic markers of inflammation [75,76], this was not the case here. High fat diets,
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and primarily SFA, have been reported to induce substantial alterations in the gut microbial flora
(i.e., increases gut mucosa permeability, epithelial brier disruption) that result in enhanced translocation
of lipolysaccharide (LPS) in the circulation, thus promoting the development of low-grade systemic
inflammation [76,77]. However, it should be highlighted here that not all SFA demonstrate equal
properties and consumption of specific SFA (i.e., C14:0, C15:0, C17:0, CLA, and trans-palmitoleic) has
been associated with positive effects on cardiovascular health [78]. On the other hand, increased intake
of MUFA and/or PUFA has been proposed to counteract the pro-inflammatory cascade by reducing
the translocation of LPS in the circulation [76] and suppressing the eicosanoid and PAF inflammatory
pathways [47]. Indeed, many studies have revealed an inverse association between higher intake of
dietary PUFA and/or MUFA and levels of pro-inflammatory mediators such as hs-CRP and IL-6 [75].
In this study, although no statistically meaningful differences were observed in dietary MUFA and
PUFA intake between groups, LSI displayed a higher intake of MUFA and PUFA, by 15% and 13.5%,
respectively, compared to ESI.
Interestingly, we noted significant differences between LSI and ESI in terms of antioxidant vitamin
intake. More specifically, daily dietary intake of vitamins A, C, and E in LSI was higher by 37%, 59%,
and 33%, respectively, as compared to ESI. These vitamins play a major role in immune function,
so that adequate intake enhances innate, cell-mediated, and humoral antibody immunity while
deficiency promotes the opposite effects [44,79]. With aging, the production of reactive oxygen and
nitrogen species and that of pro-inflammatory cytokines rises significantly, propagating a vicious cycle
of oxidative stress and inflammation that promotes a chronic low-grade inflammatory state [48,67].
Vitamin A has been shown to promote a T-helper type 2 immune response by reducing the expression of
pro-inflammatory cytokines (i.e., interferon-γ, TNF-α and IL-12) and adipocytokines (i.e., leptin) [44,79]
while it may also inhibit the activation of the redox-sensitive nuclear factor-kappa B (NF-κB) [44,79],
a principal mediator of the bidirectional interaction between oxidative stress and inflammation [48].
Moreover, the pivotal role of vitamin A in chronic inflammation is further supported by the fact that a
deficit in vitamin A intake is associated with a pronounced pro-inflammatory state and inability to
cope with pathogens, as well as with reduced phagocytic capacity of macrophages [44]. Vitamin C
also reduces the production of pro-inflammatory cytokines through inhibition of the transcription
factor NF-κB [44]. The anti-inflammatory effect of this micronutrient is further supported by a
previous investigation where vitamin C intake was inversely associated with levels of CRP and
tissue plasminogen activator (t-PA) antigen in elderly men [80]. Furthermore, vitamin C acts as a
potent antioxidant, protecting cells from ROS-mediated oxidative damage, while it may also boost
the synthesis of other antioxidants such as vitamin E [44]. Likewise, vitamin E is able to confer
protection against oxidative stress by increasing the concentration of endogenous antioxidant enzymes,
such as SOD, CAT, and GPX, and it also prevents oxidative damage in the cell membrane [44,81].
Evidence based on human studies indicates that vitamin E supplementation in older adults improves
immune function [44] and is associated with a lower concentration of pro-inflammatory mediators [82].
Collectively, these data corroborate the higher antioxidant vitamin intake observed in LSI in the
present study, indicating that vitamins A, C, and E may contribute to the control of low-grade systemic
inflammation in the elderly. By contrast, no differences were observed in selenium intake between
LSI and ESI, although selenium is also considered a micronutrient that may efficiently influence both
innate and acquired immune function and may enhance the antioxidative defense system [44].
5. Conclusions
We found that elderly men with low levels of systemic inflammation are characterized by higher
quality and quantity of habitual PA and ingested higher amounts of antioxidant vitamins A, C, and E
through normal diet when compared to those with increased systemic inflammation. To the best of
our knowledge, this is the first study to directly compare elderly men of low and increased low-grade
systemic inflammation in respect to habitual PA and dietary profile. PA and antioxidant vitamin intake
appear to be discriminant factors of inflammaging and healthy aging. Future research should further
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explore the cause and effect as well as the dose-response relationship between PA and/or antioxidant
vitamins and inflammaging.
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Σύγκριση ηλικιωμένων ανδρών με χαμηλή και υψηλή χρόνια συστημική φλεγμονή σε δείκτες
δύναμης, οξειδωτικού στρες και φλεγμονής
Δραγανίδης Δημήτριος,1 Πούλιος Αθανάσιος,1 Λάσχου Βασιλική,1 Τζατζάκης Θεοφάνης,1
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Αυλωνίτη Αλεξάνδρα,2 Παππάς Άγγελος,1 Τζιαμούρτας Αθανάσιος,1 Φατούρος Ιωάννης1
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Περίληψη
Σκοπός της μελέτης ήταν να διερευνήσει την ύπαρξη διαφορών μεταξύ ηλικιωμένων ανδρών με
χαμηλή και υψηλή χρόνια συστημική φλεγμονή (ΧΣΦ), σε δείκτες ανοσοποιητικού συστήματος,
οξειδωτικού στρες, αντιοξειδωτικής ικανότητας και δύναμης άνω και κάτω άκρων. Στη μελέτη έλαβαν
μέρος συνολικά 33 υγιείς, άνδρες εθελοντές ηλικίας 65-75 ετών, οι οποίοι κατηγοριοποιήθηκαν με βάση
τα επίπεδα της C-αντιδρώσας πρωτεΐνης υψηλής ευαισθησίας (hs-CRP) σε δύο ομάδες: α) ομάδα
χαμηλής ΧΣΦ (hs-CRP < 1 mg/L) και β) ομάδα υψηλής ΧΣΦ (hs-CRP > 1 mg/L). Όλοι οι συμμετέχοντες
υποβλήθηκαν σε αξιολόγηση των σωματομετρικών τους χαρακτηριστικών, της σύστασης σώματος με
μηχάνημα διπλής ενεργειακής απορρόφησης ακτινών Χ (DXA), της μέγιστης δύναμης χειρολαβής και
των 10ΜΕ κάτω άκρων στο μηχάνημα εκτάσεις γονάτων. Επιπλέον υποβλήθηκαν σε αιμοληψία για τη
βιοχημική αξιολόγηση των λευκοκυττάρων και των υποπληθυσμών τους, των πρωτεϊνικών
καρβονυλίων, που είναι δείκτης οξείδωσης των πρωτεϊνών, και της συνολικής αντιοξειδωτικής
ικανότητας στον ορό. Η μέση συγκέντρωση hs-CRP στην ομάδα υψηλής ΧΣΦ ήταν περίπου 4 φορές
μεγαλύτερη από εκείνη στην ομάδα χαμηλής ΧΣΦ (υψηλής ΧΣΦ: hs-CRP=0.6±0.1 mg/L / χαμηλής
ΧΣΦ: hs-CRP=2.3±0.8 mg/L, p=0.00). Οι δύο ομάδες δεν διέφεραν μεταξύ τους όσον αφορά τα
σωματομετρικά χαρακτηριστικά, το δείκτη μάζας σώματος, το ποσοστό λίπους, τη λιπώδη μάζα, την
άλιπη μάζα, τη μυϊκή μάζα καθώς και τη δύναμη χειρολαβής και κάτω άκρων. Επίσης δεν εντοπίστηκαν
διαφορές μεταξύ των ομάδων στη συγκέντρωση λευκοκυττάρων και πρωτεϊνικών καρβονυλίων.
Αντίθετα, σημαντικές διαφορές εντοπίστηκαν στη συνολική αντιοξειδωτική ικανότητα, με την ομάδα
χαμηλής ΧΣΦ να παρουσιάζει κατά 60% υψηλότερη αντιοξειδωτική ικανότητα από την ομάδα υψηλής
ΧΣΦ (p<0.05). Συμπερασματικά, η συγκέντρωση λευκοκυττάρων και πρωτεϊνικών καρβονυλίων αλλά
και τα επίπεδα δύναμης δεν διαφοροποιούνται μεταξύ ηλικιωμένων ανδρών με χαμηλή ΧΣΦ και υψηλή
ΧΣΦ. Ωστόσο, τα άτομα με χαμηλή ΧΣΦ χαρακτηρίζονται από υψηλότερη αντιοξειδωτική ικανότητα.
Λέξεις κλειδιά: χρόνια συστημική φλεγμονή, λευκοκύτταρα, πρωτεϊνικά καρβονύλια, μυϊκή δύναμη
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Comparison of elderly men with low and elevated chronic systemic inflammation in indices of
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Abstract
The aim of the study was to examine differences among elderly men with low and elevated chronic
systemic inflammation (CSI) in indices of the immune system, oxidative stress, antioxidant capacity and
strength of the upper and lower body. A total of thirty-three, healthy, elderly men aged 65-75 years were
included in the study and grouped as either ″low‶ CSI (LCSI: n=16; hs-CRP: < 1 mg/L) or ″elevated‶
CSI (ECSI: n=17; hs-CRP: > 1 mg/L) according to their serum levels of high-sensitivity CRP (hs-CRP).
All participants were assessed for anthropometrics, body composition via Dual Emission X-ray
Absorptiometry (DXA), handgrip strength and lower limb muscle strength on a leg extension machine.
Blood samples were also collected for the determination of white blood cells (WBC), granulocytes
(GRA), monocytes (MON) and lymphocytes (LYM) concentration as well as for the measurement of
protein carbonyls (PC) and total antioxidant capacity (TAC) in serum. ECSI was characterized by almost
a 4-fold greater hs-CRP value compared to LCSI (ECSI: hs-CRP = 0.6±0.1 mg/L vs LCSI: hs-CRP =
2.3±0.8 mg/L, p=0.00). ECSI and LCSI were comparable in terms of anthropometric characteristics,
body mass index, fat percent, fat mass, fat free mass, lean body mass as well as in handgrip and lower
limb muscle strength. Moreover, no differences were observed among groups in WBC, GRA, MON and
LYM counts and in PC concentration. In contrast, significant differences observed between groups in
TAC, with LCSI displaying a greater antioxidant capacity than ECSI by 60% (p<0.05). In conclusion,
white blood cell counts and protein carbonyl concentration as well as muscle strength of the lower and
upper body are not different among elderly men with ″low‶ CSI and ″elevated‶ CSI. However, those
with low levels of CSI are characterized by a greater antioxidant capacity compared to their counterparts
with elevated CSI.
Keywords: chronic systemic inflammation, white blood cells, protein carbonyl, muscle strength.
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Εισαγωγή
Σε υγιή άτομα τρίτης ηλικίας συχνά παρατηρείται η ανάπτυξη χρόνιας συστημικής φλεγμονής
(ΧΣΦ), η οποία χαρακτηρίζεται από αυξημένα επίπεδα προ-φλεγμονώδη κυτταροκινών στην
κυκλοφορία κατά 2 έως 3 φορές σε σχέση με τις φυσιολογικές τους τιμές (Calcada et al., 2014). Η
εκδήλωση της ΧΣΦ αποδίδεται στη μακροχρόνια έκθεση του ανοσοποιητικού συστήματος σε αντιγόνα
και στρεσογόνους παράγοντες (χημικούς, φυσικούς ή/και διατροφικούς) που σε συνδυασμό με την
σημαντική αύξηση στο προσδόκιμο ζωής προάγουν την παρατεταμένη ενεργοποίηση του
ανοσοποιητικού (Claudio Franceschi, 2007; C. Franceschi et al., 2000). Το φαινόμενο αυτό στη διεθνή
βιβλιογραφία αναφέρεται ως ″inflammaging‶, βασισμένο στα δύο συνθετικά ″inflammation‶ (=
φλεγμονή) και ″aging‶ (= γήρανση) (C. Franceschi et al., 2000), ενώ για τη διάγνωσή του οι κύριες
μεταβλητές που αξιολογούνται είναι η συγκέντρωση των κυτταροκινών ιντερλευκίνη-6 (IL-6) και
ιντερλευκίνη-1 (IL-1), του παράγοντα νέκρωσης όγκων-α (TNF-α) καθώς και η συγκέντρωση της C-
αντιδρώσας πρωτεΐνης (CRP), στο πλάσμα (Calcada et al., 2014). Η ΧΣΦ αποτελεί μια απειλητική για
την υγεία κατάσταση καθώς η ύπαρξή της έχει συνδεθεί με την παθογένεση αρκετών χρόνιων ασθενειών
και γηριατρικών συνδρόμων όπως το μεταβολικό σύνδρομο, ο διαβήτης τύπου 2, η αθηροσκλήρωση, οι
καρδιαγγειακές και νευροεκφυλιστικές παθήσεις και η χρόνια αποφρακτική πνευμονοπάθεια (De
Martinis, Franceschi, Monti, & Ginaldi, 2005; C. Franceschi, Garagnani, Vitale, Capri, & Salvioli, 2016;
Singh & Newman, 2011).
Σύμφωνα με τη θεωρεία της ″μοριακής φλεγμονής‶ στη γήρανση, η οποία αναπτύχθηκε στις αρχές
της δεκαετίας του 2000 από τους Chung και συνεργάτες (Chung, Kim, Kim, & Yu, 2001), τα κύτταρα
του ανοσοποιητικού συνυπάρχουν σε έναν φαύλο κύκλο με δραστικά είδη οξυγόνου και αζώτου (ΔΕΟΑ)
κατά τον οποίο μια σημαντική αύξηση στα τελευταία πυροδοτεί την αυξημένη κινητοποίηση στα πρώτα
καταλήγοντας στην εμφάνιση της ΧΣΦ. Πιο συγκεκριμένα, η αυξημένη παραγωγή ΔΕΟΑ λόγω της
γήρανσης σε συνδυασμό με τη μειωμένη αντιοξειδωτική ικανότητα στα άτομα αυτά, προκαλεί
οξειδωτικό στρες και αυξημένο οξειδωτικό τραυματισμό σε μακρομόρια όπως το DNA, οι πρωτεΐνες
και τα λιπίδια (Kregel & Zhang, 2007; Meng & Yu, 2010). Αυτό έχει ως αποτέλεσμα τη διαταραχή της
οξειδοαναγωγικής ισορροπίας και την ενεργοποίηση του ρυθμιζόμενου από την οξειδοαναγωγική
κατάσταση μεταγραφικού παράγοντα NF-κB (nuclear factor kappa B) μέσω του οποίου διεγείρεται η
ενεργοποίηση προ-φλεγμονώδη μορίων της φλεγμονής, κυρίως των κυτταροκινών IL-6, IL-1, TNF-α
και της CRP (Li, Malhotra, & Kumar, 2008; Powers, Kavazis, & McClung, 2007). Καθώς η διαδικασία
της φλεγμονής εξελίσσεται, αυξάνεται η κινητοποίηση των μονοκυττάρων και μακροφάγων τα οποία με
τη σειρά τους εκκρίνουν περαιτέρω ΔΕΟΑ παρατείνοντας με αυτόν τον τρόπο τον φαύλο αυτό κύκλο
(Baylis, Bartlett, Patel, & Roberts, 2013). Ωστόσο, η συγκεκριμένη θεωρεία βασίζεται κυρίως σε
ερευνητικά δεδομένα προερχόμενα από μελέτες σε πειραματόζωα και κύτταρα, ενώ η διερεύνησή της
σε ηλικιωμένα άτομα είναι ελλιπής. Επίσης άγνωστο παραμένει εάν τα ηλικιωμένα άτομα με υψηλή
ΧΣΦ παρουσιάζουν διαφορετικά επίπεδα οξειδωτικού στρες, αντιοξειδωτικής ικανότητας και κυττάρων
του ανοσοποιητικού από τα αντίστοιχα άτομα με χαμηλή ΧΣΦ.
Επιπλέον, ερευνητικά δεδομένα υποδεικνύουν ότι ηλικιωμένα άτομα με υψηλή ΧΣΦ παρουσιάζουν
αυξημένο κίνδυνο για ταχύτερη απώλεια μυϊκής μάζας και δύναμης καθώς και για ανάπτυξη
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σαρκοπενίας (Draganidis et al., 2016; Schaap et al., 2009; Schaap, Pluijm, Deeg, & Visser, 2006; Visser
et al., 2002). Συγκεκριμένα, σε μελέτη στην οποία συμμετείχαν συνολικά 986 άνδρες και γυναίκες με
μέση ηλικία 74,6 έτη διαπιστώθηκε ότι όσοι χαρακτηρίζονταν από αυξημένα επίπεδα IL-6 και CRP
παρουσίασαν κατά 2 έως 3 φορές μεγαλύτερο κίνδυνο απώλειας > 40% της μυϊκής τους μάζας τρία
χρόνια αργότερα, συγκριτικά με εκείνους που χαρακτηρίζονταν από χαμηλές συγκεντρώσεις των
συγκεκριμένων κυτταροκινών (Schaap et al., 2006). Παρομοίως, σε δείγμα 2177 ηλικιωμένων ανδρών
και γυναικών (70-79 έτη) η υψηλότερη συγκέντρωση TNF-α στην αρχική μέτρηση συσχετίστηκε με
μεγαλύτερη απώλεια μυϊκής μάζας και δύναμης πέντε χρόνια αργότερα (Schaap et al., 2009). Παρ’ όλα
αυτά, η σύγκριση μεταξύ ηλικιωμένων ατόμων με χαμηλή ΧΣΦ και υψηλή ΧΣΦ σε λειτουργικά τεστ
δύναμης άνω και κάτω άκρων δεν έχει διερευνηθεί.
Συνεπώς, ο σκοπός της συγκεκριμένης μελέτης ήταν να συγκρίνει ηλικιωμένους άνδρες με χαμηλή
ΧΣΦ και υψηλή ΧΣΦ: i) στους δείκτες του ανοσοποιητικού συστήματος: α) λευκοκύτταρα, β)
κοκκιοκύτταρα, γ) μονοπύρηνα και δ) λεμφοκύτταρα, ii) στον δείκτη οξείδωσης των πρωτεϊνών:
πρωτεϊνικά καρβονύλια, iii) στην συνολική αντιοξειδωτική ικανότητα του ορού, καθώς και iv) στη
δύναμη άνω και κάτω άκρων μέσω αξιολόγησης της δύναμης χειρολαβής και της μέγιστης δύναμης στο
μηχάνημα εκτάσεις γονάτων, αντίστοιχα.
Μέθοδος και Διαδικασία
Συμμετέχοντες
Για την εύρεση εθελοντών στην ευρύτερη περιοχή της Θεσσαλίας μοιράστηκαν ενημερωτικά
φυλλάδια και πραγματοποιήθηκαν ενημερωτικές ομιλίες σε χώρους όπου συχνάζουν άτομα τρίτης
ηλικίας (π.χ. Κ.Α.Π.Η., κέντρα άθλησης και αναψυχής). Η αρχική προϋπόθεση ήταν οι εθελοντές να
είναι άνδρες ηλικίας 65-75 ετών. Περίπου 55-60 εθελοντές προσήλθαν στη Σ.Ε.Φ.Α.Α. του Π.Θ., στο
χώρο του SMART Lab, όπου συμπλήρωσαν έναν έντυπο ιατρικού ιστορικού και εξετάστηκαν επίσης
από ιατρό. Προκειμένου να συμπεριληφθούν στη μελέτη, οι εθελοντές έπρεπε να πληρούν τα παρακάτω
κριτήρια: α) να είναι μη καπνιστές, β) να είναι ανεξάρτητοι στην καθημερινότητά τους, γ) να μην
πάσχουν από οποιαδήποτε χρόνια πάθηση (π.χ. μεταβολική, καρδιαγγειακή, νευρολογική, αναπνευστική
ή νεφρική), δ) να μην πάσχουν από φλεγμονώδεις παθήσεις (π.χ. οστεοαρθρίτιδα, ρευματοειδής
αρθρίτιδα), ε) να μην πάσχουν από διαβήτη τύπου 2 και ζ) να μην χρησιμοποιούν ή έχουν
χρησιμοποιήσει πρόσφατα αντιβιοτικά ή άλλου είδους φαρμακευτικά σκευάσματα τα οποία θα
μπορούσαν να επηρεάσουν τα επίπεδα συστημικής φλεγμονής. Ακολούθως, 33 εθελοντές οι οποίοι
πληρούσαν τα παραπάνω κριτήρια συμπεριλήφθηκαν τελικά στη μελέτη και πραγματοποίησαν τρεις
ακόμη επισκέψεις. Στην πρώτη επίσκεψη, υποβλήθηκαν σε αξιολόγηση των σωματομετρικών τους
χαρακτηριστικών, της σύστασης σώματος και της δύναμης άνω και κάτω άκρων. Στις επόμενες δύο
διαδοχικές επισκέψεις (μια εβδομάδα μετά την πρώτη επίσκεψη), οι εθελοντές προσέρχονταν νωρίς το
πρωί, μετά από ολονύκτια νηστεία και υποβάλλονταν σε μια αιμοληψία (~8-10 ml) για τον προσδιορισμό
των δεικτών του ανοσοποιητικού, του οξειδωτικού στρες, της αντιοξειδωτικής ικανότητας και του
επιπέδου ΧΣΦ. Η ΧΣΦ αξιολογήθηκε με βάση τις τιμές της hs-CRP (high-sensitivity CRP), όπου ο
μέσος όρος των τιμών της hs-CRP από τις δυο μετρήσεις χρησιμοποιήθηκε ως η τελική τιμή για το κάθε
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άτομο, και η κατηγοριοποίηση των εθελοντών σε ″χαμηλή" ΧΣΦ  και ″υψηλή" ΧΣΦ έγινε ως εξής:
″χαμηλή" ΧΣΦ = hs-CRP < 1 mg/L και ″υψηλή‶ ΧΣΦ = hs-CRP > 1 mg/L, σύμφωνα με προηγούμενη
μελέτη (Draganidis et al., 2018). Οι εθελοντές ενημερώθηκαν πλήρως για τον σκοπό της συγκεκριμένης
μελέτης αλλά και για τα πιθανά οφέλη από τη συμμετοχής τους και στη συνέχεια υπέγραψαν έντυπο
συναίνεσης. Η μελέτη έλαβε έγκριση από την Εσωτερική Επιτροπή Δεοντολογίας του Πανεπιστημίου
Θεσσαλίας.
Διαδικασία μέτρησης
Σωματομετρικά χαρακτηριστικά και σύσταση σώματος: To σωματικό βάρος και ύψος των συμμετεχόντων
μετρήθηκε με ακρίβεια μισού κιλού (0,5 kg) και μισού εκατοστού (0,5 cm) αντίστοιχα, σε μηχανικό ζυγό
με αναστημόμετρο (Beam Balance-Stadiometer, SECA, Vogel & Halke, Hamburg, Germany). Οι
εξεταζόμενοι φορώντας ελαφρύ ρουχισμό και χωρίς παπούτσια πραγματοποίησαν την μέτρηση από
όρθια θέση στο κέντρο του ζυγού, έχοντας τις φτέρνες ενωμένες και τα πέλματα να σχηματίζουν γωνία
περίπου 60ο, σύμφωνα με προηγούμενη μελέτη (Fatouros et al., 2010). Η σύσταση σώματος
αξιολογήθηκε σε μηχάνημα διπλής ενεργειακής απορρόφησης ακτινών Χ (DXA, GE Healthcare, Lunar
DPX NT, Diegem, Belgium), με τον εξεταζόμενο σε ξαπλωτή θέση, όπως έχει περιγραφεί σε
προηγούμενη μελέτη (Draganidis et al., 2017).
Δύναμη άνω και κάτω άκρων: Για την αξιολόγηση της δύναμης άνω άκρων μετρήθηκε η μέγιστη δύναμη
χειρολαβής με τη χρήση φορητού υδραυλικού χειροδυναμόμετρου Jamar (Jamar 5030J1, Jamar
Technologies, Horsham, Pennsylvania, USA). Οι δοκιμαζόμενοι εκτέλεσαν την μέτρηση από καθιστή
θέση, με τον αγκώνα να σχηματίζει γωνία 90ο και τον καρπό σε ουδέτερη θέση κρατώντας το
δυναμόμετρο στη θέση 2 (Roberts et al., 2011). Από αυτή τη θέση πραγματοποιήθηκαν 3 προσπάθειες
σε κάθε χέρι με διάλειμμα 60 δευτερολέπτων, όπου στην κάθε προσπάθεια εκτελέστηκε μέγιστη
ισομετρική σύσπαση για 5 δευτερόλεπτα. Ως τελική επίδοση καταγράφηκε η μεγαλύτερη τιμή σε
χιλιόγραμμα (kg). Η αξιολόγηση της δύναμης των κάτω άκρων εκτιμήθηκε μέσω της εκτέλεσης 10
μέγιστων επαναλήψεων (10 ΜΕ) στο μηχάνημα έκτασης γονάτων. Οι εξεταζόμενοι, μετά από
κατάλληλη προθέρμανση εκτελούσαν το πρώτο σετ και σε περίπτωση που ήταν σε θέση να εκτελέσουν
περισσότερες από 10 επαναλήψεις, ο εξεταστής τους σταματούσε και τους έδινε διάλειμμα 2 λεπτών.
Έπειτα αυξάνονταν τα κιλά και επιχειρούσαν δεύτερη προσπάθεια. Αν και πάλι ήταν σε θέση να
εκτελέσουν περισσότερες από 10 επαναλήψεις, ο εξεταστής επαναλάμβανε την ίδια διαδικασία. Η
διαδικασία αυτή συνεχιζόταν μέχρι οι εξεταζόμενοι να εκτελέσουν 10 μέγιστες επαναλήψεις (περίπου
3-4 σετ).
Αιμοληψίες και διαχείριση των δειγμάτων: Σε κάθε αιμοληψία λαμβάνονταν 8-10 ml αρτηριοφλεβικού
αίματος από τη μεσοβασιλική φλέβα και ενώ ο εξεταζόμενος βρισκόταν σε καθιστή θέση. Περίπου 2 ml
διοχετεύονταν σε σωλήνα με αντιπηκτικό (EDTA) και στη συνέχεια τοποθετούνταν στον αυτόματο
αναλυτή αίματος (Mythic 18, Orphee SA, Geneva, Switzerland) για να πραγματοποιηθεί η γενική
ανάλυση αίματος. Τα υπόλοιπα 6-8 ml μοιράζονταν σε δυο σωληνάρια με κενό αέρος, τα οποία
παρέμεναν για 20 λεπτά σε θερμοκρασία δωματίου και στη συνέχεια φυγοκεντρούνταν στις 3500
στροφές για 10 λεπτά στους 4οC. Αμέσως μετά τη φυγοκέντρηση το υπερκείμενο υγρό (ορός)
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συλλέγονταν και μοιραζόταν σε σωληνάκια eppendorf και στη συνέχεια αποθηκεύονταν στους -80οC,
για την ανάλυση των πρωτεϊνικών καρβονυλίων, της συνολικής αντιοξειδωτικής ικανότητας και της hs-
CRP.
Πρωτεϊνικά καρβονύλια: Για τη μέτρηση των πρωτεϊνικών καρβονυλίων πραγματοποιήθηκε η βιοχημική
αντίδραση του κάθε δείγματος με 2,4- dinitrophenylhydrazine (DNPH) που επέφερε τη μετατροπή του
σε 2,4-dinitrophenylhydrazone (DNP-hydrazone). Ο προσδιορισμός της συγκέντρωσης του 2,4- DNP-
hydrazone, πραγματοποιήθηκε με τη μέτρηση της απορρόφησης του κάθε δείγματος στο φωτόμετρο,
στα 375 nm. Η τελική συγκέντρωση των πρωτεϊνικών καρβονυλίων υπολογιζόταν σύμφωνα με την
εξίσωση: PC (nmol/mL) = (Absδείγμα – Αbsτυφλό) / 0,022 × 1000/50 (Mohr et al., 2016).
Συνολική αντιοξειδωτική ικανότητα: Η συνολική αντιοξειδωτική ικανότητα του ορού αξιολογήθηκε
μέσω της βιοχημικής αντίδρασης των αντιοξειδωτικών συστατικών του ορού με τη ρίζα 1,1-diphenyl-2-
picrylhydrazyl (DPPH), κατά την οποία τα αντιοξειδωτικά δρουν ως δότες υδρογόνου προκαλώντας την
αναγωγή της συγκεκριμένης ρίζας, μειώνοντας με αυτό τον τρόπο τη συγκέντρωσή της. Η τελική
συγκέντρωση της ρίζας DPPH υπολογίστηκε μετρώντας την απορρόφηση του δείγματος στα 520 nm.
Τα αποτελέσματα εκφράστηκαν ως μmol DPPH που καθαρίστηκαν ανά ml ορού, χρησιμοποιώντας την
εξίσωση: [(%Αbs μείωσης / 100) x 50 x 50] / 100 (Mohr et al., 2016).
hs-CRP: Πραγματοποιήθηκε ποσοτική ανάλυση της hs-CRP στον ορό, με τη μέθοδο της θολοσιμετρικής
ανάλυσης ενισχυμένης με τη χρήση σωματιδίων λάτεξ (CRP LX High Sensitive, Cobas®), σε αναλυτή
Cobas Integra 400 plus (Roche). Το κατώτατο όριο ανίχνευσης της ανάλυσης ήταν 0,1 mg/L και ο
συντελεστής διακύμανσης μεταξύ των αναλύσεων ήταν μία τυπική απόκλιση (1 SD) (Draganidis et al.,
2018).
Στατιστική Ανάλυση
O έλεγχος της κανονικότητας των δεδομένων πραγματοποιήθηκε με βάση το Shapiro-Wilk τεστ. Για
τη διερεύνηση των διαφορών μεταξύ των δυο ομάδων (χαμηλή ΧΣΦ και υψηλή ΧΣΦ) στις εξαρτημένες
μεταβλητές χρησιμοποιήθηκε το T-Test για ανεξάρτητα δείγματα. Το μέγεθος της επίδρασης (ΜτΕ)
καθώς και τα διαστήματα εμπιστοσύνης (ΔΕ) για τις εξαρτημένες μεταβλητές υπολογίστηκαν με τη
μέθοδο του Hedge’s g. Το ΜτΕ χαρακτηρίστηκε ως κανένα, μικρό, μεσαίου μεγέθους και μεγάλο για
τιμές 0.00-0.19, 0.20-0.49, 0.50-0.79 και ≥ 0.8, αντίστοιχα. Το επίπεδο σημαντικότητας ορίστηκε στο
p<0.05. Όλα τα δεδομένα παρουσιάζονται ως μέσος όρος ± τυπική απόκλιση. Για τις στατιστικές
αναλύσεις χρησιμοποιήθηκε το στατιστικό πακέτο SPSS 20.0 (IBM SPSS Statistics).
Αποτελέσματα
Τα περιγραφικά χαρακτηριστικά των δύο ομάδων παρουσιάζονται στον Πίνακα 1. Οι δύο ομάδες δεν
διέφεραν μεταξύ τους στα σωματομετρικά χαρακτηριστικά και σε παραμέτρους της σύστασης σώματος.
Ωστόσο, σημαντική ήταν η διαφορά τους στα επίπεδα ΧΣΦ με την ομάδα υψηλής ΧΣΦ να παρουσιάζει
σχεδόν κατά 3 φορές υψηλότερες τιμές hs-CRP συγκριτικά με την ομάδα χαμηλής ΧΣΦ (χαμηλή ΧΣΦ:
0.6±0.1 / υψηλή ΧΣΦ: 2.3±0.8, p=0.00, ΜτΕ=2.86, ΔΕ=-3.84, -1.89).
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Τα αποτελέσματα έδειξαν ότι στην αξιολόγηση της δύναμης, τόσο στη μέγιστη δύναμη χειρολαβής
(t(30)=1.139, p>0.05) όσο και στις 10 ΜΕ κάτω άκρων στο μηχάνημα έκτασης γονάτων (t(30)=-0.526,
p>0.05), δεν υπήρξαν στατιστικά σημαντικές διαφορές μεταξύ των δυο ομάδων (Σχήμα 1).
Δύναμη Κάτω Άκρων


























Σχήμα 1. 10ΜΕ κάτω άκρων στο μηχάνημα εκτάσεις γονάτων (1Α) και μέγιστη δύναμη χειρολαβής
(1Β) στις δυο ομάδες.
Πίνακας 1. Περιγραφικά χαρακτηριστικά των δύο ομάδων.
Παράμετρος Χαμηλή ΧΣΦ (N=16) Υψηλή ΧΣΦ (N=17)
Ηλικία (έτη) 69.1 ± 2.8 68.8 ± 2.9
Σωματικό ύψος (μ) 1.70 ± 0.07 1.72 ± 0.05
Σωματικό βάρος (κιλά) 81.4 ± 7.6 84.7 ± 5.5
ΔΜΣ (κιλά/μ2) 26.92 ± 2.77 27.86 ± 2.51
Λιπώδης μάζα (κιλά) 23.20 ± 6.26 25.54 ± 3.14
Λίπος (%) 29.41 ± 4.14 31.25 ± 1.72
Άλιπη μάζα (κιλά) 56.89 ± 4.26 57.70 ± 4.35
Μυϊκή μάζα (κιλά) 53.86 ± 4.13 55.12 ± 5.11
Μυϊκή μάζα άκρων (κιλά) 23.32 ± 2.43 24.15 ± 1.83
Δείκτης μυϊκής μάζας (κιλά/μ2) 8.03 ± 0.78 8.11 ± 0.64
hs-CRP (mg/L) 0.6 ± 0.1 2.3 ± 0.8*
* : Υποδηλώνει σημαντική διαφορά μεταξύ των ομάδων, p < 0.01.
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Επίσης από τη σύγκριση των ομάδων χαμηλή ΧΣΦ και υψηλή ΧΣΦ ως προς του δείκτες του
ανοσοποιητικού συστήματος διαπιστώθηκε ότι δεν υπήρχε στατιστικά σημαντική διαφορά μεταξύ τους
στα επίπεδα λευκοκυττάρων (t(30)=-1.088, p>0.05), κοκκιοκυττάρων (t(30)=-0.963, p>0.05),
μονοπύρηνων (t(30)=-0.916, p>0.05) και λεμφοκυττάρων (t(30)=-0.433, p>0.05) (Σχήμα 2).
Λευκοκύτταρα (WBC)









































Σχήμα 2. Συστημικά επίπεδα Λευκοκυττάρων (2Α), Κοκκιοκυττάρων (2Β), Λεμφοκυττάρων (2Γ) και
Μονοπύρηνων (2Δ) στις δύο ομάδες.
Από τη σύγκριση των δύο ομάδων σε δείκτες οξειδωτικό στρες και αντιοξειδωτικής ικανότητας,
προέκυψε ότι η συγκέντρωση πρωτεϊνικών καρβονυλίων δεν διέφερε μεταξύ των ομάδων (t(28)=0.334,
p>0.05), ωστόσο, οι δυο ομάδες παρουσίασαν σημαντική διαφορά στη συνολική αντιοξειδωτική
ικανότητα του ορού, με την ομάδα χαμηλή ΧΣΦ να παρουσιάζει υψηλότερη αντιοξειδωτική ικανότητα
από τη ομάδα υψηλή ΧΣΦ (t(28)=-2.275, p=0.03, ΜτΕ=0.96, ΔΕ=0.24, 1.69) (Σχήμα 3).
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Πρωτεϊνικά  Καρβονύλια































Σχήμα 3. Συγκέντρωση πρωτεϊνικών καρβονυλίων (3Α) και συνολική αντιοξειδωτική ικανότητα  (3Β)
στις δυο ομάδες.
Συζήτηση
Στη συγκεκριμένη μελέτη εξετάστηκε η ύπαρξη διαφορών μεταξύ ηλικιωμένων ανδρών με χαμηλή
και υψηλή ΧΣΦ, σε δείκτες του ανοσοποιητικού συστήματος, οξειδωτικού στρες, αντιοξειδωτικής
ικανότητας και της δύναμης των άνω και κάτω άκρων. Για το σκοπό αυτό πραγματοποιήθηκε βιοχημική
αξιολόγηση για τον προσδιορισμό της συγκέντρωσης των λευκοκυττάρων, των κοκκιοκυττάρων, των
μονοπύρηνων και των λεμφοκυττάρων στην κυκλοφορία καθώς και της συγκέντρωσης πρωτεϊνικών
καρβονυλίων και της συνολικής αντιοξειδωτικής ικανότητας στον ορό. Όσον αφορά τη δύναμη,
αξιολογήθηκε η μέγιστη δύναμη χειρολαβής και οι 10ΜΕ στα κάτω άκρα στο μηχάνημα έκτασης
γονάτων. Τα αποτελέσματα της μελέτης υποδεικνύουν ότι ηλικιωμένα άτομα με χαμηλή ΧΣΦ και υψηλή
ΧΣΦ παρουσιάζουν παρόμοια συγκέντρωση λευκοκυττάρων, οξειδωτικού στρες και δύναμης, ωστόσο
εκείνοι με χαμηλή ΧΣΦ χαρακτηρίζονται από υψηλότερη αντιοξειδωτική ικανότητα.
Οι συμμετέχοντες στη παρούσα μελέτη διαχωρίστηκαν στις δυο ομάδες, χαμηλή ΧΣΦ και υψηλή
ΧΣΦ, σύμφωνα με τα επίπεδα της hs-CRP στον ορό. Ο συγκεκριμένος δείκτης συστημικής φλεγμονής
θεωρείται ένας έγκυρος και αξιόπιστος δείκτης ΧΣΦ (Morrisette-Thomas et al., 2014) και έχει
χρησιμοποιηθεί σε αρκετές μελέτες προκειμένου να κατηγοριοποιήσει ηλικιωμένα άτομα με βάση τα
επίπεδα φλεγμονής (Draganidis et al., 2018; Labonte et al., 2014). Οι δυο ομάδες παρουσίασαν παρόμοια
σωματομετρικά χαρακτηριστικά και σύσταση σώματος, γεγονός που υποδηλώνει ότι το δείγμα ήταν
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αρκετά ομοιογενές και διέφερε μόνο ως προς τα επίπεδα ΧΣΦ. Επιπλέον, σύμφωνα με τα κριτήρια του
Παγκόσμιου Οργανισμού Υγείας (WHO) για την παχυσαρκία και με βάση τις τιμές του ΔΜΣ των
συμμετεχόντων, τα άτομα των δυο ομάδων κατατάσσονται ως μη-παχύσαρκα, κάτι που είναι σημαντικό
για την ερμηνεία των αποτελεσμάτων της συγκεκριμένης μελέτης. Η ύπαρξη παχυσαρκίας έχει συνδεθεί
με την ανάπτυξη ΧΣΦ, η οποία όμως οφείλεται κατά κύριο λόγο στο λιπώδη ιστό (μεταβολική
φλεγμονή) (Cevenini, Monti, & Franceschi, 2013; C. Franceschi et al., 2016), , και όχι αποκλειστικά στη
γήρανση που είναι και ο σκοπός της παρούσας μελέτης.
Μέχρι σήμερα, η αξιολόγηση της ύπαρξης ΧΣΦ αλλά και η σύγκριση των επιπέδων της μεταξύ
ηλικιωμένων ατόμων βασίζεται κατά κύριο λόγο στη μέτρηση των κυτταροκινών IL-1, IL-6, TNF-α και
της C-αντιδρώσας πρωτεΐνης (Draganidis et al., 2018; Labonte et al., 2014; Schaap et al., 2009; Schaap
et al., 2006; Visser et al., 2002). Δεν υπάρχουν μελέτες που να εξετάζουν εάν η αύξηση στα επίπεδα των
κυτταροκινών συνοδεύεται από αυξημένη συγκέντρωση λευκοκυττάρων και των υποπληθυσμών τους
σε ηλικιωμένα άτομα με ΧΣΦ. Η κινητοποίηση των λευκοκυττάρων σε συνθήκες οξείας φλεγμονής,
όπως η άσηπτη φλεγμονή που προκαλείται από την άσκηση, είναι άμεση και η συγκέντρωσή τους στην
κυκλοφορία παραμένει αυξημένη για 24-48 ώρες (Sakelliou et al., 2016). Τα κοκκιοκύτταρα, τα οποία
αποτελούνται από ουδετερόφιλα, βασεόφιλα και ηωσινόφιλα, αυξάνονται επίσης αμέσως μετά από
άσκηση λόγω της ύπαρξης άσηπτης φλεγμονής και παραμένουν αυξημένα έως και 48 ώρες μετά (Poulios
et al., 2018). Ωστόσο, στην παρούσα μελέτη δεν παρατηρήθηκαν διαφορές στα λευκοκύτταρα και τους
υποπληθυσμούς τους μεταξύ των ομάδων χαμηλή ΧΣΦ και υψηλή ΧΣΦ, υποδεικνύοντας ότι τα
συγκεκριμένα κύτταρα του ανοσοποιητικού παρουσιάζουν διαφορετικό μοτίβο ενεργοποίησης σε
συνθήκες οξείας φλεγμονής και ΧΣΦ.
Η εκδήλωση ΧΣΦ σε άτομα τρίτης ηλικίας έχει αποδοθεί στη μειωμένη αντιοξειδωτική ικανότητα
και στην αυξημένη παραγωγή ΔΕΟΑ που έχουν ως αποτέλεσμα την πρόκληση οξειδωτικού στρες και
οξειδωτικού τραυματισμού σε πρωτεΐνες, λιπίδια και DNA (Kregel & Zhang, 2007; Meng & Yu, 2010).
Η παρατεταμένη αύξηση στα επίπεδα οξειδωτικού στρες οδηγεί σε διαταραχή της οξειδοαναγωγικής
ισορροπίας και την επακόλουθη ενεργοποίηση του μεταγραφικού παράγοντα NF-κB ο οποίος με τη
σειρά του διεγείρει την ενεργοποίηση προ-φλεγμονώδη κυτταροκινών και της CRP (Li et al., 2008;
Powers et al., 2007). Με αυτό τον τρόπο εξελίσσεται η διαδικασία της φλεγμονής, κατά την οποία τα
μονοκύτταρα και μακροφάγα εκκρίνουν περαιτέρω ΔΕΟΑ δημιουργώντας έτσι έναν φαύλο κύκλο που
έχει ως αποτέλεσμα την μακροχρόνια εκδήλωση φλεγμονής (Baylis et al., 2013; Chung et al., 2001). Στη
συγκεκριμένη μελέτη η συγκέντρωση πρωτεϊνικών καρβονυλίων, που αποτελεί δείκτη οξείδωσης των
πρωτεϊνών, ήταν παρόμοια στα άτομα με χαμηλή ΧΣΦ και υψηλή ΧΣΦ. Ωστόσο, οι δυο ομάδες
διέφεραν σημαντικά μεταξύ τους όσον αφορά τη συνολική αντιοξειδωτική ικανότητα, με την ομάδα
χαμηλής ΧΣΦ να παρουσιάζει κατά 60% μεγαλύτερη αντιοξειδωτική ικανότητα συγκριτικά με την
ομάδα υψηλής ΧΣΦ. Το συγκεκριμένο εύρημα είναι σε συμφωνία με πρόσφατη μελέτη η οποία έδειξε
ότι τα ηλικιωμένα άτομα με χαμηλή ΧΣΦ προσλαμβάνουν μεγαλύτερες ποσότητες αντιοξειδωτικών
βιταμινών μέσω της τροφής και είναι περισσότερο δραστήρια κατά τη διάρκεια της ημέρας, συγκριτικά
με άτομα ίδιας ηλικίας με υψηλή ΧΣΦ (Draganidis et al., 2018). Επομένως, τα παραπάνω ευρήματα
αποδεικνύουν πως η διατήρηση της αντιοξειδωτικής ικανότητας, μέσω επαρκούς πρόσληψης
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διαιτητικών αντιοξειδωτικών και φυσικής δραστηριότητας, μπορεί να προλάβει την εκδήλωση ΧΣΦ στα
άτομα τρίτης ηλικίας.
Προηγούμενες μελέτες έχουν συσχετίσει τα επίπεδα συστημικής φλεγμονής σε ηλικιωμένα άτομα με
την απώλεια μυϊκής δύναμης (Schaap et al., 2009; Schaap et al., 2006; Visser et al., 2002). Πιο
συγκεκριμένα, άτομα με αυξημένα επίπεδα CRP ή/και προφλεγμονώδη κυτταροκινών όπως η IL-6 και
ο TNF-α, παρουσίασαν κατά 2 έως 3 φορές μεγαλύτερη απώλεια δύναμης στα επόμενα 2-5 χρόνια, τόσο
στη μέγιστη δύναμη χειρολαβής (Schaap et al., 2006) όσο και στη δύναμη κάτω άκρων (Schaap et al.,
2009; Visser et al., 2002). Στην παρούσα μελέτη ωστόσο, συγκρίνοντας τη μέγιστη δύναμη χειρολαβής
και τις 10ΜΕ κάτω άκρων μεταξύ των ομάδων χαμηλή ΧΣΦ και υψηλή ΧΣΦ, δεν εντοπίστηκαν
στατιστικά σημαντικές διαφορές. Η απώλεια μυϊκής δύναμης ως αποτέλεσμα της ΧΣΦ φαίνεται πως
επέρχεται μέσω της προκαλούμενης από τη ΧΣΦ απώλεια μυϊκής μάζας (Draganidis et al., 2016; Visser
et al., 2002). Σύμφωνα με πρόσφατη ανασκοπική μελέτη, η ΧΣΦ μπορεί να οδηγήσει σε απώλεια μυϊκής
μάζας και λειτουργικής ικανότητας, είτε μέσω αύξησης της πρωτεόλυσης ενεργοποιώντας το σύμπλοκο
του πρωτεασώματος, είτε μέσω μείωσης της δυνατότητας ενεργοποίησης των σηματοδοτικών
πρωτεϊνών που επάγουν την πρωτεϊνοσύνθεση στο μυ (Draganidis et al., 2016). Επομένως, το γεγονός
ότι οι δυο ομάδες στη παρούσα μελέτη δεν διέφεραν ως προς τα επίπεδα δύναμης άνω και κάτω άκρων,
μπορεί να αποδοθεί στο ότι δεν εντοπίστηκαν μεταξύ τους διαφορές στη μυϊκή μάζα.
Συμπερασματικά, τα ευρήματα της παρούσας μελέτης υποδεικνύουν ότι ηλικιωμένα άτομα με
χαμηλή ΧΣΦ και υψηλή ΧΣΦ δεν διαφέρουν μεταξύ τους ως προς τα συστημικά επίπεδα λευκοκυττάρων
και οξείδωσης των πρωτεϊνών, ωστόσο οι συμμετέχοντες με χαμηλή ΧΣΦ παρουσιάζουν μεγαλύτερη
αντιοξειδωτική ικανότητα από εκείνους με υψηλή ΧΣΦ. Η συγκέντρωση των λευκοκυττάρων και των
υποπληθυσμών τους στην κυκλοφορία φαίνεται ότι δεν επηρεάζεται από την ανάπτυξη ΧΣΦ. Αντίθετα,
η καλύτερη αντιοξειδωτική ικανότητα εμφανίζεται ως αποτρεπτικός παράγοντας για την εκδήλωση
ΧΣΦ. Επιπλέον, άτομα με χαμηλή και υψηλή ΧΣΦ δεν παρουσιάζουν διαφορές στη δύναμη άνω και
κάτω άκρων εφόσον παρουσιάζουν παρόμοια επίπεδα μυϊκής μάζας.
Σημασία για την Ποιότητα Ζωής
Η εκδήλωση χρόνιας συστημικής φλεγμονής στα άτομα τρίτης ηλικίας είναι μια απειλητική για την υγεία
κατάσταση καθότι συνδέεται άμεσα με την παθογένεση αρκετών χρόνιων ασθενειών και γηριατρικών
συνδρόμων, αλλά και με την απώλεια μυϊκής μάζας και λειτουργικής ικανότητας. Όλα αυτά
συνεπάγονται την επιδείνωση της ποιότητας ζωής αυτών των ατόμων έχοντας παράλληλα σοβαρό
αντίκτυπο στην οικονομική τους κατάσταση καθότι αυξάνονται σημαντικά τα έξοδα νοσηλείας. Η
διατήρηση της αντιοξειδωτικής ικανότητας με την αύξηση της ηλικίας είναι ένας σημαντικός
παράγοντας που μπορεί να προλάβει την εκδήλωση χρόνιας συστημικής φλεγμονής και επιτυγχάνεται
μέσω επαρκούς πρόσληψης διαιτητικών αντιοξειδωτικών και φυσικής δραστηριότητας.
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Αγαπητέ κ. Δραγανίδη,
Η εργασία σας με τίτλο «Σύγκριση ηλικιωμένων ανδρών με χαμηλή και υψηλή
χρόνια συστημική φλεγμονή σε δείκτες δύναμης, οξειδωτικού στρες και
φλεγμονής» η οποία έχει κατατεθεί για δημοσίευση στο περιοδικό «ΑΝΑΖΗΤΗΣΕΙΣ
ΣΤΗ ΦΥΣΙΚΗ ΑΓΩΓΗ & ΤΟΝ ΑΘΛΗΤΙΣΜΟ» έχει ελεγχθεί από δύο κριτές, τα σχόλια
των οποίων ακολουθούν, και από εμένα. Όλοι πιστεύουμε ότι η εργασία περιέχει
ενδιαφέροντα στοιχεία τα οποία συνδέονται με το τους στόχους του περιοδικού. H
εργασία σας γίνεται δεκτή προς δημοσίευση. Παρακαλώ δώστε βάση στην
παρατήρηση του κριτή 1, που αναφέρει ότι στην εργασία χρειάζονται να γίνουν
ορισμένες γραμματικές και συντακτικές διορθώσεις, και στη συνέχεια καταθέστε
την εργασία στην τελική της μορφή. Ελπίζω τα σχόλια των κριτών να ήταν
εποικοδομητικά για τη δόμηση της εργασίας. Σας ευχαριστώ για την τιμή που
κάνατε να επιλέξετε τις «ΑΝΑΖΗΤΗΣΕΙΣ ΣΤΗ ΦΥΣΙΚΗ ΑΓΩΓΗ & ΤΟΝ ΑΘΛΗΤΙΣΜΟ»
να δημοσιεύσετε την εργασία σας.
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